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Abstract 
This thesis describes the optimisation and implementation of a conditional transgene 
expression system in mouse embryonic stem (ES) cells for the investigation of signalling 
pathways controlling in-vitro differentiation. This system, the tetracycline-induced 
conditional gene expression system (tet-system) allows exquisite control over transgene 
expression in vitro and in vivo. The system itself is comprised of two components, a 
transactivator gene, and a transactivator-response element (TRE) which is linked to the 
transgene to be regulated. The transactivator gene encodes a fusion protein consisting of 
a modified tetracycline repressor and transcriptional activation domain moieties, and is 
constitutively expressed. In the presence of doxycyline (dox) the transactivator protein 
binds to the TRE sequence, which itself consists of an array of operator sequences from 
the tetracycline operon linked to a minimal promoter region. Transcription of the 
transgene consequently ensues. This version of the tet-system is referred to as the tet-on 
system. 
In order to establish high and homogenous expression of inducible transgenes in ES cells 
using the tet-on system, the utilisation of different promoters to direct expression of the 
transactivator component (rtTA2sM2)  was investigated, as was the use of different loci 
at which to target the system components. 
It was found that the promoter sequence CAG (which contains a CMV enhancer, a 
actin promoter and a 3-globin intron), when linked to the transactivator rtTA2sM2 
sequence and targeted to the 5' region of the housekeeping gene hypoxanthine 
ribosyitransft'rase (hprt) gave rise to homogenous expression of the transactivator. 
However upon targeting the 3' region of hprt with the TRE and a linked DsRED2 
reporter transgene, addition of dox resulted in heterogenous expression of the transgene. 
In an alternative strategy, cells expressing the rtTA2sM2  transactivator from the 
endogenous ROSA26 promoter (R26rtTA2sM21F  cells), were targeted to integrate the 
TRE and linked DsRED2 reporter to the 5' region of hprt. In cell lines harbouring both 
components of the tet-system, addition of dox resulted in high and homogenous 
expression of the DsRED2 transgene. This latter strategy of targeting components to 
independent loci was therefore superior in terms of inducible transgene expression, and 
was subsequently used to establish the inducible expression of an activated form of the 
MAPK pathway component MEKI (MEK act). Cell lines overexpressing MEK at were 
thereby analysed for activation of the MAPK pathway in the absence of growth factor 
and cytokine stimulation, with the view to analysing the involvement of the MAPK 
pathway in the in vitro differentiation of ES cells into neural progenitor cells. However, 
analysis of ES cell lines overexpressing MEK act revealed that the levels of expression 
achieved were not sufficient to activate the pathway above basal levels - as determined 
by analysis of levels of phosphorylated (and therefore activated) ERK1/2, the only known 
substrate of MEKI/2. 
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The application of reverse genetics in the study of gene function has greatly improved the 
understanding of many areas of biology, and the genetic engineering technologies that 
can be used in this approach are growing evermore sophisticated. The purpose of this 
introduction is to present the reader with an understanding of the strategies available for 
manipulating gene function in mammals both in vitro and in vivo, starting with a review 
of the basic types of genetic modification, and then leading to a description of more 
recently developed approaches, with particular focus on methods for induced conditional 
gene expression. 
1.1 	Genetic engineering in vitro 
The cellular genome can be genetically manipulated in a wide variety of ways, ranging 
from the relatively simple scenario of constitutively overexpressing a transgene, to the 
sophisticated implementation of a conditional gene expression system (the description of 
which will be described later on). Such manipulations usually involve the transfection of 
foreign sequences into cells followed by selection for cells harbouring stable integration 
of the exogenous sequences into the genome. This selection is usually made possible 
either by the incorporation of an antibiotic resistance selection marker into the sequences 
to be inserted or by co-transfection of a separate antibiotic resistance gene encoding 
plasmid. Those cells resistant to the applied antibiotic will have incorporated the 
exogenous sequences and these can be further expanded in appropriate selective media. 
An exception to this is the use of retroviral vectors in the delivery of foreign sequences 
into genomic DNA. This form of sequence delivery can be very efficient and therefore in 
some instances there is no need to select for integration. 
The constitutive overexpression of a complementary DNA (cDNA) sequence is often 
achieved by the transfection of DNA encoding a promoter and downstream transgene, 
into cells (along with a selectable marker as mentioned previously), followed by suitable 
selection. This will result in the isolation of a number of clones all harbouring insertions 
at different locations within the genome and therefore this process is referred to as 
'random' integration. As there is no control over the site of sequence insertion, random 
integration carries with it the risk of insertional mutagenesis, due to the possibility of 
insertion into, or in close proximity to endogenous genes, leading to abrogation of, or 
misregulation of gene expression. In addition, independent clones harbouring the same 
exogenous sequences are likely to express different levels of the transgene as the foreign 
sequences will be subject to different position effects due to their random integration 
throughout the genome. This calls for the screening of large numbers of clones in the 
search for those that express the cDNA appropriately. Multiple copy number at the site 
of insertion also frequently occurs. 
These potential problems can be overcome by the 'targeted' insertion of transgenic 
sequences to a predetermined locus which is known to be optimal for transgene 
expression. This form of insertion usually results in the integration of just one copy of 
exogenous sequence into the genome. For targeted insertion to a predetermined locus, 
foreign sequences are inserted into a vector that encodes homology to that locus. Upon 
transfection of the targeting vector, in a small proportion of cells, crossing-over events 
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occur between regions of homology encoded within the endogenous locus and within the 
vector sequences (Figure 1.l a). Those cells harbouring integrated foreign sequences can 
subsequently be isolated in appropriate selection media and clones in which correct 
targeting of the locus has occurred can be identified by analysis of their genomic DNA. 
Homologous recombination can be used to target a cDNA to a locus known to be 
permissive for transgene expression (Figure 1.1 a). The resulting clones should all 
express similar levels of transgene as they are genetically identical, and this therefore 
obviates the need to screen large numbers of targeted clones for appropriate expression of 
the transgene. 
In some cases the disruption of an endogenous gene is desired, for example in the 
creation of a null allele. Gene targeting technology makes this possible as targeting 
vectors can be designed to 'knock-out' endogenous exons (Figure 1.1 b). A second round 
of targeting to the remaining wild-type allele results in the establishment of cell-lines 
homozygous for the mutation in the gene of interest. This enables investigation into the 
function of this gene by the direct comparison of these modified cells to cells possessing 
wild type alleles. Homologous recombination can also be used to add sequences to 
endogenous genes, resulting in the 'tagging' of endogenous protein with antigenic 
epitopes or fluorescent moieties which may aid in the detection of that protein (Figure 
l.lc). The targeting vector has to be carefully designed to insert the exogenous sequence 
in frame with the endogenous gene at the desired locus (the exogenous sequence is 
usually inserted at the beginning or the end of the ORF). Transcription and subsequent 
translation of this unit therefore results in the production of a fusion protein, with one 
moiety comprising the cellular protein and the other, the foreign protein. In an alternative 
scenario gene targeting can be used to insert transgenes downstream of endogenous 
regulatory sequences so that the expression of the foreign sequences mimics that of the 
endogenous gene (Figure 1.1 .d). This strategy is often used to spatially restrict transgene 
expression in vivo (see below). 
Figure 1.1 The targeting of endogenous loci. a) The hypothetical targeting of a transgene 
to an endogenous locus that is known to be permissive for transgene expression. The 
targeting vector encodes the transgene sequence with linked promoter and polyA 
sequence and also a neomycin resistance gene (depicted as neo) and a herpesvirus 
thymidine kinase gene (depicted as tk). Promoter and polyA sequences are not shown for 
either of the two selection genes. The endogenous locus incorporates the exogenous 
sequences after two cross-over events occur between homologous regions of the locus 
and targeting vector. This event can be selected for using positive G418 selection. 
Illegitimate recombination can be selected against by using negative ganciclovir selection 
(in a correct targeting event the tk gene is not incorporated). b) Creation of a knock-out 
or null allele by the removal of a coding region after homologous recombination between 
the targeting vector and endogenous locus. Correctly targeted clones can be selected for 
using positive G418 selection and negative ganciclovir selection. c) 'Tagging' of an 
endogenous gene by insertion of an epitope tag downstream of the coding region. For 
simplicity antibiotic resistance transgenes are not shown. d) 'Knock-in' of a reporter 
sequence to an endogenous locus. Correct targeting of the reporter transgene results in its 
regulation by the endogenous promoter. The endogenous allele is no longer expressed 
due to the replacement of vital coding sequences with the transgene ORF. Antibiotic 
resistance transgenes are not shown. 
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1.2 	The creation of transgenic organisms 
Currently transgenic mice can be created by three different routes, pronuclear injection, 
an ES cell-mediated route, and nuclear transfer. Pronuclear injection is not only 
restricted to mice, but can be used to create transgenic mammals of any species and is 
carried out by the microinjection of foreign DNA (usually a transgene and linked 
promoter), into either pronuclei of a one cell embryo. Animals that have incorporated the 
foreign DNA into their genome and carry the manipulation through the germline (the 
tissue that produces gametes), are referred to as founder animals, and these can be used to 
establish transgenic lines heterozygous and homozygous (if this is not lethal) for the 
manipulation. All founder animals are genetically dissimilar as the foreign DNA 
integrates at random positions within the genome. As a result transgene expression is 
likely to vary between founder animals as the exogenous sequences are subject to 
different position effects (in a similar manner to the random integration of exogenous 
sequences in vitro). In addition concatemerization of the foreign sequences before 
integration into the genome often takes place, resulting in the incorporation of multiple 
copies of the transgene (Brinster etal., 1981). Large numbers of repeats have previously 
been reported to lead to transgene silencing (Mehtali etal., 1990). 
The creation of transgenic organisms via pronuclear injection is a well established and 
generally applicable technology. However the type of genetic modification is limited to 
the random integration of foreign sequences. The establishment of murine embryonic 
stem (ES) cell lines in 1981 (Martin., 1981; Evans and Kaufman,, 1981), paved the way 
for the creation of transgenic mice containing directed genetic alterations of endogenous 
genes. ES cells are derived from the inner cell mass (1CM) of the early embryo, a 
transient population of cells that eventually gives rise to all the differentiated cells types 
found in the adult mouse. ES cell lines are established by plating out early blastocysts in 
vitro and subsequently disaggregating and culturing undifferentiated outgrowths arising 
from these blastocysts. Upon replating, these outgrowths often give rise to 
undifferentiated colonies that can be expanded further to give rise to ES cell lines which 
can be continuously passaged in the presence of a feeder layer of fibroblasts, or 
leukaemia inhibitory factor (LIF) cytokine, and serum. These ES cell lines retain the 
pluripotent nature of their 1CM precursors. When injected into early blastocysts they are 
able to contribute to all cell lineages including the germ layer. Unlike the embryonic 
1CM which is a transient population, ES cells can be cultured indefinitely, and thus 
provide an invaluable tool for the creation of transgenic mice. The genetic manipulations 
created in ES cells, for example by the gene targeting methods described above, can be 
transferred to the mouse germline by injecting these cells into early blastocysts. These 
embryos will give rise to chimeric mice which contain two genetically distinct 
populations of cells. In a successful chimera cells derived from the manipulated ES cells 
will colonise the germline, and the chimera can be used to create by subsequent breeding 
heterozygous and homozygous transgenic mouse lines. ES cells can therefore be used as 
a vehicle to transfer complex genetic manipulations to the murine germline, and as a 
result the advent of this technology revolutionised the field of reverse genetics. 
The third route of creating transgenic animals is the process of nuclear transfer (NT), 
which involves the transfer of a nucleus from a genetically manipulated cell (somatic or 
embryonic) into an enucleated egg. Although several species of transgenic animal have 
been created by this method, including mice (Rideout et al., 2000), goats (Keefer et al., 
2001), cows (Krisher etal., 1995) and pigs (Uhm etal., 2000). the efficiency of this 
process is very low, with success rates of around 2-4 live-born animals per 100 NT 
embryos (Wolf et al., 2001). In addition postnatal abnormalities often arise, such as 
increased body weight and premature ageing. Whilst NT enables the manipulation of 
endogenous loci by homologous reconibination in those animals which have not 
successfully generated ES cell lines (Denning ci' al., 2001, Dai ci' al., 2002), the low 
success rate of obtaining live-born animals and prevalence of postnatal problems at 
present prevent this technology from becoming a practical alternative to ES cell-based 
transgenesis in mice. 
1.3 	The application of conditional technology 
The approaches described above have all described constitutive genetic manipulations, 
that is the permanent overexpression, or mutation of a gene upon stable engineering of a 
cell line, or in an in vivo setting, the modification or inactivation of a gene in all tissues of 
the body, for the entire lifespan of the organism. For reasons that will be elaborated on 
further, constitutive genetic manipulations are not always desirable when attempting to 
elucidate gene function or establishing models for human disease. Recently methods 
have been devised to spatially and temporally restrict either the inactivation of an 
endogenous gene, or the expression of an exogenous transgene. The technology used to 
bring about such conditional manipulations will be discussed in detail below. However 
the advantages of using conditional strategies over constitutive approaches will first be 
discussed. 
In the study of gene function in vivo, the spatially-restricted inactivation of a widely 
expressed endogenous gene enables the study of the function of that gene in the tissue of 
interest. This approach is superior to the use of constitutive null mutants as interpretation 
of gene function can be hindered by the indirect effects of inactivating the gene in 
surrounding tissues. In addition the timing of gene inactivation can be very important as 
in extreme cases constitutive inactivation of a gene will result in embryonic lethality 
which will preclude analysis into its requirement at later stages of development. Both 
these points are exemplified in a study investigating FGF8 signalling in the developing 
limb bud in which fg/8 gene inactivation was conditionally restricted to early limb 
ectoderm (Lewandoski ci al., 2000). This approach not only circumvented the 
requirement for FGF8 during gastrulation but it also restrictedfg,f8 ablation to the tissue 
of interest without compromising its other functions in the developing organism. 
Studies of gene function by the constitutive inactivation of an endogenous gene can 
sometimes be hindered by the compensatory effects of closely related genes. Knock-out 
mice, for example sometimes exhibit less severe phenotypes that their conditional 
counterparts, owing to adaptive mechanisms that occur during development. Such 
compensatory mechanisms were recently reported in a study by Sage et al, which 
highlighted the problem of using transgenic animals containing constitutive inactivating 
mutations as models for cancer. It was found that mouse embryonic fibroblasts (MEFs) 
that underwent an acute (conditional) inactivating mutation of the retinoblastoma (Rb) 
gene, responded differently to various imposed cellular states (such as senescence and 
quiescence), than MEFs harbouring a constitutive mutation. This was found to be due 
partly to compensation by the upregulation of the Rb-related p107 gene in the 
constitutively mutant Rb line. Although such compensation also occurred in MEFs 
exhibiting acute Rb mutation after time in culture, the analysis of this cell line 
immediately after mutation more accurately recapitulated the situation in cancer, which is 
often caused by the sporadic genetic mutation of Rb and other oncogenes involved in the 
regulation of the cell cycle. 
Conditional manipulations are not soley limited to the inactivation of genes. Indeed the 
spatiotemporal restriction of trans gene expression can lead to far more sophisticated 
experimental approaches than those possible by simple constitutive overexpression. 
Ultimately the experimental approach will depend upon the study in question. The 
availability of a vast repertoire of conditional technology however provides greater 
experimental flexibility. 
1.4 	The technology used to conditionally control gene expression 
Genetic manipulations can be rendered conditional, principally by the utilisation of two 
types of technology, one which is largely used to permanently inactivate alleles or 
reactivate a transgene in a conditional manner (using recombinase-mediated site-specific 
recombination), and the other which is used to manipulate the expression of a transgene 
in a reversible manner, the timing of which is up to the discretion of the experimenter 
(this involves the use of conditional inducible gene expression systems). Here both types 
of technology shall be discussed with a focus on inducible gene expression systems. It 
should be noted that recently the separate identity of these two technologies has become 
blurred with the development of inducible recombinase-based technology (Imai et al., 
2001, el Marjou etal., 2004) and recombinase activated inducible systems (Belteki et al., 
2005, Guo et al., 2005). 
1.4.1 Recombinase mediated site-specific recombination 
Recombinase mediated site-specific recombination involves the use of either Cre-
recombinase (found in bacteriphage P1) or Flp recombinase (found in Saccharomyces 
cerevisiae), which act on pairs of corresponding loxP and FRT sites respectively. Both 
systems are based on the same principle, therefore only the Cre/loxP system shall be 
expanded on here. 
Cre-recombinase is a site-specific protein that binds to 34 bp loxP recognition sites (two 
Crc proteins bind per site), and is able to mediate conservative recombination between a 
pair of loxP sites. The recognition sequences comprise 13 bp inverted repeat sequences, 
which flank an asymmetric 8 bp core sequence conferring directionality to the site. The 
positioning of loxP sites either side of coding regions (or non-coding regions that are 
essential to the expression of that gene), orientated in the same direction, will lead to 
inactivation of the gene due to excision of the intervening DNA sequence between them 
upon Cre-mediated recombination. This technique is referred to as 'floxing' a gene and is 
widely used to achieve conditional gene inactivation by expressing Cre in a temporally 
and/or spatially restricted manner. 
Cre-mediated inactivation of an endogenous gene can be achieved in vitro by introducing 
Crc-encoding sequence into a cell line harbouring a 'floxed' allele, via transfection of a 
Crc-expressing plasmid, or introduction of the sequence using a viral vector (Sage et al., 
2003). Recently a technique has been developed for efficiently introducing proteins into 
cells via fusion to the protein transduction domain (PTD) of the HIV tat protein, 
(Schwarze et al.. 1999). The fusion of Cre to this PTD domain therefore offers an 
alternative mode of delivery of the recombinase. 
Site-specific recombination has been widely applied in vivo to inactivate endogenous 
genes in a spatioteniporal manner (Figure 1.2a). This is usually achieved by creating two 
transgenic lines, one containing the 'Jioxed allele, and the other expressing Cre-
recombinase in a specific tissue (this is done by utilising a tissue-specific promoter to 
drive Cre expression) and in addition harbouring a mutated 'null' allele of the gene of 
interest. The breeding of these two lines will result in a proportion of the progeny 
expressing Cre-recombinse and containing one endogenous 'Jioxed' allele and one null 
allele. This will result in inactivation of the conditional allele in every Cre expressing 
tissue (Gu et al., 1994, Trumpp et al., 1999). 
This recombinase-mediated technology can also be applied to reactivate transgenes or 
endogenous genes that have been engineered so that expression is blocked by the 
insertion of a foreign stop' sequence, which is usually a selection cassette which 
contains a transcriptional or translational stop (Figure 1.2b). For the activation of a 
transgene, the transgenic line is usually engineered for near ubiquitous expression of the 
gene, and once established this is crossed to an appropriate tissue-specific Cre-expressing 
line (Grieshammer et al., 1998, Heidt c/ al., 2005). Alternatively endogenous loci can be 
manipulated in a similar manner. Endogenous gene activation has been used to create 
mouse models of human skin-blistering disorders by ubiquitously mutating endogenous 
genes involved in these disorders and then expressing the mutant alleles in a tissue-
specific manner (Cao et al., 2001). 
1.4.2 Inducible gene expression systems 
The first inducible gene expression systems developed were single transgenes that were 
linked to a promoter responsive to an external stimulus or inducer, such as heat shock, 
heavy metals or hormones. However, the use of such activating stimuli and inducing 
agents resulted in pleiotropic effects in the target cells due to interference with 
endogenous cellular pathways. Furthermore, promoters driving the transgenic sequences 
were also prone to activation by endogenous transcription factors resulting in high basal 
transgene expression in the absence of inducer and therefore the use of these systems in 
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Figure 1.2 Examples of Cre-recombinase mediated site-specific recombination. a) Creation of a 
hypothetical conditional knock-out allele. A targeting vector encoding sequence homologous to 
the endogenous locus and two homospecific loxP sites flanking exon 2 is transfected into cells. 
Legitimate recombination results in the faxing' of exon 2. The presence of cre-recombinase 
results in the excision of exon 2 by site-specific recombination between the loxP sites. b) 
Hypothetical reactivation of an endogenous gene. A targeting vector encoding a transcriptional 
'stop' cassette flanked by two loxP sites is transfected into cells. Legitimate recombination 
results in the integration of the 'foxed stop cassette between the endogenous promoter and 
exon 1, creating a 'null' allele due to early termination of transcription. Cre-recombinase action 
results in the removal of the stop cassette and expression of the gene. For simplicity selection 
cassettes are not depicted for either of the strategies. 
the conditional expression of transgenes was limited (these systems are reviewed in 
Yarranton., 1992). 
More advanced forms of conditional gene expression were subsequently developed, 
based on the interaction of two components. Most of these systems utilise a 
transactivator that responds to the addition or withdrawal of inducer by binding 
specifically to a transactivator-response element (TRE) (Figure 1.3). cDNA encoding a 
transgene is linked to the TRE and upon sequence specific binding by the transactivator, 
expression of the transgene is induced, (a repressor-based system has also been 
developed, which will be described at a later point). 
The early versions of these binary systems utilised viral proteins as transactivators and 
were prone to high levels of basal transgene expression and tumorigenesis (Khillan et al., 
1988). Today most inducible gene expression systems rely on chimeric transactivator 
proteins comprised of a combination of eukaryotic/bacterial and viral sequences, which 
are engineered so as to not interfere with endogenous cellular metabolism. in addition 
careful selection and modification of transactivator response elements aim to ensure that 
these sequences are only regulated by the system transactivator and not by endogenous 
host factors. 
Such binary inducible gene expression systems can be established in vitro by the 
integration of both the transactivator (TA), and transactivator-response element (TRE) 
into the genonie. Transcription of the TRE-linked cDNA is initiated upon addition, or 
withdrawal (depending on the system in question) of inducer to the culture. As 
expression of the transgene is wholly dependent on the presence or absence of inducer, 
the experimenter has exquisite control over the transcriptional state of the cDNA, and can 
therefore turn the transgene on or off as required. 
Binary systems can be utilised in vivo by generating two transgenic lines, one that 
expresses the transactivator, and the other that harbours the TRE and linked transgene. 
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Figure 1.3 Binary inducible gene expression systems. The systems are comprised of two elements, one 
encodes a transactivator and the other contains the transactivator-response element (IRE) linked to the 
cDNA to be regulated. The transactivator is expressed irrespective of the presence or absence of inducer. 
a) A hypothetical system that requires inducer for transgene expression. i) In the absence of inducer the 
transactivator is not able to bind the IRE, ii) upon addition of inducer an inducer/transactivator complex 
is formed that binds the IRE and activates transgene expression. b)i) A hypothetical system that 
overexpresses the transgene in the absence of inducer. ii) The inducer binds the transactivator rendering 
it incapable of binding to the TRE, thus transgene expression is terminated. 
system, and transgene expression can be regulated by the addition of inducer to the 
animals food or water, intraperitoneal or intravenous injection, or by topical application 
(the route of administration depends upon the system used and also the experimental 
design). Tissue-specific expression of the transgene can be achieved in a similar manner 
to that of the Cre-recombinase system mentioned above, by using a tissue-restricted 
promoter to drive expression of the transactivator. The crossing of a line expressing 
tissue-restricted transactivator, to a line with potential ubiquitous TRE-linked eDNA 
expression results in tissue-specific transgene activation upon application or withdrawal 
of inducer, (Saam et al., 1999, Shigehara et al., 2003, Nguyen et al., 2005). 
The ability to induce the expression of a transgene and switch it off at a later timepoints 
has opened up new experimental opportunities in many areas of biology. In the field of 
cancer research for example, the induction and further silencing of oncogenes allows 
investigation into the requirement of an oncogene not only for initial tumorigenesis, but 
also for tumour maintenance (Feisher et al., 1999, Chin et al., 1999). Similarly in the 
creation of transgenic models of disease, the subsequent repression of an overexpressed 
pathogenic transgene gives insight into the permanency of the disease phenotype and in 
cases where symptoms gradually diminish, provide models for remission. This was 
exemplified in a study in which the conditional overexpression of a Gi-coupled human 
heptahelical receptor in mice was found to model human congestive heart failure 
(Redfern et al., 1999). It was observed that when the transgene was subsequently 
switched off there was a dramatic reversal of the illness, which provided a useful model 
in which to investigate the processes underlying disease regression. Similarly the 
symptoms of Huntington disease were alleviated in a mouse model expressing an 
inducible huntinglin gene after expression of this transgene was terminated, highlighting 
the possibility of developing therapeutic treatments to specifically target this gene 
product, and in addition providing a useful model in which to test any future therapy 
(Yamamoto et al., 2000). 
Inducible transgene technology also offers an exciting tool for the investigation of 
signalling pathways and regulatory genes involved in early development, and particularly 
in the study of cell fate decisions that occur during embryogenesis or during the 
differentiation of ES cells. This will be discussed further in section 1.7. 
1.4.2.1 Types of inducible gene expression systems 
Several conditional inducible gene expression systems have been developed and are in 
use today, however the most successful and widely cited system is the tetracycline 
inducible gene expression system (hereon referred to as the tet-system) developed by 
Hermann Bujard and Manfred Gossen. The next section will briefly describe a selection 
of the inducible binary gene expression systems available with the aim of introducing the 
reader to the variety of ways of achieving inducible gene expression. This will be 
followed by a detailed description of the function and development of the tet-system. 
Ecdysone system 
The ecdysone-regulated gene expression system is a binary system that was originally 
operated by the addition of the insect molting hormone ecdysone. The transactivator is 
comprised of two receptor components, the modified insect ecdysone receptor VgEcR 
(containing an N-terminal truncation fused to a VP 16 activation domain) and the 
mammalian retinoid X receptor RXR. These two receptors heterodimerise and bind to 
the E/GRE composite response element upon the addition of ecdysone steroid, an 
interaction which initiates the transcription of the E/GRE linked transgene (Figure 1.4a). 
The ecdysone inducible system can activate homogenous expression of 3-gal in vitro (No 
e. al., 1996), and throughout the mammary epithelium in vivo (Albanese et al., 2000). 
The steroid inducers are able to mediate very rapid inductions of transgenes owing to 
their ability to efficiently transpass cellular membranes as a result of their lipophilic 
nature. They are also rapidly eliminated both in vitro and in vivo to ensure speedy 
termination of transgene expression (Saez el al., 2000; Hoppe et al., 2000). Although 
the insect hormone ecdysone and the alternative phytoecdysteroids inducers (ecdysteroids 
released by plants that 'mimic' ecdysone), have no effect on mammalian physiology, an 
PA 
Figure 1 .4 a) The ecdysone conditional gene expression system. I) The two transactiving 
elements VgEcR and RXR are expressed constitutively but are unable to bind the 
transactivator-response element E/GRE due to the absence of inducer. ii) Upon addition 
of ponasterone A inducer, VgEcR and RXR heterodimerise to form a functional 
transactivator and bind to E/GRE, activating transcription of the regulatable transgene. 
b) The GLVP inducible gene expression system. GLVP, a chimeric fusion protein 
between VP 16, GAL4 and a mutant progesterone receptor is expressed constitutively, but 
unable to bind the UASPr response element due to the sequestration of the fusion protein 
by heat-shock proteins in the cytoplasm. ii) Addition of RU486 inducer renders GLVP 
free to translocate into the nucleus, where it activates transgene expression by binding the 
UASPr transactivator-response element. Abbreviations: Pr, promoter; VgEcR, ecdysone 
receptor; RXR, retinoid X receptor, E/GRE ecdysone composite response element; pA, 
polA; mPr, mutated progesterone receptor; HSP, heat-shock protein; UASPr, GLVP 
transact  vator-response element containing four UA S sequences; TR E, transactivator-
response element. 
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initial concern was the availability of the most potent steroid inducer— muristerone A. 
The phytoecdysteroid ponasterone A was however found to have the same inductive 
capabilities as muristerone A and its abundance in the leaves of many species of plant 
ensures its availability (Saez et al., 2000). 
Despite reported inductions of over four orders of magnitude in stably derived clones in 
vitro (No et al., 1996), such levels of induction have not yet be obtained in vivo, (Saez et 
al., 2000; Hoppe etal., 1999). Indeed there is a scarcity of papers describing any 
physiological effect from overexpressing transgenes using the ecdysone system in cell 
culture or in transgenic organisms. Also, whilst the penetrance of steroidal inducers are 
advantageous in certain situations, the downside of this is that sustained levels of 
transgene expression is difficult to achieve in vivo as the inducer is rapidly eliminated 
from the bloodstream and host tissues. The most promising delivery of inducer to date 
for continuous transgene expression is via the subcutaneous implantation of pellets 
(Albanese et al., 2000). 
GLVP system 
A promising system that has been developed in recent years and has seen widespread 
application is the GLVP conditional gene expression system. GLVP is the chimeric 
transactivator component of the system, and is comprised of the GAL4 DNA binding 
domain, a mutated progesterone receptor and the viral protein VPI6 activation domain 
(Figure 1.4b). GLVP is constitutively expressed but unable to activate transgene 
expression due to its sequestration by heatshock proteins in the cytoplasm (an interaction 
that is mediated by the binding of the mutated progesterone receptor moiety). Addition 
of a progesterone antagonist (such as the synthetic steroid RU486), results in the release 
of GLVP and enables it to bind to the GLVP response element in the nucleus (that 
consists of four GAL4 binding sites juxtaposed to a minimal thymidine kinase promoter). 
This results in activation of transcription of the downstream cDNA. 
Numerous examples of utilisation of the GLVP gene expression system have been 
documented in vivo (Wang et al., 1999; Zhao et al., 2001; Pierson et al., 2000), with no, 
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or low basal levels of transgene expression detected in the absence of inducer. A major 
disadvantage of this system however, is its restriction to use in adult mice due to the 
abortigenic properties of synthetic steroids (doses of above 100 pig/kg bodyweight induce 
abortion in mice - Chua et al., 1998, thus precluding its use in the study of early 
development). It is not yet clear if this system leads to uniform transgene expression, as 
it has largely been used to study the overexpression of secreted proteins, however 
inductions of up to 1500-fold have been obtained in vivo (Chua ci al., 1998), and levels 
of expression have been reported to be dose dependent (Zhao et al., 2001). 
Lac Repressor-based system 
Whilst the ideology of utilising transactivators to mediate transgene expression has been 
the most popular way of achieving inducible expression in the binary systems developed 
to date, it is worth commenting on alternative ways that have been explored. 
One such strategy is to use a repressor to block expression of an otherwise constitutively 
expressed transgene by tight binding to part of the transcription unit (Cronin et al., 2001; 
Dancz et al., 2002). Although this strategy is not as popular as the previous systems 
described, Cronin et al have utilised a system based on the lac repressor (lad) and lac 
operator (lacO) interaction to achieve inducible expression of the murine lyrosinase gene 
in mice (Figure 1 .5a). Tyrosinase catalyses the first step in melanin biosynthesis, and the 
authors showed that derepression of the tyrosinase transgene after IPTG inducer ingestion 
resulted in a coat colour change in adult mice (IPTG binds to lacE and renders it incapable 
of binding the lacO sequences). 
This experiment yielded a very obvious and impressive phenotype, however a limitation 
of this repressor-based system is the necessary modification to the promoter element 
driving transgene expression. In order for transgene expression to be repressed, lac 
operator sequences need to be integrated into the promoter element in a way that will 
lead to transgene repression upon lacl binding, yet still enable appropriate transgene 
expression on the application IPTG inducer to the system. It is therefore important that 
the incorporation of lacO sequences into the promoter element does not impair promoter 
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function or promoter specificity. In addition the relatively low binding affinity of IPTG 
inducer for the lac repressor (Ka 106  Md ), in comparison to other systems, results in 
only moderate induction (Hu etal., 1987). 
Mutant estrogen-receptor based system 
Inducible systems based on the mutant estrogen-receptor have largely been used to create 
ligand-inducible forms of cre-recombinase by developing fusion proteins that comprise of 
the mutant estrogen-receptor and Cre-recombinase moieties (Cre-ER), as shown in figure 
1.5b. Mutation of the estrogen receptor renders it insensitive to activation by endogenous 
13-estradiol agonist, but not 4-OH-tamoxifen - a synthetic antagonist, (this system is 
therefore not subject to activation by endogenous pathways). When cDNA sequence 
encoding this fusion protein is linked to a suitable promoter, expression of the fusion 
protein is achieved, and the protein is sequestered in the cytoplasm due to the interaction 
of the estrogen binding domain with the Hsp90 complex (Schwenk et al., 1998). 
However, upon application of 4-OH-tamoxifen, the fusion protein is released from the 
complex and able to translocate into the nucleus where the cre-recombinase mediates site 
specific recombination between identical lox? sequences. 
This inducible system has been widely used in vivo to temporally regulate somatic 
mutagenesis by injecting transgenic animals containing 'foxed' alleles and expressing 
Cre-ER, with tamoxifen inducer (Vooijs et al., 2001, Weber et al., 2001 to name two 
examples). An improved inducible Cre-recombinase (CreER T2), has recently been 
developed that is 10-fold more sensitive to tamoxifen induction (Vallier et al., 2001; 
Leone et al., 2003). 
1.5 	The tetracycline-repressor based conditional gene expression system 
The tetracycline-dependent conditional gene expression systems owe their popularity to 
their versitility, effectiveness, and ease of manipulation over the other conditional 
expression systems available. Since the first papers emerged detailing the use of such 
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Figure 1.5 a) The lac repressor-based inducible gene expression system. i) In the absence 
of IPTG inducer the lac-repressor (lad) binds to the lac operator sequences embedded in 
the promoter and thus represses transcription. ii) When inducer is added, it binds to the 
lac repressor and renders it unable to hind the responsive promoter, thus enabling 
transcription of the transgene to occur. b) The induble creER T2 conditional expression 
system. i) A fusion protein between cre-recombinase and the mutated estrogen receptor 
is expressed constitutively but unable to act in the nucleus due to sequestration in the 
cytoplasm by heat-shock proteins. ii) Addition of tamoxifen inducer renders the chimeric 
protein free to translocate into the nucleus and mediate site-specific recombination 
between homospecific loxP sites to inactivate or 'knock-out' an allele (shown in biii), or 
reactivate an endogenous allele or transgene (shown in biv). Abbreviations: Pr, promoter; 
lad, lac repressor; lacOPr, lacl responsive promoter containing lac operator sequences; 
pA, polyA; HSP, heat-shock promoter; ER 2  mutated estrogen receptor; STOP, 
transcriptional stop cassette (promoter and polyA sequence not shown). 
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systems over 10 years ago (Gossen et al., 1992), a lot of work has been carried out to 
improve the expression system's integral components, firstly in order to achieve tighter 
control of transgene expression, and secondly to make the tet-systems more attractive for 
use in a wider number of applications. Here, I will briefly discuss their basic operation, 
and detail the most important advances that have occurred in the development of these 
systems to date. 
1.5.1 The tet—system - general overview 
The tet system is a transactivatory gene expression system which is comprised of a 
chimeric transactivator and a transactivator-response element (TRE). In accordance with 
the binary systems previously described, the cDNA to be overexpressed is linked to the 
TRE element and its expression is induced upon binding of the transactivator to the 
response element. There are two versions of the tet-system which are commonly used, 
the tet-off (Figure 1.6a) and the tet-on (Figure 1.6b) systems. The transactivators of both 
systems are fusion proteins comprising of tet repressor (found in E.coli see below), and 
viral VP 16 moieties. The transactivator used in the tet-on system however has reverse 
DNA binding properties to that of its counterpart utilised in the tet-off system and is 
therefore referred to as a reverse transactivator. The kinetics of transgene activation and 
inactivation between the two systems differ, and therefore choice of tet-system depends 
upon the experimental setup (this will be expanded on below). 
1.5.2 Development of the tet-off system 
The original paper detailing the development of the tetracycline inducible conditional 
gene expression system was published in 1992 by Manfred Gossen and Hermann Bujard. 
Having previously focussed on the Lac repressor-based inducible system, dissatisfaction 
with the efficacy of IPTG-mediated transgene induction prompted the authors to develop 
a novel system, this time utilising regulatory elements of the TnIO-specified tetracycline-
resistance operon of E.coli. The integral components of this system are the tetracycline 
repressor (teiR) (Figure 1.6c), and the tetracycline operator (tetO) sequences. The 
tetracycline repressor functions in E.coli to inhibit the expression of the tetracycline 
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Figure 1.6 The tet-on and tet-off systems a) Schematic of 
the tet-off system. In the absence of inducer, the TetR 
moiety of the tTA transactivator binds to the tetO sequences 
encoded within the transactivator-response element (TRE). 
The VP16 moiety of tTA recruits transcriptase complex and 
transcription of the transgene ensues. Upon addition of 
G 	 inducer it binds the tTA inducing a conformational change 
that renders it unable to bind the TRE, and thus expression 
of the transgene in abolished. b) Schematic of the tet-on 
system. In the absence of dox the reverse transactivator 
(rtTA) is unable to bind the TRE and activate transcription of 
the transgene. Upon the addition of dox rtTA binds the tetO 
sequences within the TRE resulting in transgene expression. 
C) Stereo plot of TetR homodimer with the two TetR 
monomers shown in different colours. The two DNA 
reading heads bind to the 19 bp tetO sequence 
(tccctatcagtgatagaga). Figure adapted from Gossen et al., 
1995. 
resistance gene (tetA) in the absence of tetracycline (Tc) antibiotic. TetR binds as a 
homodimer to a palindromic 19 base pair tetO sequence upstream of the resistance gene 
thereby repressing its transcription when no antibiotic is present. Upon influx of 
tetracycline (Tc) into the cell, it binds TetR with high affinity, inducing a conformational 
change in the dimer which increases the distance between the two tetR DNA binding 
heads from 34A to 39A. This renders TetR unable to bind to the adjacent major grooves 
within the tetO sequence and this interaction is subsequently extinguished. 
The high affinity (Ka l0' 2-10' 3 M', Hillen et al., 1983), and high specificity of this 
TetR/tetO interaction was harnessed by Gossen and Bujard to create an inducible binary 
transactivatory system (Gossen & Bujard 1992). To create the tetracycline-controlled 
transactivator (tTA), sequence encoding full length teiR was fused to sequence encoding 
the C-terminal domain of HSV-VP16 (which when translated is comprised of 130 amino 
acids. Figure 1.7). To produce the transactivator response element to which tTA binds to 
activate transgene transcription, an array of 7 tetO sequences were fused to a minimal 
CMV promoter fragment (which extends 53 bp upstream and 75 bp downstream of the 
transcription initiation site and lacks the enhancer element. Figure 1.8). The tTA was 
placed under the control of a CMV promoter and enhancer sequence, and the TRE was 
linked to a firefly luciferase reporter gene after which both elements were stably 
introduced into HeLa cells by random integration. Upon the addition of Tc inducer some 
clones exhibited negligible basal levels of luciferase expression yet induced the reporter 
to over five orders of magnitude upon withdrawl of Tc (Gossen & Bujard., 1992). This 
provided evidence that the system was able to activate high levels of transgene 
expression without exhibiting 'leaky' transgene expression in the absence of tTA binding 
(the TRE) due to activation by endogenous factors. 
Some clones were shown to exhibit high levels of basal transcription in the presence of 
Tc. Due to the random integration of both system components this was most likely due 
to the insertion of the TRE into a region that was under the influence of an enhancer 
element or in close proximity to an endogenous promoter. As clones were also derived 
that exhibited undetectable levels of basal transgene expression this suggested it was not 
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Figure 1.7 A selected panel of transactivators and reverse transactivators. Not all 
transactivators that have been developed are depicted. There is a series of tTAs and 
rtTAs that contain different numbers of VP 16 minimal activation domains and differ in 
activation potential (Baron et al., 1997). In addition a novel reverse transactivator has 
been developed that has an increased range of dox sensitivity (Akagi etal., 2001). 
Abbreviations: aa, amino acid; F, HSV minimal activation domain termed F domain 
(amino acid sequence is shown for tTA2). 
Amino acid substitutions 	Further modifications 
in original TetR peptide 
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Figure 1.8 Representation of tet-responsive elements (TREs). a) The original TRE is comprised of 
an array of 7 tetO sequences fused to a CMV minimal promoter fragment spanning 53 bp upstream 
of the transcription initiation site and 75 bp downstream of the initiation site. This minimal 
promoter element lacks the CMV enhancer and therefore transcription is only inititated upon 
binding of the tetO sequences by transactivator. The same IRE is shown schematically in b. C) 
The bi-directional TRE contains two CMV promoter fragments, which lead to the transcription of 
linked transgenes in convergent directions after the central tetO seqeuences are bound by 
transactivator. 
a problem intrinsic to the system itself. Similarly clones derived exhibiting low transgene 
induction levels may have harboured either or both elements integrated into regions of 
chromatin that were not permissive for high levels of transcription (in the case of tTA), or 
inaccessible to transcription factors (in the case of the TRE). 
Transgene inactivation by addition of Tc to the culture media was found to be very rapid, 
with luciferase levels reaching 2% of their original values 12 hours after addition of the 
antibiotic (at a concentration of I .xg/ml). Activation of the luciferase transgene was not 
as efficient as this required the efflux of Tc from the intracellular environment, however 
over 20% of fully induced levels were reached within 12 hours of withdrawl, and 
inductions of over 70% after a further 12 hours. It was found that a range of luciferase 
expression levels could be obtained between the concentrations of 0 and I .1g/ml Tc, a 
phenomenon which the authors ascribe to the partial activation of the TRE at 
intermediate Tc concentrations (Figure 1.9). However, as the luciferase assay is based on 
lysis of the whole cell population this conclusion was premature as it is plausible that the 
detection of intermediate luciferase levels was the result of only a subpopulation of cells 
expressing the transgene with the remaining cells negative for luciferase expression, 
rather than the detection of homogenous population-wide levels of intermediate luciferase 
transcription. 
The initial publication of the tet-off inducible system was promptly followed by a report 
of the feasibility of its use in vivo, (Furth et al., 1994). Several founder lines containing 
either CM V-driven tTA, TRE-linked luciferase, or TRE-linked 3-galactosidase were 
created by pronuclear injection. Transactivator-expressing lines were then crossed with 
lines harbouring TRE-1 inked transgenes and transgene expression in the presence and 
absence of Tc (administered via slow-release subcutaneous pellets) was assayed. Whilst 
many of the double-transgenic lines arising from the tTA/TRE-luciferase cross exhibited 
luciferase expression in most tissues in the absence of Tc, and low expression in the 
presence of Tc, transgene inductions were not of the same magnitude as those achieved in 
vitro (the highest reported being around 103  fold). Inductions were also shown to vary 
greatly between different tissues, a phenomenon which is probably due to the positioning 
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of the tet-system elements within chromatin regions that possess varying permissivity for 
gene transcription depending upon cell type. This would be expected to lead to variation 
in tTA transcription and in the case of the TRE, variation in its recruitment of tTA 
between different tissues of the same organism. 
The progeny of the tTA/TRE -galactosidase crosses exhibited mosaicism of3-
galactosidase expression in all tissues analysed, suggesting that both transgenes were 
only expressed in a subset of cells. This was thought to be due to mosaic properties of 
the CMV promoter used to drive tTA expression rather than a problem intrinsic to the tet-
system components. Indeed a later publication reported homogenous and hepatic-
specific expression of 3-galactosidase when tTA was placed under the regulation of a 
LAP promoter (Kistner et al., 1996). Inductions of over five orders of magnitude were 
also reported when these tTA lines were crossed with TRE-luciferase reporter lines, 
indicating that in viva transgene expression can be induced to levels comparable to those 
obtained in vitro. 
1.5.3 Development of the tet-on system 
The system described above requires the continuous administration of tetracycline to 
keep transgene expression switched off (tet-off system). Whilst the concentration of Tc 
required to keep the transgene silent (0. 1 j.ig/ml in HeLa cell culture) has no obvious 
deleterious effect on HeLa cells over prolonged periods of time, such a situation is 
suboptimal in certain experimental setups, for example sustained transgene inactivation 
when using the system in vivo, or when it is imperative that a transgene is activated 
rapidly. 
The development of a transactivator which possessed reversed DNA binding properties to 
that of the original tTA gave rise to the tet-on version of the tet-system (Gossen et al., 
1995). This reverse transactivator (rtTA) requires Tc to initiate transgene expression 
(Figure 1.6b). It was created by randomly mutagenising teiR sequence and then using a 
genetic screen established in E.coli to select for the repression of a reporter in the 
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presence of Tc (Gossen ci' al., 1995). The most promising mutant isolated contained four 
amino acid substitutions, three of which were predicted to be involved in the 
conformational change of tetR during induction (Figure 1.7). This mutated tetR sequence 
was then fused to the C-terminal VP 16 sequence (which was identical to the sequence 
present in tTA) to produce the reverse Tc-dependent transactivator. 
In contrast to the tet-off system (which utilises tTA), the tet-on system is favoured in 
situations in which a transgene has to be activated rapidly. HeLa clones stably 
harbouring both rtTA (driven by a CMV promoter and enhancer), and the TRE-linked 
luciferase element, exhibited maximum levels of reporter induction in less than 24 hours 
after addition of inducer (Gossen ci' al., 1995). However, in comparison to the levels 
achieved with tTA, the use of rtTA gave rise to inductions of only a 1000 fold (Figure 
1.9). Studies in vivo however show that rtTA is able to activate the expression of a TRE-
linked luciferase reporter to over five orders of magnitude above basal levels upon the 
administration of inducer (Kistner ci al., 1996). 
The lower transgene inductions observed in vitro when utilising the reverse transactivator 
prompted investigation into the search for other more potent inducer compounds. 
Anhydrotetracycline (Atc) was found to be a very effective inducer (Lederer ci' al., 1996) 
of the tet-on system, as was Doxycycline (Dox). Currently the standard inducer of choice 
for both versions of the tet-system is Dox, owing to both its high activation capabilities 
and its commercial availability. 
1.5.4 Utilisation of the tet-on or tet-off system 
As previously described, the tet-off system activates transgene expression in the absence 
of dox. The use of this system is therefore favourable in experimental situations where it 
is necessary that the tet-inducible transgene is active for long periods of time (as this does 
not require the presence of dox). This is especially relevant in vivo, where the continued 
administration of inducer (via whichever route) is not a trivial matter, as the dosage and 
timing of drug administration needs to be carefully calculated to produce the required 
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internal bioavailability of dox. In those situations in which it is necessary for the 
trarisgene to remain silent for prolonged periods, the utilisation of the tet-on system is 
therefore desirable. 
Another factor in determining what version of the tet-system is most suitable for the 
experimental context is whether rapid activation, or inactivation of the transgene is 
required. This is dependent upon the kinetics of cellular saturation, or elimination of dox 
inducer. In vitro, antibiotic can be washed out of culture efficiently and therefore when 
using the tet-off system, transgene repression (which requires dox uptake) is only slightly 
more rapid than transgene induction (which requires the elimination of dox from cells). 
In vivo however transgene induction using the tet-off system is substantially slower than 
transgene repression as it requires the depletion of dox from the tissue under observation. 
This can take between 3 and 10 days depending on the organ in question, and is most 
likely due to the time required to eliminate dox depots that have accumulated in various 
tissues (Baron & Bujard 2000). In situations that require efficient transgene induction in 
vivo, the tet-on version is therefore the system of choice. 
A study into the requirement of endothelin receptor B (EDNRB) during development 
utilised both the tet-off and tet-on systems and highlighted their different functional 
capabilities (Shin et al., 1999). Mice homozygous for a mutation in the Ednrb gene die 
as juveniles as a result of the inability of neural crest-derived enteric neurons to colonize 
the distal colon leading to the condition megacolon. In an effort to establish the precise 
window during development at which EDNRB signalling is required, Ednrb was 
conditionally expressed using the either the tTA or rtTA transactivators, so that 
transcription of Ednrb could be manipulated by the administration or withdrawl of dox to 
the pregnant mother (Ednrb expression was entirely dox-dependent with both 
endogenous alleles rendered null). The tet-on system was used to investigate the earliest 
requirement for EDNRB function in development by inducing Ednrb expression at 
different times during development (with Ednrb transcription off previous to this). The 
rapid induction of the endogenous gene (between 9 and 13 hours after antibiotic 
administration as determined by northern blotting) during mid-gestation enabled the 
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earliest requirement to be estimated at between ElO and Ell. Subsequently the latest 
requirement for Ednrb function was identified using the tet-off system. Ednrb was 
expressed throughout early development and then rapidly inactivated by administering 
dox to pregnant females (complete inactivation occurred 6 hours after dox 
administration). Using this technique it was found that Ednrb expression was required 
before E12.5 but not after this time (Shin et al., 1999). 
1.5.5 The use of VP16 minimal activation domains 
When transactivator-encoding elements are randomly integrated into chromatin, the 
subsequent screening process results in the selection of clones which express the 
transactivator at sufficiently high enough concentrations to activate high levels of the 
TRE-linked transgene, yet low enough to prevent deleterious effects such as squelching 
(which is a toxic effect sometimes exhibited when overexpressing exogenous 
components, due to their interaction with endogenous factors and subsequent 
sequestration of these factors from their intracellular pools). Despite this screening 
process, squelching has been reported to be a problem in some cell lines overexpressing 
the tetracycline-transactivator (Markusic et al., 2005), and is likely to result from the 
aberrant interaction of the VPI 6 moiety with the intracellular regulatory factors. Indeed 
it has been shown previously that the overexpression of VP 16 as a fusion protein with 
GAL4 is not tolerated by cells (Berger et al., 1992). 
Additionally it was envisaged that the targeting of the transactivator to predetermined loci 
in an effort to place it under the control of a tissue-restricted promoter would result in 
intracellular transactivator concentrations that were dependent on the activity of the 
regulatory promoter. If the promoter in question was highly active it may result in the 
inability to derive stably targeted clones if such high levels of transactivator are toxic to 
the cell. With this in mind a series of transactivators were developed which were more 
readily tolerated by the intracellular environment. This was achieved by creating a panel 
of transactivators in which the C-terminal moiety of VP 16 was replaced with varying 
numbers of 12-amino acid VP 16 minimal activation domains (Baronet al., 1997). 
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Analysis of protein extracts, prepared from pools of cells stably expressing the original 
and the novel transactivators showed that in comparison to tTA, the newly developed 
transactivators were present at higher intracellular concentrations, and therefore are 
presumed to be more readily tolerated. The most promising transactivator was tTA2 
which contained three minimal activation domains (Figure 1 .7), and exhibited 
activational properties similar in magnitude to the original tTA. 
1.5.6 The development of rtTA2SM2  and  rtTA2sS2 
Whilst tTA is able to induce transgene expression to over five orders of magnitude, the 
original rtTA was less capable of activating transgene expression to the same extent. 
This was mainly due to residual affinity of rtTA for the TRE in the absence of inducer, 
which often resulted in high basal activity of the responder element. As a result of this 
there was therefore a need to develop an improved reverse transactivator which exhibited 
no affinity for the TRE in the absence of inducer yet was still able to activate high levels 
of transgene expression. 
The de novo creation of a reverse transactivator possessing these properties was carried 
out using a novel screening assay set up in S.cerevisiae (Urlinger et al., 2000). The tetR 
gene was first amplified by PCR under mutagenic conditions and then integrated into a 
plasmid upstream of the C-terminal VPI6 sequence. The plasmid also contained a TRE 
and juxtaposed GFP coding region. After transformation into yeast, TetR proteins that 
possessed a reverse phenotype were selected by screening for GFP positive colonies 
under UV light. It was envisaged that such a eukaryotic based screen would overcome a 
major problem of the previous E.coli based screen, that is the loss or reduction in 
phenotype of the TetR after fusion to the VP 16 moiety and establishment in a eukaryotic 
environment. 
One of the most promising clones identified in this first round of screening was rtTA-S2, 
which contained four amino acid exchanges within the TetR moiety and possessed an 
activation potential similar in magnitude to that of the original rtTA, yet exhibited lower 
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background activation in the absence of dox. In an effort to examine the functional 
contribution of the different amino acids, stretches of sequence encoding either the two 
most N-terminal or two most C-terminal amino acid substitutions were exchanged with 
the corresponding sequence from the original tTA and these chimeric transactivators 
were analysed for reverse phenotype and activation potential. It was observed that just 
two of the amino acid substitutions were sufficient to confer a reverse phenotype and this 
coding sequence was therefore subject to a second round of mutagenesis and screening, 
yielding the clone rtTA-MI. The reintroduction of the two amino acid substitutions that 
were removed before the second round of mutagenesis led to production of rtTA-M2 
possessing elevated induction levels whilst still retaining the reverse DNA binding 
properties. 
In order to improve the stability of the novel rtTA-S2 and rtTA-M2 reverse 
transactivators the VP 16 C-terminal sequence was replaced by three minimal activation 
domains and codon frequencies were altered to resemble those found in mammalian cells 
to produce rtTA2sS2  and  rtTA2sM2  respectively (Figure 1.7). They were then stably 
introduced into a HeLa cell line that contained an already integrated TRE-linked 
luciferase. It was found that both reverse transactivators exhibited many improved 
characteristics over the original rtTA, such as a comparable activation potential with no 
background activity of luciferase in the absence of dox (Figure 1.9). rtTA-M2 exhibited 
increased sensitivity to dox and was able to fully activate transgene expression at 
concentrations ofjust over 100 ng/ml dox in comparison to the original rtTA which 
requires I tg/ml (Figure 1.10). A recent study in MCF-7 cells reported that continual 
expression of this novel transactivator can be tolerated by cells for months in culture 
indicating the reduced toxicity effects of these new generation reverse transactivators 
over their original counterparts (Qu et al., 2004). 
1.5.7 The development of transcriptional silencers 
The tet-responsive transcriptional silencers tTS " ' (Freundleib et al., 1999) and TetR-
KRAB (Deuschle et al., 1995), bind and silence the TRE in the absence of inducer. 
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Figure 1.9 Dose response at varying concentrations of Tc or dox inducer. All results are based upon the stable integration of both 
transactivator and luciferase linked tet-response elements into HeLa cells, a) Luciferase reduction with increasing concentation of Tc 
inducer using tTA. The dose response profile is depicted for two clones. b) Dose response profile for rtTA expressing cells. Note maximal 
luciferase induction is lower than that achieved when using tTA. c) Profiles for the two reverse transactivators rtTA2s-M2 and rtTA2s-S2. 
These novel transactivators exhibit a larger range of transgene induction when compared to rtTA and can also activate maximal luciferase 
expression at lower concentrations of dox, with the rtTA2s-M2 transactivator being the more sensitive of the two. 
These silencers were originally developed to address the problem of leaky transgene 
expression sometimes seen when using the earilier version of the tet-on system. With the 
advent of rtTA2SM2  the use of tet-responsive silencers is now largely irrelevant. 
However, there are certain applications in which they are still useful (see below), and 
therefore the development of tTS' (the most widely used of the silencers) will now be 
described. 
The silencer (tTS'), is a fusion between the Tet repressor and transcriptional silencing 
domains derived from the human kidney protein Kid-I (Freundlieb et al., 1999). During 
the development of tTS 	its dimerisation sequence was exchanged for the dimerisation 
sequence encoded by the E class tet repressor, (the TetR moiety of the transactivators 
belongs to the B class), in order to prevent heterodimerisation of the silencer and 
transactivator monomers and formation of non-functional dimers. In the absence of Dox, 
tTSkid binds to the TRE and inhibits the formation of transcriptase complex around the 
minimal promoter. It is able to bind and repress TRE activity at dox concentrations of up 
to 10 ng/ml when used in conjunction with the tet-on system, without negatively 
impacting on maximum transgene levels induced by rtTA. 
The tTS' silencer has been shown to act to reduce background levels of transgene 
expression both in vitro and in vivo using the original rtTA-tet-on system (Rossi et al., 
1998, Zhu et al., 2001). Nowadays basal transgene levels are generally not found to be a 
problem when utilising rtTA2sM2.  However, there is one field in which tTSkid  can still 
play an important role and that is in the area of gene therapy. Despite the improved 
properties of rtTA2sM2  over the original rtTA, upon transient transfection of this novel 
transactivator and TRE-reporter element into cells, basal levels of the reporter in the 
absence of dox can sometimes be detected (Lamartina et al., 2003). One application in 
which this could pose a problem is in the extra-chromosomal regulation of therapeutic 
genes, where is it necessary that the gene product is tightly regulated. A study 
investigating the expression of tet-regulated Epo after intramuscular injection of the tet-
system components found that levels were undetectable when tTSktd  encoding sequence 
was also injected (Lamartina et al., 2003). 
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1.5.8 Application of the tet-system 
The efficacy of the tet-system is exemplified by its widespread application in a variety of 
different organisms including plants, bacteria, worms and mammals. Its ability to 
function well both in mammalian cell lines and transgenic organisms has led to its varied 
application. Besides the temporal-spatial overexpression of exogenous genes, it has been 
used to overexpress endogenous genes (Bond et al., 2000), ablate subpopulations of 
olfactory neurons in vivo (Gogos et al., 2000), mark populations of epithelial stem cells 
in the postnatal mouse (Blanpain et al., 2004), and create temporal knockouts (Saam et 
al., 1999), to name but a few examples. There are also a number of ways of establishing 
the system, including the random integration of elements, the targeting of elements to 
predetermined loci, and the integration of elements utilising viral vectors (Hofmann et 
al., 1996, Markusic et al., 2005). 
Whilst tet-systems enjoy varied application, the focus of this project is on its 
implementation in ES cells, therefore its use in this pluripotent cell type will now be 
examined. 
1.6 	Previous establishment of the tet system in ES cells 
Embryonic stem cells, owing to their pluripotent nature, offer a model of differentiation 
for potentially every lineage. Indeed, in vitro differentiation of ES cells has been shown 
to generate many differentiated cell types including pancreatic, hepatic, cardiac and 
neural. These differentiation procedures not only provide an opportunity to gain insight 
into the pathways involved in the specification and acquisition of cell fate but also allow 
the information gained to be harnessed in order to direct differentiation either by altering 
the external environment or genetically manipulating the cells with the aim of producing 
unlimited sources of cells useful for therapeutic purposes. 
M. 
The differentiation of a precursor cell to that of a more restricted fate involves the 
expression of endogenous cell fate determining factors at discrete windows in time. In 
analysing the pathways involved, it is therefore often desirable to overexpress genes at 
different stages in differentiation. In such experimental situations inducible gene 
expression technology is the perfect tool, as it allows the experimenter exquisite control 
over the expression of a transgene. In a recent study by Kyba et al, investigation into the 
potential contribution of primitive embryonic blood progenitor cells to definitive 
hematopoiesis was investigated by constitutively overexpressing the HoxB4 transcription 
factor in cells isolated from precirculation murine yolk sac. After subsequent culture on 
an 0P9 stromal cell layer the cells were engrafted into lethally irradiated recipients, 
whereby they were found to reconstitute the hematopoietic system (Kyba el al., 2002). 
Engraftment of donor-derived bone marrow from primary into secondary recipients 
however, showed that constitutive expression of Hox134 was inhibitory to the 
differentiation of the lymphoid lineage. The authors thereby established conditional 
expression of the transcription factor in ES cells using the tet-on system. These cells 
were differentiated via an embryoid body stage with overexpression of HoxB4 induced 
only between days 4 to 6 of differentiation. The cells were cultured on a stromal layer 
before engraftement into lethally irradiated recipients. This conditional overexpression 
of Hox134 enabled the cells to give rise to multilineage engraftment in both primary and 
secondary recipients. Therefore, it was concluded that induced overexpression of HoxB4 
was only required for a transient period in order to confer definitive multilineage 
engraftment potential on ES cells. 
Another study in which the tet-system provided the means to temporally overexpress a 
transcription factor involved in differentiation was conducted by Sonntag et al, who 
investigated the link between the acquisition of a midbrain dopaminergic cell fate and 
differentiation into a dopaminergic cell type. It was found that overexpression of the 
transcription factor Nurrl (which is necessary for the specification of the mesencephalic 
dopaminergic phenotype during embryogenesis) in vitro, in non-neuronal cells, led to a 
dopaminergic biochemical identity. This was achieved by establishing tet-regulatable 
Nurri expression in ES cells and overexpressing the transcription factor at different 
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stages during an in vitro differentiation protocol. Overexpression ofNurrl at later stages 
of differentiation was shown to give rise to non-neuronal dopaminergic cell types 
suggesting that dopaminergic phenotype can be acquired independently of a neuronal 
context (Sonntag et al., 2004). 
The directed differentiation of ES cells down defined lineages has important implications 
for cell replacement therapies, which aim to replace diseased or damaged cells in vivo 
with viable counterparts. One way to direct differentiation in this manner is to 
genetically manipulate ES cells to overexpress key regulators of differentiation. 
Miyazaki ci al, reported that tet-regulated overexpression of pdx- 1 (a transcription factor 
which is an essential regulator of pancreatic development), at discrete timeframes during 
a previously established embryoid-body based differentiation protocol, promoted the 
differentiation of insulin-producing cells. It is worth noting that conditional expression 
of pdx-1 was necessary as previous attempts to establish stable ES cell lines 
overexpressing pdx-1 had failed, probably as a result of toxicity effects of pdx-1 on ES 
cells. 
Inducible systems have also been used to study the self-renewal properties of ES cells 
themselves. It is important to gain an understanding of the mechanisms behind ES cell 
self-renewal and their pluripotent nature in order to determine how this unique cell type 
can ultimately give rise to every cell type in the adult organism. The Oct4 transcription 
factor was shown to be a key regulator in the maintenance of the pluripotent state of ES 
cells in a study where conditional expression of Oct4 was achieved via the tet-system 
(Niwa ci al., 2000). It was reported that the level of Oct4 expression was crucial in 
maintaining pluripotency as increased expression of Oct4 (to over 150% of original 
levels) resulted in differentiation of the cells into primitive ectoderm and mesoderm, 
whereas a decrease in Oct4 levels resulted in differentiation into trophectoderm. 
The search for gene products which play an important role in the maintenance of the ES 
cell state may be greatly facilitated by the recent development of a strategy used to create 
an ES cell library which contains genome-wide bi-allelic mutations (Yusa ci al., 2004). 
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The loss of function of Bloom's syndrome gene (B/rn) results in increased rates of loss of 
heterozygosity owing to a high rate of recombination between non-sister chromatids of 
homologous chromosomes in G2 of the cell cycle, in a recent report both B/rn alleles in 
ES cells were manipulated so that their transcription was dependent upon the withdrawl 
of doxycyline (with the utilisation of the tet-off system). Subsequent transient loss of 
B/rn expression coupled with N-ethyl-N-nitrosourea mutagenesis led to the production of 
an ES cell library containing an estimated 4.2 independent clones per locus bearing bi-
allelic mutations. The usefulness of the library in phenotype-based genetic screening was 
validated by screening for mutants of glycosyiphosphatidyl inositol-anchor biosynthesis. 
1.7 	The targeting of both tet system components in ES cells 
High basal levels of transgene expression in the absence of inducer is a frequently 
reported problem upon random integration of tet-system elements, (Izumi and Gilbert., 
1999, Qu et al., 2004,), and as a result of this it is necessary to screen large numbers of 
clones. This background transcription can be attributed to the action of endogenous 
enhancer sequences upon the TRE component (and in those cases where the original rtTA 
is used, residual binding of the transactivator to the TRE is also an issue as discussed in 
1.5.5). In order to overcome the problem of background expression, it was decided in 
this project to target both elements of the tet-system to pre-characterised loci in an 
attempt to find suitable genomic sites that would allow for tightly regulated expression of 
cDNAs. This strategy has the added advantage that once such a system has been 
established it can be used to directly compare the overexpression of independent cDNAs. 
Such an approach was undertaken by Wutz et al., to investigate the domains of Xist RNA 
that are responsible for the silencing and localisation functions of Xist during X-
inactivation. A series of Xist cDNA deletion mutants were overexpressed with the tet-
system in ES cells. As both components of the system were targeted into the genome the 
array of clones expressing different mutant forms of Xist could be directly compared 
(Wutz et al., 2002). 
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The X-linked hypoxanthine phosphoribosyltransferase (hprt) gene was initially chosen to 
incorporate both elements of the tet-system (as described in chapters 2 and 3 of this 
thesis). HPRT is an enzyme which catalyses one of the first steps in the salvage pathway 
of nucleoside biosynthesis in mammalian cells. The gene itself spans 33 kilobases and is 
comprised of 9 exons. The hprt locus is well characterised, and there are a number of 
vectors (Thompson etal., 1989; Reid et al., 1991), and cells lines (Hooper et al., 1987; 
Magin et al., 1992) available to facilitate the targeting of exogenous sequences to the 
locus. Indeed there are targeting vectors available to target both the 5' region and the 3' 
region of the hprt locus. The targeting of the reverse transactivator to the 5' region and 
the TRE to the 3' region of hprt results in an intervening distance of 30 kb between both 
elements. 
At such a distance it was considered that the promoter driving the expression of the 
transactivator was unlikely to activate expression of the TRE-linked transgene in the 
absence of inducer, a problem which has been reported when both tet-components are 
integrated in a single construct, (Hofmann et al., 1996, Markusic ci al., 2005). 
Several transgenes have previously been targeted to the hprl locus. Kirby et al used the 
pMPN8 replacement vector to target a truncated receptor for the growth factor 
erythropoietin upstream of the hprt coding region. When treated with exogenous 
erythropoietin these mice exhibited a increase in multipotent, clonogenic haematopoietic 
cells (Kirby etal., 1996). In an independent study Bronson et al., 1996, targeted a single 
copy of the murine bcl-2 transgene under the control of either a human or chicken /3-actin 
promoter to the 5' region of hprt using the pMP8SKB correction vector. Widespread 
expression of the transgene was detected in most tissues analysed in the resulting 
transgenic mice. The expression oftransgenic sequences from the hpri locus in ES cells 
have also been described (Kyba et al., 2002; Wutz et al., 2002), supporting the notion of 
hprt being an ideal candidate for the expression of exogenous sequences. 
The utilisation of the ROSA26 locus is also described in this project. This locus was 
originally discovered during a gene trap screen carried out in ES cells (the gene trap 
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encoded a p-gal reporter). The derivation of transgenic mice using ES cells harbouring 
the 'gene trapped' ROSA26 locus led to the discovery that 3-gal expression was present 
throughout all the tissues of the embryo (Zambrowicz et al., 1997). Subsequent analysis 
of the locus allowed the construction of a vector which yields efficient targeting of 
ROSA26. This vector contains the original splice acceptor site that was contained within 
the gene trap and therefore transgene expression can be driven from the endogenous 
ROSA26 promoter (this is discussed in greater detail in chapter 4). The ubiquitous 
expression of transgenes targeted with this vector was exemplified by the creation of a 
transgenic mouse line that expressed Cre-recombinase from the endogenous ROSA26 
promoter (Soriano et al., 1 999). When this line was crossed to a reporter line, which 
contained a 'Jioxed' p-gal sequence (also at targeted to R05A26), the resulting mice 
were uniformly blue upon staining with X-gal. The endogenous ROSA26 promoter has 
previously been used to drive the expression of the rtTA in ES cells (Wutz et al., 2002, 
Kyba et al., 2002), which exemplifies its suitability in conjunction with the tet-system. 
It has previously been described that the application of the tet-system in ES cells can 
greatly facilitate the study of lineage differentiation, and even pluripotency itself. The 
aim of this project was initially to establish the tet-on system in ES cells, using a 
fluorescent reporter transgene to validate the system (this will be described in chapters 2 
to 4 of this thesis). Pre-characterised loci were targeted with the components of the tet-
system to obtain tight and uniform expression of the inducible reporter. Transgene 
expression levels over a range of concentrations of inducer were also investigated in 
order to determine whether or not intermediate levels of transgene expression could be 
obtained. Upon the establishment of a suitable strategy cDNAs were overexpressed to 
investigate the involvement of the mitogen activated protein kinase (MAPK) pathway in 
neural induction using an established in vitro differentiation cell monolayer protocol 
(Yiiig et al., 2003), the results of which are presented in chapter 5 of this thesis. 
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Chapter 2 
The targeting of the transactivator to the 5' hprt locus in El 4TG2a cells 
2.1 	Introduction 
The initial strategy for integrating both the driver and responder elements of the tet-
system into ES cells was to target both sequences to the hypoxanthine ribosyltransferase 
(hprt) locus, the reverse transactivator (rtTA2sM2)  into a 5' proximal position, and the 
transactivator-response element (TRE) into a 3' position. In this chapter, the targeting of 
the rtTA 2 -M2 eDNA, driven by the different promoters CMV and CAG is described. The 
subsequent analysis shows that the composite CAG promoter is far superior in terms of 
driving homogenous levels of rtTA2sM2  throughout an ES cell population. 
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2.2 	The cytomegalovirus promoter and enhancer to drive expression of the 
rtTA2sM2 transactivator 
In the aim of establishing a conditional gene expression system in ES cells, which allows 
complete control over the induction and levels of transgene expression, it is optimal that 
the transgene in question is expressed at homogenous levels, ubiquitously throughout the 
cell population. It is therefore important to choose a promoter that in turn, drives 
constitutive and homogenous levels of the reverse transactivator. Throughout the early 
development of the tet-system, the cytomegalovirus CMV promoter and enhancer 
element (hereon just referred to as the CMV promoter) was used to drive the expression 
of tTA and rtTA. After the initial development of tTA, it was reported that stable 
integration of both the transactivator and luci ferase-1 inked transactivator response 
element into HeLa cells, gave rise to luciferase inductions of over 10 fold in magnitude, 
upon the withdrawal of tetracycline inducer (Gossen & Bujard, 1992). In more recent 
studies, the CMV promoter element has been shown to give rise to homogenous 
expression of TRE-linked transgenes when used to drive tTA expression in CHO 
(Chinese hamster ovary) cell lines (Izumi etal., 1999), and rtTA2sM2  expression in 
ML20 (a derivative of MCF-7) cell lines (Qu etal., 2004). The CMV promoter was 
therefore the first candidate of choice for regulating rtTA2sM2  expression in ES cells. 
2.3 	The hprt targeting vectors 
EI4TG2a cells were used to incorporate both elements of the tet system. This ES cell 
line is karyotypically male, and lacks endogenous HPRT activity. The EI4TG2a cell line 
was derived from the parental E14 line, by selection for an HPRT negative phenotype in 
medium containing 6-thioguanine (which is converted to a toxic metabolite by HPRT). 
This resulted in the isolation of clones which contained spontaneous deletions at the hprt 
locus (Hooper etal., 1987). E14TG2a was one of those clones isolated. These cells 
harbour a 55 kb deletion in the 5' region hprt, which encompasses the promoter region, 
and exons 1 and 2 (Tsuda et al., 1997). 
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Two correctional vectors were available to independently target the reverse 
transact i vator-encod ing sequences to this locus. Both vectors contain the genomic hprt 
sequences deleted upon the derivation of the E14TG2a cell line, and the targeting of these 
vectors to hprt results in the reestablishment of the ORF and restoration of HPRT 
activity. Clones exhibiting HPRT activity can be selected for in HAT medium (which 
contains hypoxanthine, aminopterin and thymidine). Aminopterin blocks the de novo 
nucleoside synthesis pathway and only those clones possessing functional salvage 
pathway metabolism (of which HPRT is an essential component) are able to generate 
nucleotide tn phosphates. 
The two vectors utilised possessed different modes of integration. The insertion vector 
pDWM 101 (Thompson ci al., 1989) contains genornic sequence from the wild type hprt 
allele which extends from 650 base pairs upstream of the hpri promoter, to an EcoRl site 
located within intron 3 (Figure 2. la). During the construction of this vector, intron 1 of 
hprt was reduced from 10.8 kb (the size found in the wild type hprt allele) to 4.1 kb. A 
region encompassing exon 3 and the immediate flanking area is homologous to the 
corresponding region in EI4TG2a cells (the size of this homology is between 2.3 and 4.2 
kb depending on the exact endpoint of the hprt deletion). The linearisation of this vector 
at aXhol site within the region of homology, and subsequent targeting, results in the 
formation of a functional hprt allele and in addition the duplication of exon 3 (Figure 
2.2a). A correct targeting event results in the positioning of transgenic sequences 
encoded within the vector, 2.5 kilobases upstream of the newly integrated hprt promoter 
(Figure 2.2a). These transgenic and promoter sequences are separated by plasmid 
backbone sequence that also integrates into the locus. 
Manipulation of the pDWM 101 vector was required to facilitate the incorporation of 
transgenic sequences into this vector. Plasmid pDWM1OI was linearised by partial 
digestion with EcoRl, after which a oligonucleotide sequence encoding KpnI, Nod, 
BamHl and SmaI restriction sites and with EcoRl compatible ends was inserted into the 
cut vector (Figure 2,1b). This resulted in the recreation of the EcoRI site at one end of 
34 
Figure 2.1 Schematic representation ofpDWM101 and pSKBI targeting vectors. 
a) Insertion vector pDWMIOI with the size of genomic encoding region and the region of 
homology to the endogenous hprl locus in E14TG2a cells indicated. b) Modification of 
the pDWM 101 vector by insertion of a polylinker into the EcoRl site downstream of 
exon 3 of the genomic insert. c) The pSKBI replacement vector with the size of the 
genomic encoding region and the region of homology indicated. Potential restriction 
enzyme sites which can be used to incorporate exogenous sequence are shown in red. 
Underlined restriction sites represent sites of linearisation. 
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Figure 2.2 Targeting of the pDWM101 and 
pSKB1 vectors to hprt. a) Targeting of the 
integration vector pDWM1O1 after linearisation 
with PmeI results in the establishment of a 
functional hprt gene with duplication of exon 3. 
The pDWM 101 plasmid backbone is also 
integrated. Transgenic sequences lie 2.5 kb 
from the newly inserted hprt promoter 
(indicated in red). b) Targeting of the 
replacement vector pSKB1 to hprt after 
linearisation with Pmel also results in the 
formation of a functional hprt gene. As two 
crossover events occur during targeting, 
plasmid backbone sequence is not incorporated 
into the hprt locus. Transgenic sequences are 
positioned immediately upstream of the hprr 
promoter. 
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Not drawn to scale 
the inserted oligonucleotide sequence. The orientation of the oligonucleotide within 
pDWM 101 was determined by sequencing and is shown in Figure 2.1 b. 
The XhoI site for linearisation is located within exon 3 of the hprt genomic sequence. It 
was deemed necessary to change this site to a less common restriction site so as to reduce 
the chance of the linearisation restriction site also being present within any additional 
sequences that were to be cloned into the targeting vector. The vector was therefore 
digested with XhoI, and after filling in the recessed 3' ends with kienow polymerase, 
PmeI linkers were inserted to create an eight base pair site of linearisation. 
The alternative targeting vector available, pSKB I (Bronson et al., 1996), not only 
encodes homology to exon 3 and the surrounding region but also to the region 5' of the 
hprt deletion in EI4TG2a cells, and thus can integrate as a replacement vector (Figure 
2.2b). Transgenic sequences can be cloned into either the NotJ site or MluI site of 
pSKB1, which are located immediately 5' to the genomic hprt promoter (Figure 2. ic). 
The linearisation of this vector at a Pmel site within the plasm id backbone, and 
subsequent electroporation results in the formation of a functional hprt gene. As two 
crossover events occur during the correct targeting of this vector, no duplication events 
result from integration and the plasmid backbone sequence is not incorporated into the 
targeted locus. The pSKB I vector required no additional manipulation before inserting 
the transgenic sequences. 
2.4 	Cloning steps involved in the construction of the reverse transactivator 
containing targeting vectors 
For the purpose of monitoring the expression of the rtTA2'-M2 transcription unit after the 
targeting of the exogenous sequences, the reverse transactivator coding sequence was 
linked to an Internal Ribosome Entry Site (IRES) sequence and a fluorescent reporter 
sequence. The reporter used was humanised renilla GFP (hrGFP), a fluorescent protein 
found in Renilla renformis that has similar emission and excitation spectra to that of 
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Figure 2.3 Cloning strategy for creating the 	 fragment 
and subsequent insertion into the targeting vectors, a) The )GioI site upstream of the 
CMV promoter in pUl-1rT62-1 was abolished (as indicated by X), and a NotI site inserted 
in its place. Restriction digest with Notl plus BamHl yielded the CMV-rtTA2-M2 
sequence, and this was subsequently inserted into Notl/BamHl digested pIRES-hrGFP-la 
plasmid. b) The BamHI site of this resulting plasmid was removed and the CMV_rtTA2s 
M2-IRES-hrGFP-pA fragment was excised by NotlIMluI digest and inserted into 
NotI/MluI digested pSKB 1 to create the p5'hprtCMV" P targeting vector as shown in d). 
c) The unique MluI site found in pCMVrtTA2 5-M2ihrGFP was replaced with a BamHI 
site and the CMV-rtTA-IRES-hrGFP-pA sequence was subsequently extracted as a 
NotIIBamHI fragment. This was then ligated into NotI/BamHl digested modified 
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eGFP. The codon frequencies of this reporter have been altered to resemble those found 
in mammalian genes (hence the term 'humanised') 
A unique Xhol site in the rtTA2sM2encoding  plasmid pUHrT 62-1 was first abolished 
and replaced with a NotI site (Figure 2.3a). The CMV- rtTA2sM2 fragment was then 
removed by Notl plus BamHI digestion and ligated into NotIIBamHI digested pIRES-
hrGFP-Ia (Figure 2.3b). The BamHI site downstream of the rtTA2sM2  was 
subsequently removed by digesting pCMVrtTA2SM2ihrGFP  with BamHI and making 
the fragment ends flush by incubation with klenow polymerase and dNTPs before 
religating the plasmid. A Notl plus MluI digest of the resulting vector yielded the CMV-
rtTA-IRES-hrGFP fragment, which was subsequently inserted into NotlIMlul digested 
pSKBI to create the final replacement targeting vector p5'hprtCMV" (Figure 2.3d). 
Plasmid pCMVrtTA2-M2ihrGFP (Figure 2. 3c) was further manipulated to replace the 
Mlul site with a BainHI site. Digestion with NotI plus BamHI yielded the CMV- rtTA2S 
M2 -IRES-hrGFP sequence, which was then ligated into the polylinker of modified 
pDWM 10 1  (the fragment was inserted into Notl/BamHI digested vector), to create the 
p5'hprtCMV targeting vector (Figure 2.3e). 
2.5 	The targeting of p5'hprtCMV and p5hprtCMVs  into E14TG2a cells 
Both targeting vectors were linearised with PmeI restriction endonuclease and 
electroporated into E14TG2a cells. After electroporation, the cells were replated, and the 
next day seeded out in HAT selection medium. After 6-9 days of selection, HAT 
resistant colonies were picked and three clones from each transfection were expanded, 
after which genomic DNA was extracted and digested with BamHl or EcoRI prior to 
analysis by Southern blot hybridisation. 
Figure 2.4a depicts the predicted targeting of the endogenous hprt locus with 
p5'hprtCMV", and the expected fragment sizes yielded after digestion with BamHl and 
EcoRl. Sequence encoding CMV rtTA2SM2IREShrGFP was used as an internal probe 
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Figure 2.4 Targeting of p5'hprtCMVins to the hprt locus 
a) p5'hprtCMVins was linearised with Pmel restriction 
endonuclease and electroporated into E14TG2a cells. A 
correctly targeted hprt allele is shown with predicted 
fragment sizes after digestion with BainHl and EcoRI. The 
distance separating the hprt promoter and exogenous 
sequences is 2.5 kb as indicated in red. b) After 
electroporation and subsequent selection in HAT medium, 
the genomic DNA from HAT resistant colonies was digested 
with BamHl and EcoRl and analysed by Southern blot 
hybridization. The sequence encoding CMV-rtTA2s-M2-
IRES-hrGFP was used as an internal probe (as shown in a). 
The pDWM 101 lane represents a cell line targeted with the 
vector alone. pdp: partial digest product 
in the analysis of clones by Southern blot hybridisation. For a correctly targeted clone a 
12.4 kb fragment was predicted after digestion with BamHl and detection by 
hybridization to the vector-specific internal probe. Only clone 12 showed the band of 
predicted size, with clones 8 and 9 exhibiting a smaller sized band of about 9 kb in size 
(as determined by comparison to Hindul digested lambda marker, not shown), Figure 
2.4b. The band sizes predicted from EcoRl digest were 2.0, 1.9 and 0.8 kb. Again, only 
clone 12 exhibited all three of these bands, however 0.8 and 1.9 kb bands appeared in the 
lanes of clones 8 and 9. The 2.0 kb band was absent in the digests of clones 8 and 9 and a 
band of around 5 kb was detected, which was not found in the digest of clone 12. The 
presence of unexpected band sizes found in both the BamHI and EcoRI digests of clones 
8 and 9 suggest that the integration event in these clones involved an alternative and 
unpredicted configuration of exogenous sequence at the hprt locus. A band of about 3 kb 
in size was seen in the lanes of all three clones in the EcoRI digest. This could possibly 
be a partial digest product of the 0.8 and 1.9 kb EcoRI fragments. 
Figure 2.5b depicts the targeting of p5'hprtCMVinto EI4TG2a cells. Correctly 
targeted integrants yielded a 15.7 kb band upon BamHl digest, and 1.9 and 0.8 kb bands 
upon digestion with EcoRI. All three clones analysed showed the predicted bands after 
BamHI and EcoRI digest and subsequent hybridisation to the internal probe. Once again 
a 3.0 kb band was seen after EcoRl digest of the clones, which probably represents a 
partial digest product. 
The targeting efficiency of the replacement vector was approximately 10 fold higher than 
that of the insertion vector, with the efficiency for p5'hprtCMV 111 approximately 106 
HAT resistant colonies generated per cell electroporated with vector DNA, and for 
p5'hprtCMV approximately 10. The difference in targeting efficiency is most likely 
due to the replacement vector encoding longer stretches of homology to the endogenous 
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Figure 2.5 Targeting of p5'hprtCMVrep to the hprt locus 
a) p5'hprtCMVrep was linearised with Pn1el restriction 
endonuclease and electroporated into E14TG2a cells. A 
correctly targeted hprt allele is shown with predicted 
fragment sizes after digestion with BamHl and EcoRl. b) After 
electroporation and subsequent selection in HAT medium, the 
genomic DNA from HAT resistant colonies was digested with 
BamHl and EcoRl and analysed by Southern blot hybridization. 
The sequence encoding CMV-rtTA2s-M2-IRES-hrGFP was 
used as an internal probe (as shown in a). The pSKB1 lane 
represents a cell line targeted with the vector alone. pdp: 
partial digest product. 
	
2.6 	Analysis of rtTA2SM2  expression by RT-PCR 
The six targeted clones, CMVins 8, 9 and 12, and CMVrep 4, 7 and 10 were analysed for 
expression of the rtTA2sM2  transcript (Figure 2.6a). RNA was extracted from each cell 
line and quantified before being used as a template for the production of cDNA by 
incubation with Superscript 11 reverse transcriptase (Invitrogen), oligoT primers (that 
bind to the polyA tracts of messenger RNA), and dNTPs. The cDNA derived from this 
reaction was then analysed for the presence of rtTA2sM2  sequences by using a primer 
set designed to amplify a 700 base pair fragment of rtTA2sM2.  EI4TG2a eDNA was 
used as a negative control. A 700bp band was detected for all clones analysed, with no 
fragments amplified in the minus reverse transcriptase controls (data not shown) or 
E14TG2a control. All targeted clones therefore expressed the rtTA2sM2  transcript. 
2.7 	Analysis of rtTA2SM2 function by transient luciferase assay 
Following on from the detection of the rtTA2sM2  by RT-PCR, the production of 
functional rtTA2sM2  protein was determined by transiently transfecting all cell lines 
with the reporter plasmid pBl-L which encoded a TRE and linked firefly luciferase gene, 
followed by the assay of luciferase levels. 
The targeted clones were transfected with pBl-L and pREN (a renilla luciferase-
expressing plasmid which acted as an internal control for variations in transfection 
efficiency; see materials and methods). The following day I xg dox was added to each 
cell line (with some cultures from each cell line remaining free of dox), and 48 hours 
later the cells were lysed and analysed for the expression of the luciferase reporters. 
All clones were shown to induce the expression of firefly luciferase in the presence of 
dox (Figure 2.6b), although the degree of expression varied between the cell lines. 
Negligible basal levels of luciferase expression were detected in the absence of dox. The 
fold induction of luciferase is shown graphically in Figure 2.6c. It can be seen that whilst 
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Figure 2.6 Analysis of rtTA2s-M2 expression. a) RT-PCR of the six 
targeted cell lines using primers specific for rtTA2s-M2. A 700bp band 
was detected in all targeted clones. b) The cell lines were transiently 
transfected with a reporter plasmid encoding a TRE and linked firefly 
luciferase sequence, and the following day some cells of each 
transfected clone were treated with lug/ml dox whilst others were left 
untreated. 48 hours later the cells were assayed for luciferase 
expression. c) Representation of the same experiment as fold induction 
of luciferase for each clone. All transfections were normalised by 
cotransfection with a renilla luciferase-expressing plasmid. All 
transfections were carried out in triplicate. 
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differences in the levels of induction between the CMVins group and the CMVrep group 
of clones. 
2.8 	Flow cytometry of targeted clones 
Flow cytometry was used to analyse the expression of rtTA2sM2  at a cellular level. As 
described in section 2.3, the rtTA2sM2  ORF was linked to an IRES-hrGFP sequence to 
create a bicistronic element. Once targeted, expression of hrGFP should therefore 
parallel that of rtTA2sM2,  and thus acts as a reporter of transactivator expression. 
The analysis of all the targeted cell lines by flow cytometry is shown in Figure 2.7. 
EI4TG2a acted as a negative control in order to establish the hrGFP positive region, and 
the percentage of cells falling within this positive region is shown in the bottom right-
hand corner of each plot. Although all the clones analysed exhibited some degree of 
hrGFP fluorescence and therefore rtTA2sM2  expression, only small populations of cells 
were positive for hrGFP. In addition those cells that were positive, were only marginally 
so, as determined by the very slight shift along the x-axis. It would appear that the 
CMVins cell lines contain a higher number of hrGFP positive cells on average, when 
compared to the CMVrep cell lines, however more clones would need to be derived and 
analysed in order to establish if this is a consistent trend. 
In order to produce a system which exhibits population-wide induction of a transgene in 
the presence of dox, it is necessary that rtTA2s,M2  is expressed in every cell within a 
population, and in addition, at levels sufficiently high enough to induce homogenous 
expression of the transgene. RT-PCR and luciferase analysis of the CMVins and 
CMVrep clones showed that rtTA2sM2  was expressed and active in all clones analysed, 
however flow cytometry revealed that rtTA2s.M2  expression was very mosaic and at low 
levels. It was therefore deemed necessary to utilise another promoter to drive the 
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Figure 2.7 Flow cytometry of targeted cell lines. All six cell lines were 
analysed for hrGFP expression. hrGFP fluorescence is shown on the x-
axis, with the y-axis redundant. E14TG2a was used as a negative 
control to determine the hrGFP positive region (this region is shown). 
The percentage of hrGFP positive cells falling within this region is 

















2.9 	The CAG promoter to drive expression of the reverse transactivator 
The CAG promoter is a composite promoter comprised of viral and eukaryotic 
sequences. In addition to a CMV enhancer and chicken 13-actin promoter, it encodes a 
chimeric intron (derived from chicken 3-actin, and rabbit 13-globin introns) and a splice 
acceptor sequence. Transgenes placed downstream of this regulatory element have been 
reported to be expressed at high levels in ES cells (Chung et al., 2002, Niwa el al., 2000). 
The CAG element was therefore chosen as the second candidate promoter to drive 
expression of rtTA2sM2 . 
In order to link the CAG promoter sequence to the transactivator, plasmid CAGGS-S was 
digested with EcoRI plus BamHI and the rtTA2sM2IREShrGFPfragment yielded from 
the digestion of pCMV rtTA2sM2ihrGFP  with the same restriction enzymes was ligated 
into the digested pCAGGS-S backbone to generate CAG- rtTA2sM2ihrGFP  (Figure 
2.8a). 
A Spel/BamHl double digest of plasmid CAG-rtTA2'-M21hrGFP excised the CAG-
rtTA2"-M2-IRES-hrGFP-pA fragment. After the 5' protruding ends were made flush 
with klenow polymerase this fragment was inserted into Nod digested, pSKB1 (which 
had also been treated with klenow polymerase), to create the targeting vector 
p5'hprtCAG'. The orientation of the inserted sequences was determined by restriction 
digest. The final p5'hprtCAG targeting vector contained the CAGrtTA2sM2lRES 
hrGFP-pA sequence in an opposite orientation to that of the 5' to 3' transcriptional 
orientation of genomic hpr/ sequence encoded within same the vector (Figure 2.8c). This 
orientation is identical to that of the CMVrtTA2sM21REShrGFP  sequences contained 
within the p5'hprtCMV"I targeting vector used in the previous electroporation. 
Due to the increased targeting efficiency of the pSKBI vector over that of the pDWM1O1 
vector, and also the possibility of targeted sequences becoming excised after use of the 
pDWM1OI vector (see discussion), only pSKBI was used for the targeting of CAG 
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Figure 2.8 Cloning strategy for constructing the CAG-rtTA2s-M2-
IRES-hrGFP-pA fragment and subsequent insertion into the pSKB1 
targeting vector, a) Partial digest of pCMV-tTA2s-M2ihrGFP with 
EcoRl, followed by digestion with BamHl yielded the tTA2s-M2-IRES-
hrGFP-pA sequence, which was then inserted into EcoRl/BaniHl 
restricted pCAGGS. b) Spel/BamHl double digest of the resulting 
plasmid yielded the CAG-rtTA2s-M2-IRES-hrGFP--pA fragment. The 
3 recessed ends of this fragment were made flush with klenow 
polymerase and then inserted into Nod digested, pSKB1 replacement 
vector (the ends of this vector had also been made flush by klenow 
polymerase treatment), to create the p5'hprtCAG targeting vector 
Not drawn to scale 
The targeting vector was linearised with PmeI and electroporated into EI4TG2a cells 
(Figure 2.9a). The next day the cells were plated out in HAT selection. After 6-9 days 
colonies were picked and eight clones were expanded and analysed by Southern blot 
hybridisation, using the 	 sequence as an internal probe. 
The fragment sizes predicted from BamHI and EcoRI digestion of genomic DNA from 
correctly targeted clones are shown in Figure 2.9a. Digestion with BamHI was expected 
to yield a 16.7 kb band, and indeed this fragment was observed for all clones except clone 
CAGrepA3 (Figure 2.9b). Correctly targeted clones were expected to yield 1 .9, 0.8 and 
1.7 kb bands upon EcoRl digestion and subsequent hybridisation. Surprisingly only the 
0.8 kb band was visible. The reason for the absence of the expected 1.9 and 1.7 kb bands 
has yet to be determined. Once again no bands were seen in the lane of CAGrepA3 
suggesting that the endogenous hprt locus had not been targeted in this line. 
2.10 Flow cytometry of the CAGrep cell lines 
The analysis of the CMVins and CMVrep clones by flow cytometry proved to be the 
most definitive test of rtTA2-M2 expression. Four correctly targeted CAGrep cell lines 
were therefore analysed for expression of hrGFP by flow cytometry. 
The outcome of this analysis is shown in Figure 2.10. In marked contrast to the previous 
CMVins and CMVrep cell lines, all four CAGrep clones analysed showed a definite and 
relatively homogenous shift along the x-axis, with the vast majority of cells possessing a 
clear hrGFP positive phenotype. The proportion of hrGFP positive cells between cell 
lines was remarkably consistent, with values of over 98% for each clone. This result 
establishes the CAG sequence as a suitable choice of promoter to drive expression of 
rtTA2sM2 at the 5' region of hprt. 
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Figure 2.9 Targeting of pS'hprtCAG to hprt a) pS'hprtCAG 
was linearised with Prnl restriction endonuclease and 
electroporated into E14TG2a cells. A correctly targeted hprt 
allele is shown with predicted fragment sizes after digestion 
with BamHl and EcoRl. b) After electroporation and 
subsequent selection in HAT medium, the genomic DNA 
from HAT resistant colonies was digested with BamHl and 
EcoRl and analysed by Southern blot hybridization. The 
sequence encoding CAG-rtTA2s-M2-IRES-hrGFP was used 
as an internal probe (as shown in 2.9a). The pSKB1 lane 
represents a cell line targeted with the vector alone. 
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Figure 2.10 Analysis of targeted cell lines by flow cytometry. Four 
CAGrep clones were analysed for hrGFP expression. hrGFP fluorescence is 
shown on the x-axis, with the y-axis redundant. E14TG2a was used as a 
negative control to determine the hrGFP positive region (this region is 
shown). The percentage of hrGFP positive cells falling within this region is 
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The targeting of rtTA2sM2  to the 5' region of hprt using the pDWM1OI and 
pSKBI correction vectors 
Two types of targeting vector were used to independently integrate the reverse 
transactivator and linked sequences into the 5' region of hprt. The main reason for 
utilising two vector types was the different mode of integration for each; pDMW 101 
integrates as an insertion vector with one cross-over event taking place between the 
endogenous hprl locus and homologous vector sequences, whereas pSKB 1 integrates as a 
replacement vector, via two cross-over events (Figure 2.2). As a consequence, the 
integrated transgenic sequences were predicted to be positioned at different distances 
from the hprt promoter. Use of the pDWM 101 targeting vector resulted in the integration 
of transgenic sequences 2.5 kilobases upstream of the hprt promoter, whilst the pSKB1 
vector integrated sequences immediately upstream of the promoter. Whilst both vectors 
have previously been used to target transgenic sequences to the hprt locus (Bronson et 
al., 1996), previous studies have not included the analysis of transgene expression on a 
single cell basis. As it is essential that the rtTA2s_M2  transactivator is expressed 
throughout the ES cell population in order for the tetsystem to be utilised effectively, it 
was decided to use both vectors to independently target the reverse transactivator 
sequence, with the view that one vector may give rise to superior rtTA2SM2 expression. 
The rtTA2sM2  ORF was linked to a fluorescent reporter gene via an IRES sequence to 
enable the detection of rtTA2sM2  levels indirectly by the flow cytometric analysis of 
hrGFP expression. 
No substantial difference in expression of hrGFP was observed in cell lines derived from 
the targeting of the CMVrtTA2sM2IREShrGFP  encoding sequence, using the two 
different vectors. As described previously, the correct integration of the pDWM 101 
vector results in the duplication of exon 3 (in the region upstream of the inserted 
exogenous sequences). This duplication event could potentially lead to the excision of 
42 
the integrated exogenous sequences via homologous recombination between the 
duplicated regions. Although the continued presence of HAT medium could select 
against this event, such a situation would not allow the further targeting of the TRE into 
the 3' region of hprl, as this requires the selection of an HPRT negative phenotype (to be 
described in the next chapter). Due to these concerns the sequence encoding the CAG 
promoter, and linked transactivator, was targeted using only the pSKB I targeting vector. 
An additional advantage to using this vector was the increased efficiency of targeting 
over the pDW M 101 insertion vector. 
The cytomegalovirus immediate early enhancer and promoter to drive the 
expression of rtTA2sM2 
It was found that despite the initial promising results of detecting the rtTA2SM2 
transcript by RT-PCR, and the induction of luciferase upon transient transfection of a 
TRE and linked luciferase reporter plasmid into the newly targeted clones (upon the 
addition of dox), flow cytometry analysis revealed that expression of hrGFP (and 
therefore rtTA2sM2)  was very low and mosaic, with most cells possessing a hrGFP 
negative phenotype. This observation was very surprising as it has been reported that the 
CMV promoter and enhancer sequence is able to direct high expression of transgenes 
both in numerous cell lines (Muller et al., 1990; Keating et al., 1990) and in transgenic 
animals, (Furth et al., 1991). 
It has previously been described that the transient transfection of a plasmid encoding an 
eGFP ORF directly linked to a CMV promoter gave rise to eGFP fluorescence in over 
50% of the population in several ES cell lines, as determined by flow cytometry, (the 
authors state that under optimal conditions 50%-80% transfection efficiencies could be 
achieved; Ward & Stern 2002). However an earlier paper by a independent group 
revealed evidence that the transient transfection of a plasmid encoding an IRES-hrGFP 
sequence, linked to a CMV promoter did not result in hrGFP fluorescence in D3 or ii ES 
cells, or indeed in ES cells that underwent differentiation by embryoid body formation 
(Chung et a!, 2002). 
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The conflicting results of these two studies can possibly be explained by the fact that the 
former study utilises a plasm Id in which the fluorescent reporter sequence is directly 
linked to the CMV promoter, whereas the hrGFP reporter sequence used by the latter 
group is linked to the CMV promoter via an RES. It has been shown that IRES-
dependent gene expression is significantly lower than that of cap-dependent gene 
expression, and therefore it is possible that translation of the hrGFP sequence was too 
low for hrGFP fluorescence to be detected by flow cytometry (Mizuguchi et al., 2000). 
In addition it is likely that the transfection efficiency achieved by Chung el al was very 
low, owing to a suboptimal protocol for transfecting ES cells. In the study by Chung et 
al, adherent cells were transfected with DNA (using Lipofectamine TM 2000), whereas 
Ward and Stem transfected cells in suspension, (just after trypsinisation), using the same 
reagent. This author has found the overall transfection efficiency is increased using the 
latter protocol. 
In light of these studies it is possible to explain the poor expression of hrGFP in 
CMVrtTA2sM2rep and CMVrtTA2sM2i ns  cells. The targeting of exogenous sequences 
usually results in the integration of just one copy of sequence, (in contrast several copies 
of plasmid can reside in a single cell after transient transfection). In addition the strategy 
implemented in this study utilises an IRES sequence upstream of the hrGFP reporter, 
which as stated previously probably results in lower expression of the IRES-dependent 
second gene (when compared to the upstream cap-dependent gene). A previous study has 
also shown that when compared to the apolipoprotein (apo) locus, the targeting of 
transgenes to the 5' region of hprt gives rise to relatively low levels of expression 
(Hatada et al.. 1999). Therefore it is possible that in the context of the hprt locus, and at 
single copy number, the CMV promoter is not able to drive high level expression of the 
integrated transgenic sequences. 
It is clear from the study of the CMVrep and CMVins cell lines that all clones exhibit 
some degree of mosaicism with regards to the expression of the hrGFP reporter. It is 
possible that mosaicism is characteristic of CM V-driven transgene expression in ES cells. 
44 
In the previous studies described (Chung et al, 2002, Ward & Stern., 2002), expression of 
the transgenes involved the transient transfection of cells, and therefore cannot give any 
insight into the potential mosaic nature of this promoter in ES cells. There have however 
been previous reports that the CMV promoter gives rise to mosaic transgene expression 
in certain tissues in viva (Furth et al 1994). 
It is interesting to note that although all clones were able to induce the expression of a 
TRE-linked firefly luciferase reporter in the presence of dox (after transient transfection 
of the reporter plasmid), in reality it was only a very small proportion of the population 
that had the ability to induce luciferase. This analysis highlights how assays involving 
the detection of the luciferase reporter can often be deceptive. As detection involves the 
lysis of the cells prior to analysis, one does not gain any insight into whether luciferase 
levels are indicative of population-wide effects, or the result of induction in only a small 
sub-population of cells. In addition, the luciferase assay is based on an enzymatic 
reaction (that is the conversion of luciferin substrate into oxyluciferin by luciferase) and 
is therefore a sensitive assay that can amplify low levels of luciferase. This provides an 
explanation of how populations that contain few rtTA2SM2 express i ng  cells are able to 
induce luciferase reporter to reasonable levels (Figure 2.6b and 2.6c). 
The CAG promoter to drive the expression of rtTA2sM2 
The second candidate promoter chosen to drive expression of rtTA2S_M2  was the CAG 
promoter. Several studies which involved the placement of transgene sequences under 
the regulation of the CAG promoter reported high levels of transgene expression, 
(Nathwani et al., 2001; N iwa et al., 1991; Miyazaki et al., 1989). Robust transgene 
expression driven by the CAG promoter has also been observed in studies undertaken in 
ES cells (Niwa et al., 2000., Chambers et al., 2003). 
The CAG promoter is a composite promoter which contains both eukaryotic and viral 
sequences. The capacity of this promoter to drive high levels of transgene expression 
most likely results from the presence of numerous enhancer elements encoded within its 
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sequence. The promoter was developed over several years, with each modification 
increasing the strength of the promoter. It was first observed that inserting the 3' region 
of the second intron of a rabbit 3-globin gene (including the splice acceptor and 5' part of 
the third exon), into the first intron of the chicken 13-actin promoter, increased the 
expression of a downstream lacZ transgene (Miyazaki et al., 1989). This promoter, 
termed the AG promoter ('AG' stands for actin and globin), was then further modified by 
the addition of a CMV immediate-early enhancer element to form the CAG promoter 
(Niwa et al., 1991). It is thought that both the first intron of the J3-actin gene, and the 
3'region of the rabbit 13-globin gene contain enhancer-like activity, in addition to the 
CMV sequence. The presence of an intron in the CAG regulatory sequence may also 
enhance transcript stability as there is evidence that splicing itself is a prerequisite for 
stable RNA formation in eukaryotic cells (Hamer and Leder., 1979). 
In contrast to the CMV promoter, when the CAG promoter was used to drive the 
expression of rtTA2sM2  and hrGFP reporter sequences, over 98% of cells exhibited a 
hrGFP positive phenotype (Figure 2.10). The hrGFP levels approached two log shifts as 
represented on the two dimensional density plots. Whilst the majority of targeted cells 
fell within a discrete population of hrGFP positive cells (the lighter the areas on the plot 
indicate the areas of higher cell density), there did appear to be a small population of cells 
which expressed lower levels of fluorescence. This could indicate a slight mosaicism in 
transgene expression upon regulation by the CAG promoter, or alternatively epigenetic 
differences in the 5'region of hprt between cells, which affect the levels of transgene 
expression. 
In summary the CAG promoter is clearly a superior promoter in driving transgene 
expression at the S'hprt locus in ES cells. In contrast to the CMV promoter, high and 
fairly uniform levels of transgene fluorescence were detected. As it has previously been 
shown that the CMV promoter is active in ES cells (Ward and Stern., 2002), the poor 
transgene expression observed for the CMVins and CMVrep lines was most likely due to 
a combination of factors, including the single copy insertion of sequences, the presence 
of a IRES sequence upstream of the hrGFP ORF and possible low potential of the region 
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of chromatin targeted to give rise to high levels of transgene expression. All these 
restrictions are however overcome with utilisation of the CAG promoter. This is 
probably due to the presence of numerous enhancer sequences present within the 
promoter that enable the strong expression of the targeted sequences. 
With the establishment of ES cell lines that robustly express rtTA2sM2,  the next step 
was to target the TRE and linked transgene sequences into the 3' region of the hprt locus. 
This will be described in the next chapter. 
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Chapter 3 
Integration of the transactivator-response element into the 3' coding region 
of hprt 
3.1 	Introduction 
In the previous chapter it was described how homogenous expression of the reverse 
transactivator (rtTA2SM2)  was achieved by juxtaposing the rtTA2sM2  open reading 
frame to a CAG promoter sequence and targeting these exogenous sequences to the 5' 
region of the hprt gene in EI4TG2a cells. This chapter details the targeting of the 
transact ivator-response element (TRE) and linked DsRED2 reporter into the coding 
region of hprt, by utilising an already existing replacement vector designed to target the 
3' end of the gene. This positions the TRE at a distance of approximately 30 kb from the 
upstream transactivator and linked promoter. Analysis of the induction of DsRED2 
expression upon addition of dox is also described. 
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3.2 	Construction of the 3'hprtTREDsRED2F and 3'hprtTREDsRED2R 
targeting vectors and electroporation into CAGrepB7 cells 
Plasmid BigT1ucTREDsRED2 (kind gift from Barry Heavey) contains a bidirectional 
TRE which is juxtaposed to a luciferase open reading frame in one direction and a 
DsRED2 open reading frame in the other (Figure 3.Ia). The TRE sequence, linked 
reporter genes, and corresponding polyA sequence were extracted as an AscI, ScaI 
fragment from plasmid BigTIucTREDsRED2, and the protruding fragment ends were 
made flush by incubation with klenow polymerase and dNTPs. The M42 targeting vector 
(gift of M. Richardson and A.J.H.Smith, unpublished work), is a plasmid containing 9kb 
of hprt genomic sequence (spanning introns 4 to exon 9), and encodes a NotI site within 
exon 6 (which is used to insert transgenic sequences). This vector was digested with NotI 
and subjected to klenow treatment. The M42 vector and fragment sequences were then 
ligated (Figure 'Mb and 3.1c). The resulting blunt-ended ligation produced two vector 
products. Plasmid 3'hprtTREDsRED2F contained the DsRED2 sequence in the same 5' 
to 3' orientation as that of the genomic hprt coding sequence present in the M42 vector 
(Figure 3.1 b), and plasmid 3'hprtTREDsRED2R contained the DsRED2 sequence in the 
opposite orientation (Figure 3.1 c). 
Both the 3'hprtTREDsRED2F and 3'hprtTREDsRED2R targeting vectors were 
linearilised with Sf11 restriction endonuclease. This restriction enzyme cuts within each 
vector at a unique site located at one end of the cloned insert. The linearised vectors were 
then electroporated into CAGrepB7 cells, after which they were replated and passaged 
non-selectively for 7 days. After a week, 6-thioguanine (6-TG) selection was added to 
the transfected cells to select for those cells that exhibited a loss of HPRT activity (HPRT 
catalyses the conversion of 6-TG into a toxic metabolite that results in cell death). 6-TG 
resistance was indicative of a correct targeting event due to the disruption of the hprt 
ORF after integration, Figure 3.2a and 3.2b. 
6-TG resistant colonies were picked, expanded and analysed by Southern blot 
hybridisation to confirm correct integration of the TRE-containing sequence. Figures 
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Figure 3.1 The cloning of the TRE and linked reporter sequences into the M42 vector 
a) Plasmid BigTIucTREdsRED2 was digested with AscI and Scal to excise the TRE and 
linked reporter sequences. The protruding ends of the TRE fragment were made flush by 
treatment with klenow polymerase. The sequences were then inserted into Noll digested 
M42 targeting vector (which had also been treated with kienow polymerase) to create the 
vectors b) 3'hprtTREDsRED2F and c) YhprtTREDsRED2R that harboured the inserted 
sequences in opposite orientations. Both vectors are depicted in their linearised forms 
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Figure 3.2 The targeting vectors 3'hprtTREDsRED2F a) and 
3'hprtTREDsRED2R b) were electroporated into CAGrepB7 cells. The 
expected restriction fragments yielded after digestion with EcoRl 
	
9.2 Kb 	 and hybridisation with probe A are shown. C) After electroporation 
and subsequent selection in 6-TG supplemented media, genomic 
4. 6.7 Kb 	 DNA from 6-TG resistant colonies was digested with EcoRl and 
4—. 5.0kb 	 analysed by Southern blot hybridisation. 
3.2a and 3 .2b depict the sizes of fragments expected after digestion of genomic DNA 
with EcoRl restriction endonuclease, and hybridisation with a probe (probe A), 
corresponding to a region within intron 5 of the hprt gene. 
EcoRI digestion of the parental CAGrepB7 cell line was expected to yield a 9.2 kb 
fragment after hybridisation to probe A (Figure 3.2a). A 9.2 kb band was indeed present 
in the Southern blot analysis of E14TG2a and CAGrepB7 cells (Figure 3.2c). It was 
predicted that the correct targeting of the 3'hprtTREDsRED2F vector into CAGrepB7 
cells would yield a smaller band of 6.7 kb upon EcoRI digestion and probe hybridisation. 
Clones 2, 4 and 5 from the TREDsRED2F cell-lines exhibited this 6.7 kb band. Clones 
TREDsRED2F I and TREDsRED2F3 yielded a band that was larger than the wildtype 9.2 
kb fragment. Owing to the fact their loci were no longer wild type, and that both clones 
exhibited a 6-TG resistant phenotype it can be concluded that an integration event had 
occurred. However the nature of this integration event was not readily apparent. Both 
clones underwent digestion with EcoRl (data not shown) and indeed ihprtDsRED2Fl, 
(but not clone ihprtDsRED2F3) was able to express DsRED2 in the presence of dox, as 
discussed at a later point (Figure 3.3). It is therefore possible that the nature of the 
integration event was different for each of these clones. 
EcoRI digestion of clone TREDsRED2F6 yielded a band of around 7 kb, which was 
larger than the expected fragment by about 0.3 kb. This extra sequence could possibly be 
due to a duplication event that occurred within the vector prior to integration, however 
the aberrant nature of this recombination event has not been fully characterised. 
The correct targeting of 3'hprtTREDsRED2R was expected to yield a 5 kb fragment after 
digestion of genomic DNA with EcoRI and hybridisation to probe a. All the clones 
analysed exhibited this size of fragment, and therefore were concluded to be correctly 
targeted. 
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3.3 	Flow cytometry of ihprtDsRED2 cell lines 
Six ihprtDsRED2F and six ihprtDsRED2R clones were analysed for hrGFP and DsRED2 
fluorescence by flow cytometry, after culture in the presence and absence of I jg/ml dox 
(dox was added for 48 hours), the results of which are shown in figures 3.3 and 3.4. The 
first thing to note is that although leakiness of transgene expression in the absence of dox 
has previously been reported to be a problem when implementing the tet system (Izumi 
and Gilbert., 1999; Pacheco et al., 2000; Qu et al., 2004), virtually no transgene 
expression could be detected in any of the clones analysed in the absence of dox (the 
DsRED2 positive gate was set whereby the population of cells from the parental 
CAGrepB7 line falling within the gate was less than 1%). It was therefore concluded that 
the targeting of the TRE element to the 3'hprt locus did not render the TRE open to 
activation by nearby enhancer elements, which would have resulted in high levels of 
basal transcription. 
It was readily apparent that upon the addition of doxycyline all clones (bar 
ihprtDsRED2F3 which was shown to contain an aberrant targeting event by Southern blot 
analysis— Figure 3.1), exhibited expression of the DsRED2 reporter (Figure 3.3a and 
3.4a). However the percentage of cells positive for DsRED2 fluorescence varied from 
clone to clone with values ranging from 12.7% (ihprtDsRED2Fl) to 75.2% 
(ihprtDsRED2Rl), with all clones exhibiting heterogeneity in DsRED2 expression. There 
did not appear to be any significant difference in fluorescence levels between the 
ihprtDsRED2F and ihprtDsRED2R cell lines. 
One intriguing observation was that the addition of dox resulted in a decrease in the 
median hrGFP fluorescence value for every clone analysed. This effect is most clearly 
viewed in the histograms in figure 3.3b and 3.4b which depict hrGFP fluorescence in the 
presence and absence of I p.g/ml dox. The reason for this negative shift in hrGFP 
fluorescence has not yet been determined. However, as this phenomenon was present in 
every clone it suggests that activity of the TRE at this locus was somehow detrimental to 
the expression of the transactivator from the 5' region of the hprt locus. 
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Figure 3.3 Six ihprtDsRED2F clones were cultured in the presence and absence of I 
j.iglml dox for 48 hours and analysed by flow cytometry. a) Two dimensional flow 
cytometry plots for each cell line in the presence and absence of dox. The x-axis depicts 
hrGFP fluorescence and the y-axis DsRED2 fluoresence. The proportion of DsRED2 
positive cells within each cell population is shown. b) Histograms depicting hrGFP 
fluorescence in the presence and absence of dox, with median hrGFP fluorescence stated 
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Figure 3.4 Six ihprtDsRED2R clones were cultured in the presence and absence of I 
tg/m1 dox for 48 hours and analysed by flow cytometry. a) Two dimensional flow 
cytometry plots for each cell line in the presence and absence of dox. The x-axis depicts 
hrGFP fluorescence and the y-axis DsRED2 fluoresence. The proportion of DsRED2 
positive cells within each cell population is shown. b) Histograms depicting hrGFP 
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It was evident that some cell lines in the absence of dox contained two populations of 
cells that exhibited differential hrGFP fluorescence (the most extreme cases were 
ihprtDsRED2R4 and ihprtDsRED2R5 minus dox - Figure 3.4). It is possible that these 
cells lines underwent partial epigenetic silencing at their hprt promoter region during 
their derivation, resulting in a sub-population of cells expressing lower levels of rtTA2s 
M2 and hrGFP protein. 
	
3.4 	DsRED2 induction in a gradient of concentrations of dox. 
The ihprtDsRED2R3 and ihprtDsRED2F4 cell lines were cultured in a gradient of dox 
concentrations for 48 hours, to determine the concentrations of dox that were necessary to 
induce DsRED2 expression. Both clones were then analysed by flow cytometry and the 
population of DsRED2 expressing cells (Figure 3.5a.b and c) and median DsRED2 
fluorescence (Figure 3.5d) at each concentration was determined (Figure 3.5). 
Significant induction of the DsRED2 reporter was only observed at concentrations of 
0.01 jtg/ml doxycyline and above, and maximal induction of reporter gene expression in 
both lines was achieved at around 0.1 jig/ml. Even though the majority of the cell 
population could be induced to express DsRED2 at 0.1 jig/ml dox the expression was 
heterogenous in nature, with some cells expressing high levels of the reporter whilst 
others cells remained negative. Uniform expression of DsRED2 was not achieved by 
increasing the concentration of dox, indeed the median DsRED2 fluorescence started to 
decline at concentrations above 0.1 jig/mI for ihprtDsRED2R3 and 0.25 jig/mI for 
ihprtDsRED2F4 (Figure 3.5d). 
3.5 	Sorting of the DsRED2 positive cells 
It was hypothesised that the heterogenous nature of DsRED2 expression may be due to 
the presence of a sub-population of cells within the clonal population unable to express 
the reporter (for example due to epigenetic silencing mechanisms), with the remaining 
cells able to activate transgene expression to varying extents. If this was the case it was 
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Figure 3.5 a) ihprtDsRED2R3 and b) ihprtDsRED2F4 were cultured in a gradient of dox concentrations for 48 hours. Two 
dimensional density plots are shown with the percentage of DsRED2 positive cells indicated. The x-axis depicts hrGFP 
.+. IhPFtDSRED2F4 
	
	fluorescence, and the y-axis DsRED2 fluorescence. c) Graphical representation of the percentage of DsRED2 positive cells in each 
cell line at each concentration of dox. d) Graphical representation of the median DsRED2 fluorescence at each dox concentration. 
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Figure 3.6 The sorting of high DsRED2-expressing cells, a) Two-dimensional flow cytometry plots depicting DsRED2 (y-axis) and hrGFP 
fluorescence (x-axis) for sorted and unsorted cell populations, (+) cultured in dox for 6 days, (-/+) cultured in the absence of dox for 4 
days after which dox was added for the two remaining days. b) Single cell sorting. Flow cytometry plots of 6 clones each derived from the 
single cell sorting of DsRED2 positive cells, either maintained in dox for 8 days or cultured in the absence of dox for 6 days with the 
addition of dox for the remaining 2 days. 
reasoned that the sorting of high DsRED2 expressing cells from the rest of the 
heterogenous population may lead to the establishment of a population of cells that were 
able to reproducibly activate DsRED2 expression to high and homogenous levels. 
The ihprtDsREDF6 cell line was therefore cultured in 1 ig/ml dox for 48 hours, after 
which the DsRED2 positive cells were sorted from the negative population and cultured 
separately. Half of the highly expressing DsRED2 cells were maintained in dox for 6 
days (these will be referred to as sorted + cells), whilst the other half were cultured 
without dox for 4 days with dox subsequently added for the remaining two days 
preceding analysis (these will be referred to as sorted -1+ cells). An unsorted population 
of cells was also cultured in parallel under identical conditions (unsorted + and unsorted - 
1+ respectively). All cells were analysed at day 6 (Figure 3.6a) 
It was observed that the DsRED2 expression of the sorted + cells could not be maintained 
after six days in dox. Indeed, surprisingly the cell population of sorted + was mostly 
negative for DsRED2, with significantly lower fluorescence levels than those possessed 
by the initial pre-sort population of cells. There was no apparent difference in the levels 
of DsRED2 induction between the sorted + and the unsorted + cells. 
In a parallel experiment, single DsRED2 positive cells were sorted from the 
ihprtDsRED2F6 population into the wells of a 96 well plate. These cells were either 
maintained in dox for 8 days (sorted +) or maintained in the absence of dox, with the 
addition of dox two days before flow cytometric analysis (sorted -1+). Six clones are 
shown in figure 3.6b, the profiles of which are representative of all clones analysed. It 
can be seen that clones cultured in the presence of dox were all largely negative, whereas 
the clones cultured in the absence of dox could be induced to express DsRED2 levels 
comparable to those of the ihprtDsRED2F6 presort. It could therefore be concluded that 
high DsRED2 levels could not be maintained after the sorting of high DsRED2- 
expressing cells. 
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3.6 	Induction of DsRED2 after different periods of culture in dox 
It was clear from the cell sorting experiment that the propagation of ihprtDsRED2 cells in 
dox for long periods of time was detrimental to DsRED2 expression. This was 
investigated further by culturing the ihprtDsREDF4 and ihprtDsREDR2 cell lines in 
1ig/ml dox for 0 to 6 days (Figure 3.7). After 6 days each timepoint was analysed for 
DsRED2 fluorescence by flow cytometry. 
It can be observed from figure 3.7 that maximal induction of the DsRED2 transgene was 
achieved after 2 days in dox (78. 1% and 61.7% of cells were positive for DsRED2, 
ihprtDsREDF4 and ihprtDsREDR2 respectively). At day 3 this high expression was 
maintained in the ihprtDsREDF4 cell line whereas the ihprtDsREDR2 cell line exhibited 
a slight reduction in DsRED2 fluorescence. 
After day 3 the two cell lines exhibited a decline, in both in the percentage of cells that 
remained positive and in the median DsRED2 fluorescence recorded (Figure 3.7c and 
3.7d). At day 6 a large proportion of the cell population was negative for DsRED2 in 
both clones. Maintenance of the clones in dox for periods of longer than 3 days therefore 
appears to be detrimental to DsRED2 expression, which correlates with the inability to 
maintain DsRED2 reporter expression in the previous sorting experiment. 
3.7 	Discussion 
It has been shown previously that homogenous inducible expression of fluorescent 
reporter transgenes can be achieved using the tet-system (Izumi and Gilbert el al., 1999, 
Qu et al., 2004). In both studies, the reporter sequences were linked to the TRE, and the 
expression of these transgenes was analysed by flow cytometry upon the addition of dox 
to the cell culture. 
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Figure 3.7 a) ihprtDsRED2F4 and b) ihprtDsRED2R2 were cultured in 1 tg/mI dox for 0 to 6 days. Two dimensional density plots are 
—$-- ihprtDsRED2R3 	shown with the percentage of DsRED2 positive cells indicated. The x-axis depicts hrGFP fluorescence, and the y-axis DsRED2 
-I- ihprtDsRED2F4 	fluorescence. c) Graphical representation of the percentage of DsRED2 positive cells for each cell line at each timepoirit. d) Graphical 
representation of the median DsRED2 fluorescence. 
The main problem encountered by these authors, and indeed an issue that has been 
widely cited by users of the tet-system (Shockett et al., 1995, Meyer-Ficca et al., 2004) is 
the problem of high basal expression of the transgene in the absence of dox. This has 
been attributed to the residual affinity of the rtTA for the TRE in the absence of dox in 
those situations where the original rtTA has been used, and also to activation of the TRE 
by nearby enhancer-like elements upon random integration of the TRE element (Izumi 
and Gilbert et al., 1999, Qu et al., 2004). In light of this evidence a strategy was devised 
to target both the reverse transactivator and the response element to the hprt locus, a 
housekeeping gene which is expressed in all tissues (Bronson et al., 1996). The novel 
rtTA2sM2 reverse transactivator, which is an updated version of the original rtTA, has 
no residual affinity for the TRE in the absence of dox, and was targeted to 5'hprt as 
described in chapter 2. Once this parental cell line had been established, the TRE 
element (linked to D5RED2) was targeted into the hprt open reading frame, at a distance 
of 30 kilobases from the CAG promoter driving rtTA2-M2 expression, and at a 
considerable distance from any known enhancer (thus it was reasoned that the integration 
of the TRE at this location would not result in high basal levels of transgene transcription 
in the absence of dox). This targeting strategy was therefore designed to assess whether 
or not hprl was a viable locus for implementing transgene expression via the tet-system. 
After the derivation of the ihprtDsRED2 cell lines, they were analysed for transgene 
induction in the presence and absence of dox. 
It was clear upon analysis of the ihprtDsRED2 cells lines derived, that background 
activity of the TRE element in the absence of dox was not a problem encountered with 
this strategy. However, an issue of concern was the heterogenous expression of 
DsRED2, which was observed in every clone analysed. For the tet-system to be used 
optimally, it is necessary that homogenous expression of the transgene in question is 
observed. There are a number of possible explanations for this heterogeneity. Firstly one 
must question the possibility of toxicity effects of DsRED2 in ES cells. Secondly the 
integrated TRE may not be fully accessible to the rtTA2sM2,  or indeed it may be the 
case that the levels of rtTA2sM2  expressed are too low to activate the TRE-linked 
fluorescent reporter maximally. There is also the question of mosaicism of transgene 
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expression due to epigenetic silencing of the locus. These will all be discussed in further 
detail below. 
DsRED2 toxicity 
The DsRED2 reporter gene, a variant of the original DsREDI exhibits improved 
solubility and reduced tendency to form aggregates within transfected cells. Toxicity in 
mammalian cells was reported to be a problem with DsRED1, however, owing to the 
existence of several mutations within the ORF of the novel fluorescent protein, DsRED2 
shows improved ability to be tolerated in vivo (manufacturers product information). 
In the event of possible DsRED2 toxicity to ES cells, there would be a selective pressure 
on cells within a population to express low amounts of DsRED2. Whilst this would seem 
to be a plausible explanation for the heterogenous profiles viewed for the ihprtDsRED2 
clones, it is known from independent experiments with the tet system (Fisher, Heavey 
and Cunningham, unpublished data) that high levels of DsRED2 can be tolerated in ES 
cells for at least three days without there being any obvious signs in reduction of 
DsRED2 levels. Therefore the heterogeneity viewed here cannot be attributed to possible 
toxicity of DsRED2 to ES cells. 
Accessibility of the TRE to rtTA2sM2 
i) Is the TRE located in a region of chromatin which is suboptimal for rtTA2sM2 
binding? 
The random integration of the TRE and linked luciferase reporter into cell lines which 
overexpress tet-transactivators has been shown to give rise to varying levels of reporter 
induction depending on where the exogenous sequences integrate into the genome 
(Gossen et al., 1992; Kistner et al., 1996). Whilst some clones exhibit high basal levels 
of transgene expression in the absence of inducer, presumably as a result of integration of 
the TRE close to nearby enhancers, other clones do not exhibit any luciferase expression 
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in the presence of inducer. One reason for this could be the integration of the TRE and 
linked reporter into a region devoid of any transcriptional activity, such as areas of 
heterochromatin. 
Other clones reportedly generated from the random integration of the TRE exhibit poor 
expression of the linked luciferase reporter in the presence of inducer. In this case it can 
be imagined that whilst the TRE has inserted into a locus permissive for transcription, the 
chromatin configuration is not completely supportive of maximal transgene expression. 
In light of this observation it may be hypothesised that the heterogenous expression 
exhibited by the ihprtDsRED2 cell lines may be the result of integration into a locus that 
was not permissive for maximal activation of the TRE. As the element was integrated 
into exon 6 of the hprt gene however, and hprt is a housekeeping which is ubiquitously 
expressed, it seems intuitive that this locus would possess a fairly open chromatin 
configuration, leading one to presume that this hypothesis is unlikely to be true. 
ii) Read-through of hprt mRNA resulting in inhibition of transgene transcription 
initiation 
In a previous study in which exogenous sequences were targeted to the coding region of 
hprt it was reported that there was read-through from the hprt promoter (Shaw-White et 
al., 1993). The authors placed a LacZ reporter gene downstream of a combination 
promoter which contained a herpes simplex virus, thymidine kinase (HSVtk) promoter 
plus a modified polyoma enhancer, and targeted the sequences into exon 3 of the hprt 
gene in ES cells (a neomycin selection gene was also contained within the construct). 
LacZ expression was observed in 40 out of 45 of the targeted clones analysed, and mosaic 
expression was seen in all the positive clones. Read-through transcripts that originated 
from the hprt promoter and that contained the targeted exogenous sequences could be 
detected by Northern blot. The authors concluded that the mosaicism in LacZ expression 
was due to 'transcriptional interference' that occurred as the transcriptase complex passed 
through the exogenous promoter, inhibiting initiation of transcription from this promoter. 
However in a parallel experiment, random integration of the promoter and linked LacZ 
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sequence failed to give rise to any uniformly blue LacZ positive lines and it is therefore 
unclear if the heterogenous expression was indeed due to 'transcriptional interference' as 
a result of read-through, or if the composite promoter and enhancer sequence was unable 
to drive homogenous expression of transgenes in ES cells. It is also possible that 
methylation of the exogenous promoter and LacZ sequences resulted in mosaicism in 
expression of the LacZ transgene (Chevalier-Mariette et al., 2003). 
Although the argument put forward by Shaw-White et al, that the observed mosaicism 
was due to hprt read-through from the endogenous promoter could not be substantiated 
from their evidence presented, it was clear that read-through did indeed occur, as 
transcripts originating from the hprl promoter region, containing the exogenous 
sequences were detected by Northern blot hybridisation. It is very likely that this 
phenomenon also occurs in the ihprtDsRED2 cell lines established, although this has yet 
to be confirmed by Northern analysis. In addition this form of 'promoter occlusion' 
arising from transcriptional read-through has previously been documented in HeLa cells 
in a study where two tandem HIV- I promoters were integrated into the genome (Greger 
et al., 1998). It was found that the transcriptional activation of the upstream promoter 
reduced transcription from the downstream promoter, the mechanism of which was found 
to be due to the occlusion of Spi transcription factors from the downstream promoter as 
determined by in vivo footprinting. This reduction in downstream promoter activity was 
abolished when a transcriptional terminator sequence was placed between the two 
promoters and thus it was hypothesised that the movement of the polym erase complex 
over the downstream promoter was responsible for the promoter occlusion. 
In light of this evidence it is a possible that the non-uniform expression of the DsRED2 
reporter observed in the ihprtDsRED2 lines can be attributed to the occlusion of rtTA2 5-
M2 binding to the TRE element, as the polymerase complex passes over the TRE 
sequence. This would result in sub-optimal levels of expression of the DsRED2 reporter 
and could give rise to the heterogenous expression of reporter observed. 
58 
Heterogenous expression of DsRED2 as a result of sub-optimal levels of rtTA2sM2 
It has been reported in the literature that low internal concentrations of transactivator give 
rise to heterogenous expression of TRE-linked transgenes when using the tet-system. 
Izumi and Gilbert conducted a study whereby they linked the transactivator tTA, to a 
hygromycin antibiotic sequence via an IRES and randomly integrated the construct into 
cells. Stable transformants expressing tTA were derived by placing the transfected cells 
in hygromycin selection. It was found that upon stable integration of the TRE element 
and linked GFP reporter, a number of clones were established which exhibited 
homogenous levels of the reporter throughout the population upon withdrawal of inducer, 
and this was reasoned to be due to the initial selection for cells expressing high levels of 
tTA (using the IRES hygromycin strategy). This was in contrast to earlier tTA-
expressing cell lines, which were not established by selecting for high concentrations of 
tTA, and therefore only ever gave rise to heterogenous reporter expression when stably 
transfected with the TRE-GFP reporter construct. In these experiments, the tTA itself 
was not linked to a reporter that could be used to directly compare the levels of 
transactivator expression between the different cell types created, and therefore the 
absolute levels of tTA produced were never established. It is however logical to presume 
that maximal expression of TRE-linked transcript is in part dependant on internal 
concentrations of rtTA2sM2.  One might expect that if the internal concentration of 
rtTA2sM2 was limiting then some of the tetO sequences within the TRE would remain 
unoccupied and this would reduce the frequency at which DsRED2 would be transcribed 
(due to the sub-optimal recruitment of transcriptional machinery). This raises the issue as 
to whether or not limiting internal concentrations of rtTA2sM2  were responsible for the 
heterogenous profiles of the ihprtDsRED2 cells. 
Whilst further experimentation into the implementation of the tet system (described in the 
next chapter) suggest that the levels of rtTA2sM2  expressed in the ihprtDsRED2 cells 
(as determined by analysis of hrGFP levels in the absence of dox), should be sufficient to 
activate transgene expression at high and homogenous levels, the addition of dox inducer 
appears to decrease intracellular rtTA2sM2  levels (reasons for this are discussed below). 
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It is therefore possible that the heterogeneity in DsRED2 expression observed could be 
the result of sub-optimal levels of transactivator that are unable to activate maximal 
transgene transcription. 
The negative shift in hrGFP expression upon addition of inducer 
The reason for the observed negative shift in hrGFP upon the application of dox inducer 
to ihprtDsRED2 cells is unclear. Such a shift was observed in every correctly targeted 
cell line analysed and was in some cases so pronounced that the differences in hrGFP 
levels could be clearly visualised on the two dimensional flow cytometry plots. 
The addition of inducer leads to the formation of a functional transactivator (dox bound 
rtTA2sM2),  which in turn leads to activation of the TRE as a result of transactivator 
binding and subsequent polymerase recruitment. It therefore appears that the activation 
of the TRE-DsRED2 transcriptional unit is detrimental to the transcription of the 
bicistronic rtTA2sM2  and hrGFP sequences. Transcriptional interference between two 
transcriptional units has previously been shown to occur when independently regulated 
genes are positioned in close proximity (Eszterhas et al., 2002). In this study GFP and 
YFP fluorescent reporters each possessing their own promoter and terminator sequences, 
were positioned in a construct (with less than 100 base pairs separating the two units), in 
divergent, convergent and tandem orientations. When compared to the targeting of single 
fluorescent reporter genes to two independent loci in MEL cells, it was found that the 
expression of both transgenes exhibited reduced expression when targeted in the same 
construct at both loci analysed. This was the case for all orientations analysed. When the 
promoter region of one reporter gene was mutated so as to be rendered inactive, it was 
found that the levels of expression of the remaining gene were comparable to those seen 
when only one transcriptional until was present. This suggested that interference 
between the two promoter regions of the transgenes hindered the expression of both 
fluorescent markers. 
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In the study described, both transcriptional units were placed in close proximity. 
However, it is not unreasonable to assume that the CAG rtTA2sM2 and TRE-DsRED2 
transcriptional units, even though positioned approximately 30 kilobases apart, exert 
some influence over each other. If one thinks in terms of the three dimensional structure 
of chromatin, in real distances the two units may not be positioned that far apart. This 
can be exemplified by the fact that some endogenous enhancers are known to act over 
considerable distances, through the 'looping' of intervening chromatin which enables the 
enhancer element to interact with its target gene promoter. 
A recent study in Saccharomyces cerevisiae showed that the promoter regions of some 
genes interact with the polyA addition signal sequence contained in the same 
transcriptional unit. Transcriptional run-on analysis and chromosome conformation 
capture techniques led to the conclusion that a 'gene loop' structure juxtaposed the 
promoter and terminator sequences in the two genes analysed (O'Sullivan et al., 2004). 
Although such structures have yet to be discovered in mammalian cells it seems unlikely 
that such configurations are confined to yeast. 
If such looping configurations between promoter and terminator sequences are present in 
mammalian cells it is possible that the integration of a transcriptional unit into the ORF 
of an endogenous gene (as is the case in the targeting of the TRE to endogenous hprt), 
may disrupt the three-dimensional structure of the chromatin region, which in turn may 
influence the transcription of nearby genes. Although not enough is yet known about the 
complex chromatin structures involved in transcription to be able to predict the 
consequences of targeting exogenous elements to particular loci, the studies mentioned 
above highlight the complexity of interactions within and between transcriptional units, 
and offer a possible explanation for the observed shift in hrGFP upon addition of inducer. 
Potential silencing of rtTA2-M2 and TRE upon integration into the hprt locus 
The rtTA2sM2  and TRE sequences both contain viral and prokaryotic elements, and it 
therefore might be envisaged that host cell defence mechanisms, such as RNAi mediated 
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pathways, may act to silence the activity of these units. Possible mechanisms of silencing 
could include the cleavage of the rtTA2SM2  mRNA, or the epigenetic silencing of the 
transactivator or TRE sequences at the chromatin level, (Schramke et al., 2003). If this 
silencing effect was not to occur in all the cells within the population it may be expected 
to give rise to heterogenous expression of DsRED2 reporter as observed. 
In order to determine whether the non-uniform expression of DsRED2 was due to 
inheritable differences between the highly-expressing DsRED2 cells and the cells 
negative for DsRED2 in the presence of dox (due to chromatin based epigenetic silencing 
mechanisms), the highly-expressing DsRED2 positive cells from clone ihprtDsRED2F6 
were sorted and cultured for 6 days in dox (Figure 3.6a). It was predicted that this 
population of cells would either become heterogenous for DsRED2 expression - 
indicating that all cells within the population had the potential to express DsRED2, or 
would remain a discrete population of high D5RED2-expressers - suggesting that there 
were sub-populations that contained different inheritable transgene activation potentials. 
Surprisingly however, after 6 days in dox, most of the cell population became negative 
for DsRED2 expression. Although this proved that the high DsRED2-expressing state in 
the presence of dox was not permanent, it was not clear why the majority of the cells 
should become negative for DsRED2. This effect was investigated further in a 
timecourse experiment. 
Reduction in DsRED2 expression upon increasing time in dox 
Two clones were analysed for their DsRED2 expression after varying periods of culture 
in dox. It was clear that between 2 to 3 days (depending on the clone in question), 
DsRED2 expression peaked and thereafter declined to near negative levels (Figure 3.7). 
At first it may appear that either the application of dox, or prolonged DsRED2 expression 
is toxic to ES cells. However independent experiments using the tet-system show that 
both high levels of DsRED2, and concentrations of up to I .ig/ml dox can be tolerated by 
ES cells (Fisher, Heavey and Cunningham, unpublished data), which suggest that the 
decline in DsRED2 observed in the timecourse experiment is unlikely to be due to dcx or 
DsRED2 toxicity. 
The outcome of this experiment highlights the experimental limitations of using this 
strategy to overexpress cDNAs in ES cells, as the period of time over which a transgene 
can be expressed is limited by the rapid decline in expression levels. It would therefore 
only be applicable in situations where factors need to be overexpressed for about 3-4 
days, and in addition in situations where heterogeneity in transgene expression would not 
pose a problem (for example in the inducible expression of secreted factors). 
DsRED2 expression in a gradient of dox concentrations 
Previous studies have reported that the tet-system can be used to obtain a range of 
transgene expression levels by varying the concentration of inducer added to the cell 
population (Gossen et al., 1992). These studies however involved the use of a luciferase 
assay which was dependent on the lysis of the cell population and therefore the results 
obtained offered no insight into transgene expression at a cellular level. It is possible that 
the intermediate concentrations of luciferase observed upon culture with lower 
concentrations of inducer could have been due to the absence of luciferase expression in a 
proportion of the cell population. With these technical limitations in mind, it was decided 
to use a fluorescent reporter in the establishment of the tet-system in order to analyse 
transgene expression at a cellular level by flow cytometry. 
ES cells were cultured in a gradient of concentrations of dcx, over a period of 48 hours. 
It was found that increasing the concentration of dcx did not lead to an incremental 
increase in the levels of the DsRED2 reporter (Figure 3.5a and 3.5b). Rather a bimodal, 
all-or-nothing effect was more apparent (this is most obvious in Figure 3.5a 0.01 jig/ml), 
with a sub-population of cells expressing DsRED2 to a high level while a large 
proportion of the population remained negative for DsRED2 expression. This result did 
not support the claim that the tet-system can be used to express varying levels of 
transgene. 
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Interestingly the median levels of DsRED2 declined above approximately 0.25 j.g/ml dox 
(Figure 3.5d), and it therefore appears that high concentrations of dox lead to sub-optimal 
DsRED2 expression. Again independent experiments suggest that this is not due to toxic 
effects of DsRED2 expression, or dox addition (Fisher, Heavey and Cunningham, 
unpublished data), and the reason for the decline in transgene expression levels over 
concentrations of 0.25 tg/ml dox remain to be determined. 
After characterisation of the ihprtDsRED2 cell lines it can be concluded that the strategy 
of targeting both components of the tet-system to the hprt allele in ES cells can give rise 
to expression of the DsRED2 reporter in the presence of dox, with no basal transgene 
expression visible in the absence of dox. There is however need for improvement both in 
terms of levels of reporter expression and uniformity of expression across the whole 
population. It was therefore decided to implement an alternative strategy in order to 
address these issues. 
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Chapter 4 
A biallelic approach to implementing the tet-system 
4.1 	Introduction 
The previous chapter described how the transactivator-response element (TRE) and 
linked reporter genes were targeted into the 3' coding region of hprt in CAGrepB7 cells. 
The CAGrepB7 cell line expressed homogenous constitutive levels of the reverse 
transacti vator rtTA2sM2, however the subsequent integration of the response-element 
into these cells did not result in the anticipated homogenous expression of TRE-linked 
DsRED2 reporter. In light of this result an alternative approach was implemented, with 
the aim of achieving population-wide induction of transgene expression. 
From the previous targeting of cDNAs described in chapter 2, it has been shown that the 
5' proximal region of hprt in EI4TG2a cells is permissive for the constitutive expression 
of integrated transgenes. In an alternative approach to targeting both elements of the tet- 
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system to the hprl locus the transactivator-responsive element (TRE) was targeted to the 
5' region of hprt, in a cell line that expressed high and homogenous levels of the rtTA2s 
M2 transgene at an unlinked locus. The cell line used was R26rtTA2sM21F,  which 
expressed the reverse transactivator from the endogenous ROSA26 promoter, (this cell 
line was a kind gift from Barry Heavey, for information regarding its construction please 
refer to Figure 4.1). 
4.2 	Construction of the 5'hprtTREDsRED2F and 5'hprtTREDsRED2R 
targeting vectors and electroporation into R26- rtTA2sM2  IF cells. 
The bidirectional TRE sequence and linked luciferase and DsRED2 reporter sequences 
used in the construction of the 5'hprtTREDsRED2 targeting vectors (which are 
represented in Figure 4.2 in their linear form), were identical to those used in the 
construction of the 3'hprtTREDsRED2 targeting vectors detailed in chapter 3 (Figure 
3.1). Plasmid BigTIucTREDsRED2 was digested with AscI, plus Seat restriction 
endonucleases (Figure 4.2a), and the TRE-encoding fragment was incubated with klenow 
polymerase to fill-in the recessed 3' fragment ends. The fragment was then ligated into 
Nod digested and blunted (by klenow end-fill) pSKBI targeting vector. Two ligation 
products were produced, one in which the DsRED2 cDNA coding sequence was in the 
same 5' to 3' orientation as the genomic hprl coding sequence present in the vector 
(Figure 4.2b) and one in which the DsRED2 cDNA sequence was in the opposite 
orientation (Figure 4.2c). These two targeting vectors were termed 5'hprtTREDsRED2F 
and 5'hprtTREDsRED2R respectively. 
After linearisation of the two vectors with PmeI endonuclease, 5'hprtTREDsRED2F and 
5'hprtTREDsRED2R were transfected into R26- rtTA2sM21F  cells via electroporation. 
The R26- rtTA2sM21F cells were derived from the E14TG2a cell line and were 
therefore HPRT negative. The targeting of the correctional vectors to hprt resulted in the 
restoration of the hprt ORF (Figure 4.3a and 4.3b), and conferred an HPRT positive 
phenotype upon the cells. The day after electroporation, transfected cells were plated out 
in HAT selection media. HAT resistant colonies were then picked and expanded, after 
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Figure 4.1 The targeting of the reverse transactivator to the ROSA26 locus a) The ROSA26 targeting vector contained a splice acceptor site, a 
selection cassette and rtTA2s-M2 linked to an IRES-hrGFP sequence and was electroporated into E14TG2a cells to target the endogenous ROSA26 
locus (shown in b). c) Transfected cells were then placed in G418 selection after which G418 resistant clones were analysed by Southern blotting to 
identify clones with a correctly targeted R05A26 allele. The presence of an exogenous splice acceptor (SA), positioned downstream of the 
endogenous non-coding exon 1 resulted in the transciption of the neomycin resistance gene only, as the triple polyA, pA(x3) sequence inhibited 
expression of the reverse transactivator. d) Transfection of targeted cells with a Cre-recombinase expressing plasmid resulted in site-specific 
recombination between the IoxP sites flanking the selection cassette, and excision of the intervening sequences. This led to the expression of the 
reverse transactivator and hrGFP. Note that although three endogenous transcripts are known to arise from the ROSA26 locus, for simplicity only 
the exons of one of the transcripts have been shown. Abbreviations; Prpgk, pgk promoter; 1', homology to the 3 sequence of exon 1. 
Figure 4.2 Cloning of the TRE and linked reporter sequences into the pSKBI vector. 
a) Plasmid BigTIucTREDsRED2 was digested with ScaT plus AscI after which the 3' 
recessed ends were made flush by treatment with kienow polymerase. The fragment was 
inserted into Noll digested pSKB 1 vector in both orientations (the vector had also been 
treated with kienow polymerase after Noll digestion to end-fill the protruding ends), to 
give rise to the 5'hprtTREDsRED2F targeting vector b) and the 5'hprtTREDsRED2R 
targeting vector c). Note that the vectors are represented in their linearised forms (site of 
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Figure 4.3. The targeting vectors 5'hpDsRED2F 
a) and 5'hprtDsRED2R b) were electroporated 
into the R26-rtTA2s-M2 iF cell line. The 
expected restriction fragments yielded after 
2 digestion with BamHl and hybridisation with a 
exon sequence 
I 
loxP site probe encoding the DsRED2 sequence are shown. 
c) After electroporation and subsequent selection 
ww deleted region crossover event in HAT medium, genomic DNA from HAT 
resistant colonies was digested with BaniHl and 
restriction fragment (kb) probe analysed by Southern blot hybridisation. 
plasmid backbone B BamHl 
which genomic DNA was extracted and analysed by Southern blot hybridisation to 
determine the nature of the integration event. Figure 4.3a and 4.3b depict the fragment 
sizes predicted in correctly targeted clones after digestion with BamHl and subsequent 
hybridisation to a probe encoding the DsRED2 sequence. Eight cell lines were analysed 
(Figure 4.3c), four cell lines from the 5'hprtTREDsRED2F and four from the 
S'hprtTREDsRED2R vector transfection (the resulting cell lines were termed 
iDsRED2FI-4 and iDsRED2RI-4 respectively). The fragment size predicted after 
BamH 1 digestion and hybridisation with the DsRED2 probe was 9.6 kb for the 
iDsRED2F clones and 4.8 kb for the iDsRED2R clones. All eight clones exhibited the 
correct fragment sizes and it was therefore concluded that all clones had been correctly 
targeted. 
4.3 	Flow cytometry analysis of 1DsRED2 cell lines in the presence and absence of 
dox 
The four iDsRED2F and four 1DsRED2R cell lines were plated in tg/ml doxycyline for 
two days and then analysed by flow cytometry for expression of the DsRED2 reporter 
transgene (Figures 4.4 and 4.5). Whereas all the ihprtDsRED2 cell lines described in the 
previous chapter exhibited very heterogenous transgene expression throughout the clonal 
cell populations, the expression of DsRED2 in the iDsRED2 cell lines was far more 
homogenous, with the majority of cells becoming positive for DsRED2 expression upon 
the addition of inducer. Al! clones exhibited DsRED2 fluorescence in over 90% of their 
population (with the exception of iDsRED2R4 in which 88.8% of the population was 
positive for DsRED2). In the absence of dox no 'leaky' expression of DsRED2 was 
observed in any of the cell lines. These observations establish the 5' region of hprt as a 
locus suitable for TRE integration, as high expression levels of linked reporter are 
achieved in the presence of doxycyline inducer yet no background expression is observed 
in the absence of inducer. The orientation of DsRED2 upon integration into the genomic 
5'hprt locus did not appear to have any influence upon the extent of DsRED2 transgene 
expression, as there was no discernible difference between the profiles of the iDsRED2F 
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Figure 4.4. Four iDsRED2F cell lines were cultured in the presence and absence of 1 ug/mI dox for two days and analysed by flow cytometry. 
a) Two dimensional density plots with DsRED2 fluorescence along the y-axis and hrGFP fluorescence along the x-axis. The percentage of 
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Figure 4.5. Four iDsRED2R cell lines were cultured in the presence and absence of 1 ug/mI dox for two days and analysed by flow cytometry. 
a) Two dimensional density plots with DsRED2fluorescence along the y-axis and hrGFP fluorescence along the x-axis. The percentage of DsRED2 
positive cells is indicated. b) Histograms depicting hrGFP fluorescence. The median hrGFP fluorescence is shown. 
Figure 4.4b and 4.5b depict the hrGFP levels detected for each clone in the presence and 
absence of dox. It was observed that in contrast to the ihprtDsRED2 cell lines 
characterised in Chapter 3, which exhibit a negative shift in hrGFP fluorescence upon the 
addition of dox inducer, the iDsRED2 cell lines analysed exhibit a slight increase in 
hrGFP fluorescence when dox was added to the cells. This slight shift can be explained 
by the leakage of DsRED2 fluorescence into the FL  channel (through which hrGFP is 
detected) at the compensation settings used during the acquisition of the data. The fact 
that a negative shift in hrGFP fluorescence was not seen when dox is added to the 
1DsRED2 cell lines indicates that this is a phenomenon that is restricted to ihprtDsRED2 
cell lines. 
4.4 	Induction of DsRED2 in a gradient of doxycyline concentrations 
Four randomly selected iDsRED2 cell lines were cultured in a range of concentrations of 
dox for two days after which they were analysed by flow cytometry (Figure 4.6). All the 
cell lines were shown to respond in a similar fashion to increasing levels of doxycyline. 
At 0.25 ig/ml dox approximately half the cells from each cell line acquired a DsRED2 
positive phenotype. At 0.5 pg/ml dox the majority of cells became DsRED2 positive, 
and at 1 tg/ml each cell line exhibited DsRED2 fluorescence in over 90% of their 
population. The highest levels of fluorescence were observed at 2 jtg/ml dox. 
Interestingly at intermediate dox concentrations (such as 0.25 and 0.5 pg/ml dox), rather 
than the majority of the cell population expressing intermediate DsRED2 fluorescence 
levels, there was more of a heterogenous spread of DsRED2-expressing cells along the y-
axis. This heterogeneity seemed to have an 'all-or-nothing' element to it as cells 
predominantly fell into either a relatively high DsRED2 positive population or a DsRED2 
negative population (as indicated by the two open circles in the 0.5 j.tg/ml iDsREDR3 
density plot). 
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The median DsRED2 fluorescence values are represented graphically in figure 4.7b. It is 
clear that whilst the percentages of DsRED2-expressing cells did not vary widely from 
clone to clone (Figure 4.7a), the median fluorescence values were not so consistent 
between the four cell lines with some clones expressing higher levels of DsRED2 than 
others. This has implications experimentally, as it is not only the percentage of cells that 
over-express the desired transgene that is crucial, but also the absolute levels of transgene 
produced. 
	
4.5 	Induction of DsRED2 after different periods of culture in dox 
The four cell lines were cultured in I g/ml doxcycline over a period of 0-7 days after 
which time they were analysed for DsRED2 fluorescence by flow cytometry. Two-
dimensional density plots for each cell line at each time-point are shown in figure 4.8. It 
was observed that at day 3, the iDsRED2FI, iDsRED2F4 and iDsRED2R3 cell lines 
reached their maximum value with regards to the percentage of DsRED2 positive cells 
(also viewed in Figure 4.7c). After this time these cell lines continued to exhibit 
DsRED2 in over 90% of their cell populations, however the median DsRED2 
fluorescence levels gradually started to decline. Although the iDsRED2R2 cell line was 
correctly targeted (Figure 4.2), the two-dimensional density profile of this cell line did 
not follow those of the other cell lines during the time-course experiment. Expression of 
DsRED2 was observed to peak at day 2, after which time it rapidly declined (Figure 
4.7d). 
4.6 	Discussion 
Induction of DsRED2 in the iDsRED2 cell lines 
The strategy of targeting the rtTA2sM2  to the ROSA26 locus and the TRE to the 5'hprt 
region gives a far superior readout of transgene expression when compared to the 
previous approach of targeting both elements to the hprt locus. Whereas the 
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Figure 4.8. Four 1DsRED2 lines were cultured in dox for different periods of time. Two dimensional density plots show DsRED2 fluorescence (y-
axis) and hrGFP fluorescence (x-axis) at each time-point. The percentage of D5RED2 positive cells is indicated. 
the addition of dox, the iDsRED2 cell lines described here expressed DsRED2 at high 
levels and in a relatively homogenous manner. A similar approach has been carried out 
by two independent groups (Wutz et al., 2002, Kyba et al., 2002). In both studies the 
original reverse transactivator rtTA was placed under the control of the endogenous 
ROSA26 promoter and the TRE targeted to the 5' region of hprt. It was found that upon 
addition of 1 jig/ml dox to ES cell lines harbouring tet-inducible GFP, 94% of the cells 
became positive for transgene expression (Kyba et al., 2002). This result correlates with 
the inductions described here. 
Transgene induction in a gradient of dox concentrations 
The 1DsRED2 cell-lines appeared to exhibit some degree of intermediate level of reporter 
expression. With progressively decreasing concentrations of dox the highest DsRED2-
expressing cells could be observed to shift down the y-axis (Figure 4.6; 2 ig/ml to 0.5 
p.g/ml dox). However at concentrations of 0.5 tg/ml dox and below, an 'all or nothing' 
effect with regards to levels of DsRED2 expression appeared, where the cells either fell 
into a relatively high DsRED2-expressing population or a negative DsRED2 population. 
The tet-system has been previously described as one in which the experimenter is able to 
manipulate levels of transgene expression by varying the concentration of inducer 
(Gossen et al., 1995; Urlinger et al., 2000). Although as stated previously this 
observation was originally based on analysis of luciferase transgene expression, 
intermediate transgene expression levels have been reported using a rtTA-regulated 
fluorescent reporter in primary mouse myoblasts, (Kringstein el al., 2000). An 
independent study, however, reported that rather than population-wide low levels of 
fluorescent reporter at low concentrations of dox, an increase in the population of 
negative cells was found (Qu et al., 2004). This study was carried out in ML20 cells 
using the rtTA2sM2 version of the transactivator. It is therefore possible that the nature 
of transgene expression at intermediate concentrations of inducer may vary between cell 
types. 
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Analysis of DsRED2 expression after time in dox 
The optimum culture period in dox necessary to maximally stimulate DsRED2 reporter 
expression was 3 days for all of the cell lines analysed bar iDsRED2R2. Whilst the 
proportion of DsRED2 positive cells in these clones remained constant from 3 to 7 days, 
it should be noted that there was a gradual decrease in the median value of fluorescence. 
It is possible that high levels of DsRED2 interfere with ES cell metabolism and therefore 
over a period of time there is a gradual selection for cell that express lower levels of this 
fluorescent reporter. Alternatively the concentration of dox used (1 p.g/ml) could be 
slightly toxic to ES cells over long periods of time. If this was the case one would expect 
a gradual selection for cells able to maintain lower internal concentrations of dox, for 
example those able to efflux the antibiotic more readily. An indirect effect of this 
selection pressure would be the accumulation of lower DsRED2 expressing cells as low 
internal concentrations of dox will not result in maximal reporter transcription. 
Experimentally it can be seen that high levels of transgene can be maintained for up to 7 
days, which is in contrast to the ihprtDsRED2 cell lines that exhibited near negative 
transgene expression after 6 days in dox. Although there is a slight downregulation of 
DsRED2 after 3 days, the majority of the cells still express high levels of the reporter at 
day 7, and this strategy is therefore able to confer robust, high levels of transgene 
expression over time (Figure 4.8). The exception to this is the iDsRED2R2 cell line 
which exhibited a sharp decline in DsRED2 expression after 2 days. It is unclear why 
this cell line should respond differently to prolonged culture in dox, however it acts as a 
future caution to check that high expression of a tet-regulated transgene is maintained 
over the induction time required by the experimental application. 
In conclusion, the strategy of targeting the transactivator to the ROSA26 locus and the 
TRE to the 5' region of the hprl gene, established an inducible system that could be used 
to manipulate the expression of a DsRED2 reporter in a tight and predictable manner. 
Due to the success of this strategy, this approach was applied to investigate the 
involvement of the m itogen-activated protein kinase (MAPK) signalling pathway during 
"1 
the in vitro differentiation of ES cells into neural progenitor cells. This is described in 
the following chapter. 
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Chapter 5 
The establishment of inducible MEKi act expression in ES cells for 
investigation into the involvement of the MAPK pathway in neural induction 
5.1 	Introduction 
The mitogen-activated protein kinase (MAPK) pathway is a highly conserved signalling 
pathway that controls fundamental cellular processes such as proliferation, differentiation 
and cell survival. It is comprised of a series of protein kinase modules that are activated 
via phosphorylation by upstream kinases, and in turn activate downstream substrates by 
phosphorylation. The classical MAPK pathway is the extracellular-signal-regulated 
(ERK) kinase pathway, which comprises Raf, MEK1 (MAPKIERK kinase), MEK 2 
(MEK I and MEK 2 are collectively referred to as MEK1/2), and ERKI/2 proteins (see 
figure 5.1 for a detailed description of this pathway). The MAPK/ERK pathway can be 
activated by stimulation of many different receptor types including tyrosine kinase 
(Blume-Jensen el al., 2001), G-protein coupled (Belcheva and Coscia., 2001), and 
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Figure 5.1 The MAPK/ERK pathway. Five mammalian MAPK pathways have been discovered, with each pathway possessing distinct biological functions, a) A 
general schematic of MAPK pathway signalling. b) The extracellular signal-regulated kinase (ERK) pathway. The pathway is shown with its three basic kinase 
modules Raf, MEK1/2 and ERK1/2. Receptor activation leads to the activation of the C-protein ras which recruits Raf to the membrane by binding its N-
terminal regulatory domain. Once localised to the membrane Raf becomes activated by phosphorylation and in turn activates downstream MEK1/2 by 
phosphorylation of specific serine residues. MEK1/2 is a dual specificity kinase which activates its substrate ERK1/2 by phosphorylation of threonine and 
tyrosine residues located within an activation loop. This action is highly specific as no additional substrates have been found for MEK1/2. Upon activation, 
ERK1/2 dissociates from MEK1/2 and phosphorylates downstream nuclear and cytoplasmic substrates on serine or threonine residues (active ERK1/2 is able 
to translocate to the nucleus). 
impair self-renewal, and inhibition of MEK signalling inhibits the differentiation of ES 
cells in embryoid bodies (Burdon et al., 1999). 
It has recently been shown that the in vitro differentiation of ES cells into neural 
progenitor cells is dependent on FGF signalling in serum-free conditions (Ying et al., 
2003). The pathway acting downstream of FGF receptor (FGFR) signalling has yet to be 
determined, although the MAPKIERK pathway is a strong candidate as it is known to 
regulate the onset of neural development in invertebrate embryos (Kim ci al., 2001, 
Hudson et al., 2003). In addition, recent studies in chick suggest that it functions 
downstream of FGFR signalling in higher vertebrates to regulate neural development and 
is also required for the later differentiation of the neural plate (Eblaghie et al., 2003). A 
proposed mechanism of action is the inhibitory phosphorylation of the Smadl linker 
region by Erkl/2, leading to the exclusion of Smadi from the nucleus and attenuation in 
BMP signalling (Pera et al., 2003), a state which is characteristic of neural development 
in the frog and chick. In the chick, early neural genes can be induced by FGF signalling 
even in the presence of BMP4 (Streit et al., 2000), suggesting that FGF regulates multiple 
aspects of neural induction. 
The recent development of a serum-free adherent monoculture protocol that gives rise to 
the efficient conversion of ES cells into neuroectodermal precursors offers an in vitro 
model of early neural development and therefore enables investigation into the 
involvement of the MAPK!ERK pathway in neural induction (Ying ci al., 2003). Having 
established a robust strategy for implementing inducible gene expression in ES cells it 
was decided to use this system to overexpress an activated component of the 
MAPK/ERJ( pathway during the in vitro differentiation of ES cells into neural progenitor 
cells. The prediction was that activation of MAPKIERK signalling would either lead to 
an increase in the proportion of neural progenitors obtained after ES cells differentiation 
(the standard differentiation procedure does result in 100% conversion), or in a more 
speedy acquisition of the neural precursor fate. Such an outcome would provide evidence 
that the MAPK/ERK pathway is involved in the conversion of ES cells into neural 
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progenitor cells, and support the findings that it functions to regulate neural development 
in higher vertebrates (Eblaghie et al., 2003). 
A mutant form ofMEKI (hereon referred to as MEK act) has been developed which is 
able to stimulate the ERK pathway independently of upstream Raf activity (Brunet el al., 
1994). The mutant MEK protein is 'activated' due to the substitution of serine residues at 
positions 218 and 222 (S218/S222) with aspartic acid residues. Both S2 18 and S222 are 
phosphorylated by Raf in the MAPK/ERK cascade, and the negatively charged aspartic 
acid residues that are substituted for S218 and S222 in the mutant MEKact mimick this 
process and thus render MEK act constitutively active. The cDNA encoding MEK act was 
placed under the control of the tet-responsive promoter in ES cells, with the aim of 
investigating the effects (on neural acquisition) of activating the ERK pathway at 
different timepoints during the differentiation of ES cells into neural progenitors using 
the serum-free monoculture differentiation protocol. As the expression of tet-regulated 
transgenes can be inhibited after initial overexpression, this offers the option of 
transiently expressing MEK act during different stages of the differentiation procedure, in 
order to investigate those windows during differentiation in which the activation of 
MAPK/ERK pathway has the most pronounced effect on neuroectoderm fate acquisition. 
Transient overexpression Of MEK act during the initial stages of differentiation also allows 
effects on neural induction to be separated from possible mitogenic effects of the MAPK 
pathway on differentiated cell types. In addition, the pharmacological inhibition of the 
FGF receptors in ES cells and subsequent induction of MEK act enables investigation into 
the sufficiency of the MAPK/ERK pathway in neural specification. 
5.2 	Construction of the 5'hprtTREMEK t and 5'hprtTREMEK'' t targeting 
vectors 
In the event of inserting TRE-linked cDNAs into the pSKB I targeting vector, it was first 
necessary to create an intermediate plasmid, (TREDsRED2+MCS(AscI), Figure 5.2c) that 
contained a multiple cloning (MCS) site downstream of the TRE in order to facilitate 
cloning. This plasmid contained two AscI sites flanking the TRE and juxtaposed 
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Figure 5.2 Juxtaposition of HA-MEK to the TRE sequence. a) Plasmid 
CMVTREDsRED2 was partially digested with SspI and subsequently incubated with 
kienow polymerase and dNTPs to blunt the protruding fragment ends. An 
oligonucleotide sequence encoding an AscI restriction site was then inserted into this site. 
b) Plasmid BI-L was digested with NotI and Sap! restriction endonucleases to extract the 
fragment encoding the multiple cloning site (MCS) and the 3-gIobin poly A sequence. 
This fragment was incubated with klenow polymerase and dNTPs to make the protruding 
fragment ends flush, after which it was ligated into the modified CMVTREDsRED2 
plasmid at the HindIIl site (in preparation for this ligation the plasmid was also 'end-
filled' with klenow polymerase and dNTPs). The resulting plasmid TREDsRED2+MCS 
was digested with Nhel restriction endonuclease, and the overhanging ends were blunted 
with kienow polymerase, before an oligonucleotide sequence encoding an Ascl restriction 
site was inserted. c) Plasmid ECE-HA-MEKact and plasmid ECE-HA-MEKwt were 
digested with HindIlI and Xbal restriction endonucleases to extract the HA-MEKact and 
HA-MEKwt encoding fragments (as both plasmids yield HindIll/Xbal fragments of the 
same size only one plasmid is shown here). These fragments were then inserted into 
pTREDsRED2+MCS(ascl) which had also previously been digested with Hindu! and 
XbaI restriction endonucleases. The resulting plasmid, HA-MEKTREDsRED2 contained 
the MEK and the DsRED2 open reading frames in divergent orientations. Digestion of 
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Figure 5.3 Creation of the 5hprtTREMEKact and 5hprtTREMEKwt targeting vectors. The IRE-containing fragment yielded 
from Ascl digest of plasmids MEKactTREDsRED2 and MEKwtTREDsRED2 (see previous figure), were inserted into the pSKB1 
targeting vector immediately upstream of the promoter sequence (the pSKB1 vector had previously been modified to replace 
the Notl insertion site with an Ascl encoding oligonucleotide sequence to facilitate the cloning of these elements). The final 
targeting vectors were termed 5'hprtTREMEKact a) and 5hprtTREMEKwt b) respectively. 
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sequences to be inserted into the pSKBI targeting vector. This enabled the 
straightforward insertion of the transgenic sequences as an AscI fragment into an AscI site 
positioned just upstream of the genomic hpr/ promoter in the pSKB1 vector sequence. 
The first step in the creation of this intermediate plasmid was to change the Sspl site 
downstream of the SV40 polyA sequence in plasmid CMVTREDsRED2 to an Ascl site. 
This was achieved by partial digestion of the plasmid with SspI, followed by end-fill of 
the protruding ends by incubation with kienow polymerase and dNTPS, and subsequent 
ligation with an oligonucleotide encoding an AscI restriction site (Figure 5.2a). The MCS 
and 3-globin polyA sequences from plasmid BI-L were then inserted into 
pCMVTREDsRED2 in the opposite orientation to that of the DsRED2 sequence, (Figure 
5.2b). This was carried out by digestion of pBl-L with NotI and Sap! restriction 
endonucleases and concomitant digestion of CMVTREDsRED2 with Hind!!! enzyme. 
Both the CMVTREDsRED2 plasmid and the extracted fragment were treated with 
klenow polymerase and dNTPs to blunt the protruding ends, after which the two DNAs 
were ligated. This resulted in the production of pTREDsRED2+MCS (Figure 5.2b). 
Digestion of this plasmid with NheI restriction endonuclease, followed by kienow end-fill 
and insertion into this site of an oligonucleotide encoding an Ascl restriction site resulted 
in the production of pTREDsRED2+MCSAscI) (Figure 5.2c). 
In addition to creating cell lines harbouring an inducible form of active MEK, cell lines 
expressing inducible wild-type MEK were also created to act as control cell lines. The 
active MEK and wt MEK sequences were previously fused to an HA-epitope (Pages el 
al., 1994), and will be referred to as HAMEK aCt and HA-MEK wt respectively. HA-
MEKac1 and HA-MEK,,t were extracted as HindlII/Xbal fragments from plasmids ECE-
HAMEKact and ECE-HA-MEK respectively (kind gifts from Gilles Pages). These 
DNA fragments were inserted next to the TRE in HindlIIIXbaI digested 
pTREDsRED2+MCS(AscI) (Figure 5.2c). Digestion of these resulting plasmids with 
Ascl yielded the TRE and linked cDNAs, with respective polyA sequences, which were 
then inserted into AscI digested pSKBI targeting vector (Figure 5.3a and 5.3b), to 
produce 5'hprtTREMEK t and 5'hprtTREMEK respectively. Note that the MEK act and 
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MEKW sequences were present in opposite orientations within the pSKB I vector 
sequences, (this was due to the ability of the cloned fragment to insert in either 
orientation as a consequence of identical cohesive ends). As it has previously been 
shown that the orientation of transgenes targeted to the region 5' of hprt has no effect on 
their expression levels (chapter 4) this was considered to be of no significance to the 
subsequent experiments. 
5.3 	The targeting of the vectors to the 5' region of hprt 
After the linearisation of 5'hprtTREMEK t and 5'hprtTREMEK with PmeI restriction 
endonuclease, both vectors were electroporated into R26rtTA2SM2  I F ES cells. The day 
after electroporation the cells were plated out in HAT selective medium. After 
approximately 10 days, HAT resistant colonies were picked and expanded, and genomic 
DNA was extracted for analysis by southern hybridisation. Figure 5.4a depicts the 
expected integration even upon correct targeting of the locus by a double recombination 
event between the correction vector and the endogenous hprl locus, with the predicted 
fragment sizes detected after digestion with BamHI and hybridisation to a probe encoding 
the MEK sequence shown. The resulting blot shows that all iMEKact clones (those 
targeted with the 5'hprtTREMEK t vector), and all iMEKwt clones (those targeted with 
the 5'hprtTREMEK' vector) exhibited the expected fragment sizes (12.2 kb and 7.4 kb 
for iMEKact and iMEKWt cell lines respectively). It should be noted that the size of 
band expected for the two types of cell line are different owing to the opposite orientation 
of MEKact and MEKwt in their respective targeting vectors. The other bands visible on 
the Southern autoradiograph are presumably a result of the MEK probe hybridising to 
endogenous mek, as such bands are also visible on the EI4TG2a control. The two clones 
iMEK3 and iMEK V 4 exhibit an additional band of around 2.5 kb, which cannot be 
accounted for. 
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Figure 5.4 a)i) The targeting vectors 5hprtTREMEKact and 
ii) 5hprtTREMEKwt were electroporated into R26rtTA2s-M2 IF cells. The 
expected restriction fragments detected after digestion with BarnHi and 
hybridisation to a MEK sequence-specific probe are shown. b) Ten 
clones derived from these two electroporations were analysed by 
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Figure 5.5 a) Four iMEKact and two iMEKwt clones were cultured in the presence i) and absence ii) of 2 ig/ml dox for three days after 
which time they were analysed by flow cytometry. The resulting two-dimensional plots are shown. b) R26rtTA2s-M2 iF cells were 
targeted with ShprtTREDsRED2F vector and analysed by flow cytometry after three days in 2 [tg/ml dox. For all plots hrGFP fluorescence 
is shown on the x-axis and DsRED2 fluorescence is shown on the y-axis. 
0 	 21 	 2 
>c: 
0 
-0 	CE 	.' 	 CE 	 CE - r.J 3 	, 	
ur.J 





107'101 1'02101 1(4 Th° 16' 1 2 161 164 





5.4 	Flow cytometry in the presence and absence of dox 
The cell lines were cultured in the presence (Figure 5.5a1) and absence (Figure 5.5aii) of 
2 pg/ml dox for 3 days (as previously this was shown to be the optimal time for maximal 
induction of DsRED2 in the iDsRED2 cell lines as described in Chapter 4), after which 
time they were analysed by flow cytometry. Unexpectedly the levels of DsRED2 
fluorescence induced were not as high as those exhibited by the iDsRED2 cell lines 
described in the previous chapter. Induction of the DsRED2 reporter was seen in the 
presence of dox in every cell line analysed, with negligible basal levels seen in the 
absence of dox. There was however, a large population of cells negative for DsRED2 
fluorescence observed in every clone cultured in dox, although the size of this negative 
population varied between cell lines. The remainder of the population expressed 
DsRED2 to varying extents with the profile of expression appearing very heterogenous, 
5.5 	Induction in a gradient of dox concentrations and timecourse 
Two iMEKact and two iMEKwt clones were chosen at random to culture in a gradient of 
dox concentrations for three days after which time they were analysed by flow cytometry 
(Figure 5.6 and Figures 5.8a and 5.8b). All clones induced increasing numbers of 
DsRED2 positive cells with increasing concentrations of dox (Figure 5.6), and also 
increasing levels of DsRED2 fluorescence (Figure 5.8b). The highest inductions were 
seen at 2 jig/ml dox, however this concentration was not sufficient to induce high and 
homogenous levels of DsRED2. Indeed DsRED2 expression was heterogenous at all 
concentrations. The overall levels of transgene expression were relatively poor when 
compared to the iDsRED2 cell lines from the previous chapter. 
The four cell lines were then cultured in 2 jig/ml dox for periods of between 0 and 7 days 
(Figures 5.7, and 5.8c and 5.8d). It was observed that after two days the percentage of 
DsREIJ2 expressing cells and median fluorescence levels remained relatively constant 
until day 5 when levels started to decline. An exception to this was 1MEKwt4 which 
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Figure 5.6 Two iMEKact and two iMEKwt clones were cultured in a gradient of dox 
concentrations for 3 days. Two dimensional flow cytometry plots are shown with the 
percentage of DsRED2 positive cell indicated. HrGFP fluorescence is shown on the x-














 0.5tg/mI 	1 tg/mI 	2 tg/mI 
I 2 	 2 
I 
A 3.3%I 	ç 	 13.7% 	 27.4% 	 40.5% % 
3 LJ 	-i 	. 	 -i 	 ...i 	 0LL —LL — LL 
Tho° iol 	 io0 iouio2 io3 io 	 ioOiouio2 	 10T10 














0 	 0 	 C 
cc 	 cr 	 Cc 
12 	
297% 
 10 3  104 	1 	 104 1
LL 	 LL 









io0 	io 1 	-1,0,2 	io 	10 
FL 1-H: GFP 
5.7% 






101 1 	 2 .iImo 1 
FL14H:GFP 	 FL1-4-I:GFP 	 FL1-H:GFP 
V 	 V 	 V 
cr cc 




2oU2 :ii 	' l 1 61 63 
 
FL1-H:GFP 	 FL1-H:GFP 	 FL1-H:GFP 





0 days 	 1 day 	 2 days 	3 days 	4 days 	5 days 	 6 days 	7days 
aC~




















o2_:31 	- too  lo t 	 :° o 	21902 _0 10 	io°  101 o2 515031 	 o2_0 	O 415  163 160 
OL1-H GOP 	 FL1-H GOP 	 FL" GFP 	 FLI-H GOP 	 Ri-Il GttP 	 0-Li-H GOP 	 RI-H GOP 	 0-LI-H GFP 
OF 
32% :










100 t0 	io 	to3 to4 	I 	tü 	i 	t0 	t ° 	0 1 	02 10 	tO 	to, 	o 	I 	ü3 tO4 	00 	o 	to 	10 	to4 	- to 	io 	to2 to3 to4 	to° to 	102 IO 	o 	10 	
10t 	o2 to3 FLI-14 GFP 	 FL" GOP FLI-t-I GFP FL1-H GOP 	 I-Li-I-I GOP Ft-H GOP 	 FL 144 , GOP OLt-HGFP 
LLI 
. 	2.1% 	._ 	39.1% 	..- 	 57.7% 	
... 	
66.6% 	_. 	73.5% 	_ 72.6% 	 69.5% 	- - 65.8% 
to° io 	to2 to3 to4'2 	°  	l  to 	2 tt4 	t6 	to 	t to 	o 	 — too 	i to 	O0 	o 	 ° 	i 	io 	io 	o  
FLI-H GOP 	 FLI.H GFP 	 FLI-H GFP FL1-H GOP 	 OLI-H GOP FL1-H GOP 	 RI-H GOP 	 FLI-H GOP 
Figure 5.7 Two iMEKact and two iMEKwt clones were cultured in 2 g/ml dox for U - 7 days and then analysed by flow cytometry. Two 
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--- iMEKact5 	Figure 5,8 a) Scatter plot depicting percentage of DsRED2 positive cells in each of the four clones at different 
-- iMEKact8 	concentrations of dox. b) Scatter plot of median DsRED2 fluorescence versus dox concentration. c) Scatter plot of 
percentage of DsRED2 positive cells after different lengths of time in dox. d) Scatter plot of median DsRED2 
iMEKwt3 	fluorescence after number of days in dcx. 
—3E-- iMEKwt4 
exhibited the highest levels of DsRED2 fluorescence at day 4 (Figure 5.8d), after which 
time the levels dramatically declined. 
	
5.6 	Retargeting R26_rtTA2sM21F  cells with 1DsRED2 vectors 
The iMEKact and iMEKwt cell lines exhibited low and heterogenous expression of 
DsRED2 reporter when compared to the iDsRED2 clones of the previous chapter. Both 
experimental strategies involved targeting the TRE and linked cDNAs to the 5' region of 
hprt in R26rtTA2sM2lF  cells. However, the establishment of the iMEKact and 
iMEKwt cell lines involved the creation of new intermediate TRE-linked plasmids for the 
cloning procedure, one such consequence of which was that the DsRED2 ORF was 
positioned closer to the TRE sequence in the 5'hprtTREMEK vectors than in the 
5'hprtTREDsRED2 vectors. 
In a effort to determine whether the differences in transgene expression between the 
iMEK and iDsRED2 cell lines was due to subtle differences in the positioning of the 
transgene open reading frames in relation to the TRE, the R26rtTA2sM2lF  parental 
cells that were used in the establishment of the iMEK cell lines were thawed and 
electroporated with the 5'hprtTREDsRED2F targeting vector (see Figure 4.2). After 
selection in HAT medium for about 10 days, colonies were picked, expanded and 
cultured in dox inducer for three days. Flow cytometry was then used to detect levels of 
DsRED2 fluorescence. The resulting two-dimensional density plots are shown in Figure 
5.5b. It is clear that these iDsRED2new clones all expressed poor levels of the DsRED2 
reporter and therefore it appears that the suboptimal expression of inducible transgene 
was not a result of vector manipulation but rather an issue of the parental cell line. 
5,7 	Immunohistochemistry of iMEKact and iMEKwt cell lines 
Having previously confirmed that the iDsRED2 reporter was inducibly expressed, the cell 
lines were analysed for the expression of their exogenous MEK proteins. The cell-lines 




Figure 5.9 Immunohistochemistry of iMEKact and iMEKwt 
cell lines. iMEKact8 and iMEKwt4 were cultured in 2 ug/mI 
dox for three days after which time they were fixed and 
stained with antibody specific to HA, followed by FITC-
conjugated secondary antibody. Clockwise from top left 
panel; DsRED2, anti-HA staining to detect inducible MEK, 
merged panel of DsRED2 and anti-HA, and DAPI staining. 
a) iMEKact8 plus dox, b) iMEKact8 plus dox, c) iMEKwt4 
plus dox. Inset panels in b show images of cells cultured 
in the absence of dox. No D5RED2 is detected and 
background staining for HA is shown. 
fixed and analysed for MEK expression by immunohistochemistry and subsequent 
microscopy (as inducible MEK was fused to an HA epitope, immunostaining with an 
antibody specific to HA detected only inducible MEK, not endogenous MEK). Both 
iMEKact8 and iMEKWt4 expressed their respective HA-MEK fusion proteins (Figure 
5.9). It was shown that the inducible MEK protein co-localised with DsRED2 in the ES 
cells treated with dox (merged panels of the anti-HA and DsRED2 fields). As MEK is a 
cytoplasmic protein and DsRED2 is both nuclear and cytoplamic, a yellow halo around 
the nucleus of cells expressing the inducible proteins was seen in the merged views (most 
clearly viewed in figures 5.9b and 5.9c). This confirmed that the MEK fusion protein 
was induced in the presence of dox, and also that the TRE was truly bidirectional, as cells 
that highly expressed inducible MEK also expressed DsRED2. 
5.8 	Immunoblotting of iMEKact and iMEKwt cell lines 
In order to analyse activation of the MAPK/ERK pathway by MEKact, the iMEKact8 and 
iMEKwt4 ES cell lines were cultured in the presence or absence of dox and then analysed 
by immunoblot for phosphorylated ERKII2 levels after stimulation with either LIF, 
FGF4, or in the absence of stimulation. The detection of elevated phospho-ERK1/2 (P-
ERK) levels in the iMEKact8 cell line in comparison to those levels of the iMEKWt4 
clone cultured in identical conditions, would indicate activation of the MAPKIERK 
pathway by the exogenous active MEK. This would enable investigation into the 
involvement of this pathway during neural induction using a monoculture differentiation 
protocol, (Ying et al., 2003). 
The MAPK/ERK pathway is permanently activated by factors in standard cell culture 
conditions (such as growth factors present in serum and the addition of LIF cytokine to 
cell culture media). Before lysis of the cells for p-ERKI/2 detection, it was therefore 
necessary to culture the cells overnight in the absence of serum and LIF, in order to 
obtain basal levels ofERKI/2 phosphorylation, (basal phospho-ERK 1 /2 are routinely 
detected, after culture in the absence of serum and LIF, probably as a result of 
intercellular FGF and integrin signalling). It was predicted that the iMEKact8 cell line 
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Figure 5.10 Immunoblotting of targeted cell lines. iMEKact 8, iMEKwt4 and R26rtTA2s-M2 iF cells were plated out at the same 
density and cultured in the presence or absence of 2 tg/ml dox for 72 hours. After 60 hours all cells were serum starved 
overnight (with dox added to the appropriate cells). At 72 hours cells were either left untreated or stimulated with LIF or FGF4 for 
15 minutes, after which time they were washed once with cold PBS and then lysed in SIDS lysis buffer. Samples were sonicated and 
one fifth of the total lysate was run on a 10% Tris-HCI gels and transfered onto PVDF membrane overnight. Membranes were then 
blocked and subsequently probed with antibody to a) HA, b) phospho-ERK1/2 (p-ERK1/2) or c) ERK1/2. After washing, the 
membranes were probed with secondary antibody and protein levels were detected by chemiluminescent assay. iMEK; inducible 
MEK 
cultured in the presence of dox (iMEKact8 + dox) would exhibit higher basal levels of 
phospho-ERKI/2 in comparison to those exhibited by iMEKwt4 (also cultured in the 
presence of dox - iMEKwt4 + dox) owing to the action of activated MEK. Cells were 
also stimulated with LIF and FGF4 (which activates the MAPK/ERK pathway through 
cell surface receptors), before lysis to investigate whether p-ERK levels were elevated in 
the cell line overexpressing MEKact when compared to the MEKWt expressing line. This 
would indicate increased activation of the pathway by MEKact. 
Both cell lines and in addition, the parental R26rtTA2sM21F  line (this line acted as a 
control for the possibility of dox addition leading to ERKI/2 phosphorylation), were 
cultured in the presence or absence of 2 j.ig/mI dox for three days, in standard self-
renewal conditions. Approximately 12 hours before lysis, medium lacking serum and 
LIF was added to the cell cultures (dox was also added to those cells that had previously 
been cultured in the presence of dox). The next morning cells were either left untreated 
or stimulated for 1 5 minutes with medium containing LIF or FGF4, after which time they 
were lysed, sonicated and then analysed by immunoblotting with antibodies to HA, p-
ERKI/2 and ERK1/2 (Figure 5.10). 
Both iMEKact8 and iMEKwt4 were shown to express exogenous MEK, (MEKact and 
MEKwt respectively), in the presence of dox as determined by probing with antibody to 
the HA epitope (Figure 5.1 Oa). No inducible MEK was detected in the absence of dox, 
which supports the flow cytometry analysis that showed lack of DsRED2 fluorescence in 
the absence of dox. In the absence of LIF or FGF4 stimulation, it was found that basal p-
ERKI/2 levels were of a similar magnitude in all cell lines, irrespective of culture in the 
presence or absence of dox (Figure 5. lOb). MEKact is a constutively active form of 
MEK which has been previously been shown to phosphorylate and activate ERKI/2 in 
the absence of cytokine or growth factor stimulation (Pages et al., 1994), therefore the 
induction of MEKact was predicted to enhance basal p-ERK levels in the absence of LIF 
and FGF4 stimulation. The observed levels however, were comparable to those detected 
upon culture in the absence of dox (iMEKact8 - dox), and those seen in the iMEKwt4 
cell line cultured in the presence of dox (iMEKwt4 + dox), (it should be noted that 
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overexpression of MEKwt would not be expected to constitutively activate the MAPK-
ERK pathway). These results therefore precluded investigation into the involvement of 
the MAPK/ERK pathway during monoculture serum-free differentiation, as it was clear 
that overexpression of MEKact in the iMEKact8 cell line did not lead to increased 
activation of the pathway in the absence of stimulating conditions. 
The stimulation of all cell lines with LIF and FGF4 lead to increased pERK 1/2 levels as 
expected. However expression of MEKact did not lead to elevated pERK 1/2 levels 
when compared to iMEKact8-dox (+LIF or +FGF4), or iMEKWt4 (+LIF or +FGF4). 
These observations suggest that in stimulating conditions MEKact expression did not 
lead to increased activation of the MAPK/ERK pathway. 
5.9 	Discussion 
Low expression levels of DsRED2 in iMEKact and iMEKwt cell lines 
The previous chapter described the targeting of a TRE and linked DsRED2 reporter to the 
5' hpri locus in the R26rtTA2sM2lF  cell line, and the resulting high levels of DsRED2 
fluorescence obtained upon induction of the correctly targeted lines with dox. An 
identical strategy was used to establish the inducible expression of MEKact and MEKWt 
proteins in ES cells (again using DsRED2 as a reporter transcribed from a bidirectional 
TRE), however analysis of the newly targeted cell lines after three days in dox revealed 
that the intensities of DsRED2 fluorescence observed were much lower than those 
observed in the previous iDsRED2 cell lines (compare figure 5.3 to figure 4.4). Also the 
induction was very heterogenous in nature, with a large population of cells negative for 
DsRED2 fluorescence in every clone analysed in the presnce of dox. 
To exclude the possibility that the reason for poor induction was due to differences 
between the two vectors used in the establishment of the iDsRED2 and iMEK cell lines, 
identical passage R26rtTA2sM2lF  cells that were used to establish the iMEK clones 
were transfected with the 5'hprtTREDsRED2R vector. Had the poor expression levels 
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observed with the iMEK clones been a problem intrinsic to the targeted transgenic 
sequences, one would have expected the targeting of R26rtTA2sM2  IF cells with the 
5'hprtTREDsRED2R vector to give rise to discrete, high levels of DsRED2 as described 
in chapter 4. However the newly targeted iDsRED2new clones all exhibited transgene 
expression that was reminiscent of those obtained with the IMEK clones, and therefore 
the hypothesis of poor induction being an issue of transgenic sequence configuration can 
be discounted. 
This suggests that the poor induction observed was due to the R26rtTA2sM21F  cells 
themselves. One possibility is that the R26rtTA2sM2lF  cells used in the 
electroporations that gave rise to the iMEK clones, expressed lower levels of 
transactivator and therefore were not able to drive high levels of transgene expression in 
the presence of dox. Analysis of both cell lines simultaneously by flow cytometry 
however, uncovered no difference between the hrGFP fluorescence levels of the 
iDsRED2 and iMEK cell lines (data not shown), and therefore it is unlikely that poor 
induction levels are the result of low transactivator levels. 
An alternative explanation is that the epigenetic state of the 5' hprt region is different in 
the iDsRED and iMEK cell lines. The hprt promoter is located within a CpG island that 
is methylated during X inactivation. EI4TG2a cells are male and therefore contain only 
one (transcriptonally active) X-chromosome, however it is possible that this region of 
chromatin is prone to transcriptional silencing. If there is a gradual accumulation of 
methylation with time in cell culture, this region may be expected to be particularly 
susceptible to silencing as it contains a high proportion of CpG dinucleotides. Indeed it 
has previously been shown that the transcriptional repression of the human HPRT gene is 
highly correlated with the methylation of just three specific CpG nucleotides located 
within the HPRT promoter (Chen et al., 2001). There may therefore be the risk of 
methylation spreading to the TRE sequence which is targeted to this CpG rich area. It is 
however difficult to correlate this with the fact that the targeting of S'hprtTREMEKact 
into low passage cells (which are unlikely have accumulated many methyl-CpG 
dinucleotides) still gives rise to the poor induction of the DsRED2 transgene (data not 
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shown). The reason for the differences in transgene expression therefore still remains to 
be determined. 
Dox titration and timecourse experiments 
The four iMEK cell lines cultured in a gradient of 0-2 .ig/ml dox exhibited an increase in 
both the proportion of DsRED2 positive cells and an increase in median DsRED2 
fluorescence levels with increasing concentration of dox (Figure 5.8). This parallels the 
increase in DsRED2 observed in the iDsRED2 cell lines in the previous chapter, however 
the overall percentages of DsRED2 positive cells and median DsRED2 values were lower 
for the iMEK cell lines for reasons which have been commented upon above. 
In the timecourse experiment the four lines were cultured in 2 jtg/ml dox for between 0 
and 7 days. It was observed that for most of the cell lines DsRED2 expression (in terms 
of proportion of DsRED2 positive cells and median fluorescence) peaked at around two 
to three days and remained relatively constant until about 5 days, after which expression 
gradually declined (Figure 5.8). The exception to this was the iMEKwt4 cell line which 
exhibited maximal DsRED2 expression at day 4 after which median fluorescence levels 
rapidly declined. This pattern of expression of DsRED2 with time is reminiscent to that 
of the iDsRED2 cell lines. The iMEKwt4 cell line expressed the highest levels of 
DsRED2 out of the four clones analysed, and this suggests that the reason for the 
observed decline in transgene levels may be linked to the initial levels of transgene 
expression, with the highest DsRED2 expressing clones exhibiting the greatest rate of 
decline in DsRED2 fluorescence. This phenomenon is therefore likely to be due to a 
toxic effect of DsRED2 expression in ES cells, with the cell lines exhibiting the highest 
levels of DsRED2 being subject to greater selection pressures for lower DsRED2 levels, 
and therefore exhibiting the most pronounced reductions in transgene levels. If the 
decline was in fact due to toxicity related to dox administration as discussed in the 
previous chapter, one might expect that all cell lines would be subjected to the same 
selection pressure and therefore exhibit the same decrease in DsRED2 levels with time 
(as the selection pressure would be to decrease the internal concentration of dox, for 
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example by selecting for cells which exhibit increased efflux of the antibiotic). As the 
iMEK cell lines express very low levels to start with this would probably result in the cell 
lines becoming completely negative for DsRED2 with time. Whilst DsRED2 levels do 
decline in the iMEK cell lines, fluorescence is still observed, even after 7 days, and 
therefore it is more likely that the reason for the reduction DsRED2 levels with time, is 
linked to DsRED2 toxicity rather than to dox toxicity. 
The influence of MEKact on the MAPK pathway 
The MAPK signalling pathway plays vital roles in cellular proliferation, differentiation 
and cell cycle regulation of somatic cells. The overexpression of an activated form of 
MEK has previously been utilised to investigate the involvement of this pathway in these 
diverse cellular processes, (Cowley etal., 1994; Brunet et al., 1994; Montesano etal., 
1999). Cowley et al showed that the overexpression of a constitutively activated form of 
MEK1 was sufficient to both drive the differentiation of PC 12 cells and to transform the 
NIH 3T3 cell lines, and Montesano et al reported that overexpression of activated MEK 
conferred an invasive phenotype upon MDCK epithelial cells. 
In an attempt to investigate the involvement of the MAPK pathway in the differentiation 
of ES cells into the neuroectoderm lineage using serum free adherent monoculture 
conditions, an activated form of MEK (MEK act) was inducibly expressed in ES cells 
using the tet-system. The aim was to overexpress MEKact during monoculture 
differentiation at different timepoints in order to determine if activation of the 
MAPK/ERK pathway led to increased acquisition of a neuroectodermal cell fate. The 
use of a bidirectional TRE was used to drive the transcription of a DsRED2 reporter in 
one direction and the mek ORF transgene in the other. Upon analysing the expression of 
the MEKact and MEKwt proteins by immunohistochemistry both proteins were found to 
be expressed in their respective cell lines upon the addition of dox (Figure 5.9), however 
in correlation to the flow cytometry analysis of these cell lines, this induction was found 
to be mosaic. As anticipated the inducible MEK and DsRED2 proteins were shown to be 
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expressed in the same cells (as observed in the merged panels in figure 5.9), showing that 
the TRE was indeed functioning in a bidirectional manner. 
Investigation into the involvement of the MAPK/ERK pathway during the differentiation 
of ES cells to neural progenitor cells required that the cell line iMEKact8 overexpressed 
MEKact to levels high enough to activate the ERK pathway in serum-free conditions (as 
indicated by ERKI/2 phosphorylation), when induced by dox addition. MEKact 
expression was induced in the iMEKact8 cell line and levels ofp-ERKI/2 were analysed 
by immunoblot and compared to those detected when iMEKact8 was cultured in the 
absence of dox and also to the levels produced by the iMEKWt4 cell line cultured in 
identical conditions. The iMEKact8 and iMEKwt4 ES cell lines were therefore cultured 
in the presence or absence of dox for three days and analysed for p-ERK 1/2 levels by 
immunoblot. 12 hours before lysis, the cells were treated with medium lacking serum or 
LIP, in order to obtain basal levels of p-ERK. Just prior to lysis cells were either left 
untreated, or stimulated with either LIF or FGF4. It was found that even though MEKact 
was clearly expressed in the presence of dox, this did not result in increased activation of 
the ERK pathway in either unstimulated or stimulating conditions. 
The lack of increased MAPK/ERK signalling may result from insufficient levels of 
expression of MEKacI , unable to give rise to significant activation of ERKI/2. MAPK 
signalling is however highly regulative, and several inhibitors of this pathway have been 
identified, such as Pystl/MKP3, a dual specificity phosphatase that acts on MAPK 
(Groom el al., 1996), and Spred, which acts on Raf, (Wakioka et al., 2001). Upon 
overexpression Of MEK act in ES cells it is therefore possible that ERK pathway activation 
is 'dampened' by the activation of downstream inhibitors of signalling such as 
Pystl/MKP3. Indeed studies in chick show that activation of the MAPK pathway in the 
developing embryo (by the implantation of FGF-soaked beads into extra-embryonic 
epiblast) induce Pystl/MKP3 expression after 4 hours (Eblaghie el al., 2003). In addition 
the electroporation of a plasmid encoding an activated form of MEK into the chick neural 
tube has been shown to induce the expression of Pystl/MKP3, (Smith ci al., 2005). It 
currently still remains to be determined if the lack ofERKI/2 activation observed in the 
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iMEKact8 ES cell line resulted from the upregulation of negative inhibitors of ERK 
signalling, or if MEKact was expressed at levels insufficient to bring about significant 
phosphorylation ofERKI/2. However it is clear that higher levels of MEKact are needed 
in order to activate the MAPK/ERK pathway. Alternative strategies of tet-system 
implementation proposed to give rise to high levels of inducible cDNA expression will be 
discussed in the next chapter. 
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Concluding notes 
The tet-system is currently one of the most popular inducible gene expression systems in 
use today. The aim of this project was to develop a strategy for implementing the tet-
system in ES cells, which would give rise to robust inducible expression of cDNAs to use 
in the study of pathways involved in the in vitro differentiation of these cells. Two 
strategies have been described. The first involved the targeting of both elements of the 
system to the hprt locus, the transactivator to the 5' proximal region of hpri, and the TRE 
into exori 6 of the open reading frame of hprt to create ihprtDsRED2 cell lines. Addition 
of doxycyline inducer to the established cell lines resulted in the heterogenous expression 
of the DsRED2 reporter which instigated investigation into alternative strategies. 
The second strategy involved the use of the previously established R26 rtTA2sM2lF cell 
line. This cell line expressed the rtTA2sM2  transactivator from the endogenous 
ROSA26 promoter. The targeting of the TRE element to the 5' region of hprt gave rise 
to the iDsRED2 cell lines, which upon addition of dox, expressed the DsRED2 reporter in 
a high and homogenous manner. Further attempts to inducibly express an activated form 
of MEK in the same experimental design however, resulted in cell lines that expressed 
the MEK and DsRED transgenes at low and heterogenous levels. The reasons for the 
poor expression exhibited by the iMEK cell lines still remains to be determined, however 
it is most likely a problem of the R26rtTA2sM2lF  cell-line, as control experiments 
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suggest it was not due to differences in vector sequences (see Chapter 5, discussion 
section). 
Improved strategies for establishing the tet-system in ES cells 
In order to manipulate transgene expression in a predictable manner, new strategies of 
implementation need to be investigated. Independent work in which the rtTA2SM2  and 
TRE sequences were targeted to the endogenous ROSA26 locus within a single construct, 
gave rise to high levels of transgene expression (Heavey and Cunningham, personal 
communication - Figure 6.1). Although previous studies involving the integration of 
transactivator and TRE elements encoded within a single element, have reported that high 
basal levels of transgene expression can be a problem (Hofmann el al., 1996, Markusic et 
al., 2005), in the 'single-allele' approach mentioned above there was no detection of the 
DsRED2 reporter gene expression in the absence of inducer. 
Further adaptation of this strategy into a 'cassette-exchange' approach would facilitate 
the derivation of cell-lines with regulatable transgenes (Figure 6.2). A hypothetical 
scheme is proposed in Figure 2.1. The first step would involve targeting rtTA2sM2  to 
the ROSA26 locus in a construct that also encodes a selection cassette (encoding 
neomycin and HSV thymidine kinase selection transgenes), flanked by heterospecific 
loxP sites, (Figure 6.2a and 6.2b). Correct integrants would be isolated by selection in 
G418-containing media and subsequent analysis of genomic DNA. This step only needs 
to be carried out once as the correctly targeted cell line acts as the parental cell line in all 
future cassette-exchange transfections, as will be described. The exchange vector (Figure 
6.2c) would encode the TRE and linked cDNA (and also a reporter gene linked via an 
IRES if desired). These sequences would also be flanked by heterospecific loxP sites. 
Upon transfection of the exchange vector and a plasmid expressing Cre-recombinase into 
the rtTA2-M2-expressing parental cell line, site-specific recombination between the 
homospecific loxP sites present in the targeted ROSA26 locus and the exchange vector 
would result in the exchange of the selection cassette (from the ROSA26 locus), with the 
TRE and linked sequences (from the exchange vector) as shown in Figure 6.2d. Such an 
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Figure 6.1 The 'single-allele' approach, targeting both the rtTA2s-M2 and 
TIRE in a single construct to the ROSA26 locus (unpublished work done by 
Heavey and Cunningham). a and b) The targeting construct (here shown in 
its linearised form) was electroporated into E14TG2a cells c) Correctly 
targeted clones were isolated by selection in G418-containing media and 
subsequent analysis by Southern blot hybridisation. d) Subclone of the 
above, derived by transfection with a plasmid expressing Cre-recombinase. 
Clones with excised selection cassettes were determined by Southern blot 
hyrbridisation. e) Addition of 1 .tg/ml dox for two days to clones containing 
the selection cassette (as shown in c) resulted in high and homogenous 
expression of the DsRED2 transgene. f) Addition of 1 ig/ml dox for two 
days to clones in which the selection cassette had been excised (as shown in 
d) resulted in even higher transgene expression. The y-axis represents 
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Figure 6.2 Proposed implementation of 'cassette-exchange strategy. a) The rtTA2s-M2 encoding construct is targeted to the endogenous ROSA26 
locus shown in b. c) Upon isolation of correctly targeted clones (by selection in G418-containing media and analysis by Southern blot hybridisation) 
cells are transfected with the exchange vector encoding a TRE sequence linked to the desired cDNA. A reporter (in this case human CD2 antigen) is 
linked to the cDNA sequence via an IRES. A plasmid that encodes Cre-recombinase is also transfected. d) Site-specific--recombination between the 
two IoxP sites and two !ox5l 1 sites results in exchange of the targeted selection cassette with the TIRE encoding sequences (here only the ROSA26 
locus is shown). Clones undergoing this exchange can be selected in gancyclovir (as an exchange event results in the removal of the HSVtk ORE). 
exchange event could be selected for using ganciclovir (Mansour et at., 1988), as any 
cells harbouring 'un-exchanged' loci will not survive this drug owing to the presence of 
the HSV ik transgene (Figure 6.2d). 
The construction of an exchange vector with a multiple cloning site downstream of the 
TRE sequence would facilitate the efficient cloning of cDNAs into the vector. This is in 
contrast to the attempted integration of cDNA sequences into large stretches of vector 
sequence, as would be the problem if all elements were encoded within the same vector. 
Multiple cell-lines containing conditional genes could be derived with relative ease once 
the initial parental rtTA2sM2expressing  cell line had been established (Figure 6.2a and 
6.2b). Figure 6.2 depicts the use of a reporter gene downstream of the TRE and cDNA. 
As expression of DsRED2 at high levels was found to be slightly toxic to ES cells here 
the human CD2 marker is shown as an alternative. 
A similar strategy of cassette-mediated exchange at the ROSA26 locus has previously 
been reported (Masui et at.. 2005). It was observed however that after about five 
passages, transgene induction started to decline. This may result from intolerance of the 
cells for the reverse transactivator as the original rtTA was used. Such a rapid decline in 
DsRED2 was not seen with the aforementioned single-allele approach (Heavey and 
Cunningham, personal communication). 
Experimental approaches to investigating the involvment of the MAPKIERK 
signalling pathway in the differentiation of ES cells into neural progenitor cells 
The utilisation of the 46C ES cell-line that harbours an eGFP reporter sequence under the 
regulation of the endogenous Sax] promoter would greatly aide the investigation of 
pathways involved in neural induction (Ying et al., 2003). Soxi is the earliest known 
marker of neuroectoderm and the proportion 46C ES cells that acquire this cell fate 
during differentiation can be readily analysed by eGFP fluorescence. The establishment 
of the tet-exchange system in this cell line would therefore provide a quantitative and 
qualitative read-out of neural induction. In addition to the overexpression of MEK act, the 
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tet-regulated expression of other factors involved in the activation, or inhibition of the 
MAPK/ERK pathway would provide complementary information about the involvement 
of ERK signalling during the in vitro differentiation of ES cells. The production of such 
inducible cell lines could be efficiently established using the tet-exchange approach. The 
MAPK phosphatases (MKP5) which negatively regulate the pathway by 
dephosphorylating ERK I and 2, would be interesting candidates. indeed it would be 
possible to determine if the block in ES cell differentiation in serum-free monolayer 
conditions, resulting from blockade of FGFR signalling (Ying et al., 200' )), was due 
entirely to inhibition of the MAPKIERK pathway or if other candidate signalling 
pathways such as Phosphatidylinositol-3-OH (P13K) and Phospholipase C (PLC) 
mediated pathways play a role. If the overexpression of MKPs did result in the inhibition 
of neuroectoderm specification these induced cells could then be analysed to determine if 
they remained in a pluripotent ES cell state or if they were restricted in developmental 
potential. 
An advantage to establishing the inducible regulation of these cDNAs in ES cells is that 
the engineered cell lines can be used to investigate the MAPK/ERK pathway in multiple 
lineages by using alternative in vitro differentiation protocols. indeed ERK activation 
has also been shown to be important for the induction of mesoderm (Li et al., 200' )). The 
tet-regulated cell lines could also be used to establish conditional expression of cDNAs in 
vivo. It should be noted however that the restriction of transgene expression to a 
particular tissue would require the re-establishment of the tet-exchange system under a 
tissue-specific promoter (as the ROSA26 promoter described above is ubiquitously 
expressed in vivo). 
In conclusion, the work undertaken in this project describes two strategies that can be 
used to achieve inducible gene expression in ES cells using the tet-system, with the later 
strategy (utilising both the ROSA26 and hprl loci), giving rise to superior expression of 
the inducible DsRED2 transgene. The approaches outlined above highlight possible 
ways in which tet-inducible expression of transgenes can be further improved, both in 
terms of reproducibility in expression and in ease of inducible eDNA establishment. 
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Materials and Methods 
7.1.1 Molecular Biology Materials 
All chemicals were of analytical grade and supplied by Sigma-Aldrich Co, BDH 
Laboratory Supplies or Fisher Scientific UK Limited. All bacterial media constituents 
were supplied by DIFCO laboratories and electrophoresis grade agarose was supplied by 
Invitrogen Life Technologies. Synthetic oligonucleotides were supplied by Eurogentec 
EGT Group. Radioisotopes were supplied by Amersham Biosciences and X-ray film by 
Eastman Kodak Company. Positively charged nylon membrane was supplied by Roche 
Diagnostics GmbH and Sequi-131otTM PVDF membrane by Bio-Rad Laboratories. 
Superscript 1M First-Strand Sythesis System for RT-PCR was supplied by Invitrogen Life 
Technologies and the Dual Luciferase® Reporter Assay System by Promega UK. 
RNeasy® mini kits, Plasmid Maxi kits, Qiaprep®Spin Miniprep kits and Qiaquick® Gel 
Extraction kits were all supplied by Qiagen. 
Clone Manager Professional Suite 7. version 7.11 was used for DNA analysis. 
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7.1.2 Enzymes 
All enzymes were obtained from New England Biolabs except for the following: Klenow 
polymerase, Taq polymerase, and T4 DNA ligase from Roche Diagnostics GmbH and 
Alkaline Phosphate from Boehringer Mannheim GmbH. 
7.1.3 Plasmids 
Commercially available 
pBI-L - BD Biosciences, Clontech, 
pIRES-hrGFP-Ia - Stratagene 
Constructed/provided 
Please refer to appendix I 
7.1.4 Probes for Southern blot hybridisation 






SpeI/BamH I 4380 
a M19 SpeI/BglIl 543 
DsRED2 pCMVTREDsRED2 Null/Barn H I 697 
MEK pECEHAMEK HindlII/Xbal 1814 
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7.1.5 Primers 
Primer 	 Sequence 
rtTA2sM2 forward agactggacaagagcaaagt 
rtTA2sM2 reverse gcatgtcaaggtcaaaatcg 
HA-MEK I * ggcgtcaaagcaacatggca 
HA-MEK2 * tgtgcataatcttgtgcttc 
sequencing primers 
7.1.6 Bacterial strains 
XL-] blue - Stratagene 
DH5a - Invitrogen Life Technologies 
SIb12TM - Invitrogen Life Technologies 
7.1.7 Bacterial growth media 
Luria Broth (LB); 5 LB pellets (DIFCO) added to I litre dH20 and autoclaved 
Luria Broth based agar plates; 15 g agar (DIFCO) added to I litre LB 
7.1.8 Antibiotics 
Antibiotic 	 Stock concentration 	Working concentration 
Ampicillin 50 mg/ml in H20 50 tg/mI 
Kanamycin 25 mg/ml in H20 25 tgImI 
Tetracyline 6.25 mg/ml in 100% EtOH 12.5 tg/ml 
Doxycyline 1 mg/ml in H20 I jig/ml * 
* For use as inducer of transgene expression using the tet-system (all other antibiotics 
were used for bacterial selection during cloning procedures) 
94 
7.1.9 Standard stock solutions and buffers 
All solutions were prepared with dH 20 
TE Buffer; 10 mM Tris.HCI (pH 8.0), 0.1 mM EDTA (pH 8.0) 
20x SSC (per 4 litres); 701.3 g NaCl, 352 g tn-sodium citrate, adjusted to pH 7.0 
with HCI 
PBS (per 2 litres); 14.7 g NaCl, 4.7 g Na2HPO4 ; 2.6 g NaH2PO4 .2H20, adjusted to 
pH 7.1 
50x TAE (per 1 litre); 242 g Tris base, 57.1 ml glacial acetic acid, 100 ml 0.5 M 
EDTA (pH 8.0). 
DEPC-treaIed dH20 for RNA preparations; 0.1% DEPC in dH20. This solution 
was prepared by overnight incubation at 37°C before being autoclaved, and then allowed 
to cool to room temperature before use. 
7.2.1 Molecular Biology Methods 
Unless stated otherwise all centrifugations were carried out in a Heraeus Sepatech 
benchtop centrifuge 
7.2.2 Preperation of nucleic acids 
Small scale preparation ofplasmid DNA; A single colony was inoculated into 2 
ml of LB broth supplemented with 50 jig/ml ampicillin. The culture was incubated at 
37°C overnight, with shaking. The next day the culture was centrifuged at 13000 rpm for 
3 minutes to form a pellet. The supernatant was then removed and the plasmid DNA 
harvested using the Qiaprep® Spin miniprep system as according to the manufacturers 
instructions. 
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Large scale preparation ofplasmid DNA; A single colony was inoculated into 2 
ml of LB broth supplemented with 50 Vtg/ml ampicillin for 6-8 hours. This culture was 
then used to inoculate 250 ml LB supplemented with 50 jtg/ml ampicillin. This culture 
was incubated at 37°C overnight, with shaking. The next day the culture was centrifuged 
at 6000 rpm for 15 minutes using a Sorvall® GSA rotor in a Sorvall® RC5C centrifuge. 
Plasm Id DNA was then harvested using the Qiagen Plasm Id Maxi Kit as according to the 
manufacturers instructions. 
Preparation of RNA; For RNA extraction 5x106 cells were washed twice in PBS 
after which they were incubated with trypsin (see tissue culture materials and methods) 
and then spun at 1200 rpm for 5 minutes in a MSE Mistral 1000 centrifuge. The cells 
were then lysed and RNA extracted using the RNeasy® mini kit as according to 
manufacturers instructions. 
7.2.3 General cloning methods 
Nucleic acid digestion by restriction enzymes; 5 units of the appropriate 
restriction enzyme was used to digest I jig of DNA at the optimal temperature for 
enzyme action for 1 hour. Reaction mixes included the DNA to be digested, restriction 
enzyme, appropriate buffer (supplied with the enzyme), dH 20 and BSA when needed. 
Blunting of DNA fragment ends; When necessary 3'recessed ends were made 
flush by incubation with NEB kienow polymerase. 5 p1 of 500 tM dNTPs and 1 l of 
(2U/jil) kienow polymerase was added to previously digested DNA (that had not been 
precipitated and therefore still contained restriction enzyme buffer, the volume was 50p1), 
and incubated for 5 minutes at room temperature. The reaction was stopped by addition 
of EDTA to a final concentration of 5 mM and heating the mix at 75°C for 10 minutes. 
Dephosphorylation of linearised vectors; An equivalent volume of TE was added 
to previously digested DNA (that had not been precipitated and therefore still contained 
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restriction enzyme buffer, the volume was 50tl). Then I tl of alkaline phosphotase was 
added and the reaction mix was incubated at 37°C for 15 minutes. The reaction was 
stopped by addition of EDTA to a final concentration of 5 mM and heating the mix at 
75°C for 10 minutes. 
Phenol/chloroform extraction of reaction mixes; Phenol/chloroform extraction 
was routinely used to remove protein from reaction mixes in preparation for ligation 
reactions. An equal volume of phenol/chloroform mix was added the reaction mix (with 
the phenol/chloroform at a ratio of 1:1), for example SO p] of phenol and 50 .il of 
chloroform was added to a 100 p]  reaction mix. The mix was then vortexed and 
centrifuged at 13000 rpm for 5 minutes. The upper aqueous phase was then removed into 
a fresh tube. 
Ethanol precipitation of nucleic acids; DNA was precipitated from solution by 
addition of one-tenth volume 3 M sodium acetate (pH 8.0) and 2 volumes of ice-cold 
100% ethanol. The nucleic acid was then incubated at -20°C for 20 minutes after which 
it was centrifuged for 10 minutes at 13000 rpm. The supernatant was discarded and 100 
tl of 70% ethanol was added to the pellet and the tube inverted several times. The pellet 
was centrifuged for a further 2 minutes at 13000 rpm after which the ethanol was 
removed and the pellet air-dried for 10 minutes. The DNA was then resuspended in an 
appropriate volume of TE buffer. 
Gel purification of DNA fragments; Fragments of digested DNA were resolved by 
agarose gel electrophoresis. Gels were visualised under UV light (340nm wavelength), 
and the appropriate band excised with a scapel blade. DNA was extracted from the gel 
slice using Qiaquick® Gel Extraction Kit as according to the manufacturers instructions. 
Ligation of DNA; Ligations were carried out in 20 pd reaction volumes using three 
fold excess of insert to vector. Appropriate amounts of vector and insert were incubated 
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with 2 !.tl T4 DNA ligase and 2 jti of T4 ligase buffer at overnight at 16°C (for a blunt-
ended ligation), or for 2 hours at 16°C (for the ligation of fragments with cohesive ends). 
7.2.4 Preparation of chemically-competent cells 
10 ml LB broth supplemented with 12.5 Lg/ml tetracycline was inoculated with an E.coli 
colony, and incubated at 37°C with shaking overnight. The next day 250 ml LB broth 
was inoculated with 5 ml of the overnight culture and incubated at 37°C with shaking. 
Once the optical density of 0.5 had been achieved (absorbance was measured at 600nm), 
the culture was divided into six, 50 ml Corning tubes and centrifuged at 4000 rpm in a 
MSE Centraur 2 centrifuge for 10 minutes at 4°C. The supernatant was then discarded, 
and 20 mIs of chilled 50 mM calcium chloride was added to each tube and the pellet 
resuspended with a plastic Pasteur. After 15 minutes on ice, the culture was centrifuged 
at 4000 rpm for 10 minutes at 4°C (MSE Centraur 2 centrifuge). The supernatant was 
discarded and 4 mIs of freezing mix was added to each tube (0.1 M KCI, 0.05 M CaCl 2 , 
0.01 M CH 3 COOK, 10% glycerol). The culture was once again resuspended with a 
plastic Pasteur pipette and aliquoted into 1.5 ml screw capped tubes. 
7.2.5 Transformation of chemically-competent XL-1 Escherichia co/i 
Chemically-competent Ecoli were thawed on ice and dispensed into 100 jd aliquots in 
pre-chilled 14 ml polypropylene Falcon tubes. 10 pi ligation mix was then added to 100 
jl volume of bacterial cells and mixed by flicking the tube. The mix was left on ice for 
20 minutes. The bacterial/ligation mix was then incubated at 37°C for 2 minutes after 
which 1 ml prewarmed (to 37°C) LB broth was added to the tube. After incubation at 
37°C with shaking for 45 minutes 50 jil of the mix was plated out on LB agar plates 
containing appropriate selection (for sticky-ended ligation), or all of the mix was 
centrifuged for 2 minutes at 13000 and resuspended in 100 l LB broth before being 
plated out (for blunt-ended ligations). The selection plates were then incubated at 37°C 
overnight. 
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7.2.6 Transformation of chemically-competent recombinant StbI2TM  Escherichia 
coli 
Chemically-competent E.coli were thawed on ice and dispensed into 100 l aliquots in 
pre-chilled 14 ml polypropylene Falcon tubes. 10 jil ligation mix was then added to 100 
p1 volume of bacterial cells and mixed by flicking the tube. The mix was left on ice for 
20 minutes. The bacterial/ligation mix was then incubated at 42°C for 30 seconds, 
followed by 2 minutes on ice. I ml of SOC medium was then added to the tube after 
which the culture was incubated at 32°C for 1 hour with shaking. 50 p1 of the mix was 
plated out on LB agar plates containing appropriate selection (for sticky-ended ligation) 
or all of the mix was centrifuged for 2 minutes at 13000 and resuspended in 100 p1 LB 
broth before being plated out (for blunt-ended ligations). The selection plates were then 
incubated at 32°C overnight. 
Soc medium; 5 g/l Yeast extract, 20 g/l tryptone, 10 mM NaCl,, 2.5 mM KCI. This 
solution is autoclaved after which the following compounds are added, 20 mM Glucose, 
10mM MgCl2 , 10 MM MgSO4 . 
7.2.7 Screening of bacterial colonies - Colony lifts 
When high incidence of vector religation were observed in ligations involving compatible 
ends (at both 5' and 3' of the vector and insert fragment ends), or in blunt-ended 
ligations, the ligation of insert into the vector backbone was screened using colony lifts. 
An 8.2 cm Nytran nylon membrane (Schleicher & Schuell) was placed on top of the agar 
plate and orientation marks were made with a needle in both the membrane and agar. 
The membrane was then placed colony side up on Whatmann 3MM paper, presoaked in 
2xSSC, 5% SIDS for 5 minutes. The membrane and Whatmann 3MM paper was then 
microwaved for 2-3 minutes until the colonies had a shiny appearance. The membrane 
was then placed in 2xSSC to wet and then transferred to the probe mix which contained 
the appropriate radiolabelled probe. The agar plates were let at room temperature 
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overnight to allow the colonies to regrow. The next day the membrane was rinsed in 
6xSSC, 0.1% SDS at room temperature, followed by two 10 minute washes in 6xSSC, 
0.1% SDS, after which they were analysed by autoradiography. 
I litre of 2x hybridisation solution; 0.5 g sodium pyrophosphate, 500 ml (20x) SSC, 200 
mis (50x) Denhardt's solution and 100 mg yeast tRNA are added to 800 mIs dH20. This 
solution is stirred and then made up to I litre after which it is filtered and can be stored a 
4°C. 
Probe mix; 50 mIs (2x) hybridisation solution is added to SOmls formamide. The 
radiolabelled probe is then added. 
Denhardt 's solution (50x); 5 g Ficoll, 5 g polyvinylpyrrolidone, 5 g BSA (pentax fraction 
V) is added to 450 ml dH20, stirred and then made up to 500 mls. This is then filtered, 
aliquoted into 50 ml Falcon tubes and stored at 4°C. 
7.2.8 Lysis of ES cells, extraction and digestion of genomic DNA 
500 I cell lysis buffer was added to each confluent well of a six well plate and incubated 
overnight at 37°C for complete lysis to take place. The next day the lysate for each well 
was transferred to 1.5ml eppendorfs and 500 tl isopropanol was added to each tube. 
The tubes were inverted several times until the genomic DNA appeared precipitated. The 
DNA was then removed with a yellow tip and transferred into fresh eppendorf tubes 
containing I ml 70% ethanol. These tubes were inverted several times and the 
precipitated DNA once again transferred to fresh eppendorf tubes containing 1 ml 70% 
ethanol. The tubes were centrifuged at 13000 for 10 minutes after which the 70% ethanol 
was removed and the pellets air-dried for 10 minutes. The DNA was then resuspended in 
200 jil TE and transferred to 55°C block for to facilitate the resuspension process. Tubes 
were flicked every hour for 4 hours and then left at room temperature overnight. The 
next day once the DNA was quantified and digests were set up in 25 id reactions (5 tg 
DNA, 2.5 jil (I Ox) buffer, 2.5 pd (lO)x spermidine at 30mM, 2 jil enzyme made up to 25 
100 
jil with dH20) and incubated at the appropriate temperature. After 3 hours the reactions 
were spiked' with an additional 2 ti of enzyme and incubated at the appropriate 
temperature overnight. 
Cell lysis buffer; 100 mM Tris, 5 mM EDTA, 200 mM NaCl, 2% SDS. At pH 8.5. 
Proteinase K added just before use too 100 g/ml 
7.2.9 Electrophoresis of genomic DNA and transfer onto nylon membrane 
The next day the digested genomic fragments were resolved by gel electrophoresis. The 
digests were run alongside HindIII digested lambda DNA which acted as a marker in the 
future determination of the size of probe hybridised fragments (this marker is not shown 
in data chapter figures), after which the gel was stained with ethidium bromide for 30 
minutes. The genornic DNA within the gel was fragmented with short wave UV light for 
45 seconds after which the gel was placed in denaturing solution (87.66 g NaCl, 20 g 
NaOH made up to I litre in dH 20), for two 20 minutes washes with rocking. After 
rinsing the gel in dH2O it was then placed in neurtralising solution (175. 32 g NaCl, 60.55 
g Tris, made up to 1 litre after adding 1-ICI to ph 8), for two 30 minute washes. 
For transfer of DNA onto Hybond-N+ nylon membrane by capillary action the gel was 
placed on a wick of Whatmann 3MM paper soaked in 20x SSC with the ends of the wick 
in a reservoir of 20xSSC. The nylon membrane was then placed onto of the agarose gel 
followed by 4 sheets of 20xSSC soaked Whatmann 3MM paper. Saran wrap was placed 
around the edges of the gel to cover all areas of the wick that were not in contact with the 
gel. A stack of paper towels were then placed on top of the top sheets of soaked 3MM 
paper followed by a glass plate and a 500 g weight. The transfer assembly was left 
overnight after which the membrane was removed and baked at 120°C for 1 hour to 
cross-link the DNA to the membrane. 
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7.2.10 Random-primed 32P-labelling of oligonucleotides 
32P-labelled probes were produced from 25 ng DNA using Rediprime II Random Prime 
Labelling System (Amersham Biosciences) as according to the manufacturers 
instructions. 
7.2.11 Hybridisation of Southern blot membrane 
For the hybridisation of radiolabelled probe to the nylon membrane, the membrane was 
prehybridised in Church and Gilbert buffer for 1 hour at 65°C. The radiolabelled probe 
was then boiled for 5 minutes after which it was placed on ice for 5 minutes. It was then 
added to the membrane in fresh Church and Gilbert buffer and incubated overnight at 
65°C. The following day the membrane was rinsed in 2xSSC followed by two 10 minute 
washes in 2xSSC, 0,1% SDS at 65°C. After another 20 minute wash in 0.5xSSC, 0.1% 
SDS also at 65°C the membrane was covered in Saran wrap and exposed onto film. 
Church and Gilbert buffer; For 100 mls, SOmls (1M) anhydrous Na 2 HPO4 pH 7.2, 35 mIs 
20% SDS, 2 mIs 0.5 M EDTA, 13 mis H20. 
7.2.12 Reverse transcription 
First-strand cDNA synthesis was performed on 50 ng of total RNA using the 
SuperScriptTM First-Strand Synthesis System for RT-PCR kit (Invitrogen) as according 
to the manufacturers instructions. An additional DNase step was perfomed on the total 
RNA to remove any traces of genomic DNA. The RNase-Free DNase Set kit was used as 
according to the manufacturers instructions. 
7.2.13 Polymerase Chain Reaction (PCR) 
Each PCR reaction contained a final concentration of the following; 200 iM dNTP mix, 
I .iM of each primer, 100 ng template DNA, appropriate dilution of PCR reaction buffer 
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(containing M902) and I unit of Taq DNA polymerase. For amplification of a 0.5 kb 
fragment the following program was cycled 25 times: 94°C; 30 seconds, T,,; 60 seconds, 
72°C 45 seconds, where T, 1 is the annealing temperature of the primer set. 
7.2.14 Antibody staining of ES cells 
Cell monolayers were washed twice in PBS and then fixed for 20 minutes at room 
temperature in 4% PFA (4% PFA in PBS). After a further two washes in PBST (PBS, 
0.1% Triton X-10), blocking solution (3% goat serum, 1%BSA in PBST) was added for 
30 minutes at room temperature. The appropriate dilution of primary antibody was then 
added to the blocking solution and the cells left overnight at 4°C with rocking. The next 
day after three, IS minute washes in PBST, secondary antibody at the appropriate 
dilution was added to the monolayer in blocking solution. The cells were then wrapped 
in aluminium foil incubated for 2-3 hours after which they underwent three, 5 minute 
washes in PBST. 
7.2.15 Immunoblotting by Western protocol 
ES cells were lysed in 100 il of SDS sample buffer (for I ml; 0.5 ml Laemrnli solution, 
0.4 ml dH20, 0.1 ml (1 M) DTT, 10 1.11 (0.5 mM) PMSF protease inhibitor). Cells were 
scraped off the plastic and pipetted into 1.5 ml eppendorf tubes. Genomic DNA was 
fragmented by sonication and samples boiled for 5 minutes at 100°C. Bromophenol blue 
was added to each sample and 20 pd of protein was resolved on 10% Tris-HC1 BioRad 
gels at 20 mA in SDS running buffer. The protein was then transferred onto PVDF 
membrane (Roche) using BioRad gel transfer apparatus. PVDF membrane was activated 
in methanol after which it was soaked in transfer buffer and positioned on top of the gel. 
2 sheets of Whatmann 3MM paper were soaked in transfer buffer and placed on top of 
the PVDF membrane, followed by a transfer buffer soaked sponge. Two more sheets of 
Whatmann 3MM paper and sponge (all pre-soaked in transfer buffer) were positioned on 
the other side of the gel and the stack placed in the transfer apparatus such that the 
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membrane was positioned nearest the anode in relation to the Tris-HCI gel. Transfer was 
carried out at 30 V overnight at 4°C. 
The next day the PVDF membrane was blocked overnight in 10% milk powder in TBST 
at 4°C. The following day the membrane was placed in 5% milk solution (5% w/v milk 
powder in TBST) containing the appropriate dilution of primary antibody, this and all 
subsequent steps were done at room temperature. After incubation for an hour at room 
temperature the membrane was washed for four, 15 minute washes of TBST before being 
incubated in secondary ECLTM  peroxidase labelled antibody. After 1 hour the membrane 
was once again washed for four, 15 minute washes in TBST followed by incubated for 5 
minutes with Supersignal® West Pico Chemiluminescent Substrate. The membrane was 
then covered in Saran wrap and exposed to film. 
Laemmli solution 2x; 4% SDS, 20% glycerol, 120 mM Tris (pH 6.8). Can be stored at 
room temperature. 
lOx SDS running buffer; 250 mM Tris, 1.92 M glycine, 1% SDS in 1 litre dH2O. 
Transfer btfferl litre; I  SDS, 5.8 g Tris, 29 g glycine in 800 mIs dH20. 200 ml 
methanol was added to bring the volume up to I litre. 
TBST; 100 mM NaCl, 10 mM Tris pH 7.5, 0.1% Tween in dHO. 
7.2.16 Sequencing 
Automated sequencing was performed by ICAPB sequencing service using the 
DYEnamicTM ET Terminator cycle sequencing kit (Amersham Biosciences). 
7.3.1 Tissue Culture 
All tissue culture flasks, plates and 10cm diameter Petri dishes were obtained from 
IWAKI. 50 ml and 15 ml tubes were supplied by Corning Incorporated. 20 ml universal 
tubes were supplied by Bibby Sterilin Ltd and Cryotube 1M vials by Nunc. All 
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centrifugations were carried out in a MSE Mistral 1000 Centrifuge unless stated 
otherwise. 
7.3.2 E14TG2a cell line 
The ES cells used in all experiments were EI4TG2a cells, a feeder-independent cell-line 
which relies on an exogenous source of leukocyte inhibitory factor (LIF). These cells are 
karyotypically male and were derived from the E14 cell line by selection for a HPRT 
negative phenotype (in 6-thioguanine selection) as described in (Hooper et al., 1987). 
7.3.3 General tissue culture solutions 
ES cell culture medium (per 550 ml); The following constituents were added to 500 ml 
lx Glasgow Minimum Essential Media (GIBCO); 200 m glutamine and 100 m 
sodium pyruvate (GIBCO), 0. 1 M 2-Mercaptoethanol (Sigma), foetal calf serum 
(GIBCO), 5.5 nil IX MEM non-essential amino acids (GIBCO), 550 tl LIF (I 000x stock 
- see below) 
Leukocyte inhibitory factor (LJF), LIF was prepared by D.Colby at the ISCR by transient 
expression of human L1F expression plasmids in COS-7 cells using the method described 
in (Smith et al., 1991). Serial dilutions of the supernatant were tested on ES cells plated 
in 24-well plates. A 100-fold higher dilution than the minimal dilution required to keep 
ES cells undifferentiated was typically used. Serum batches were tested for their ability 
to sustain the growth, differentiation and viability of ES cells grown at clonal density in 
the presence and absence of LIF. 
Trypsin solution; 250 mg trypsin (Difco) and 372 mg EDTA disodium salt (Sigma) was 
dissolved in I litre of PBS. 10 ml chicken serum (Flow Labs) was then added and the 
solution filter sterilised. The trypsin was stored in 20 ml aliquots at —20°C. 
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1% gelatin; I g of gelatin was dissolved in 100 ml H20. The solution was then 
autoclaved and stored in 20 ml aliquots at 4°C. For a working solution of 0.1%, 10 ml of 
1% gelatin was added to 90m1 PBS. 
0.1M2-mercapioethanol; 100 ml 2-mercaptoethanol (Sigma) was added to 14.1 ml PBS. 
This was stored for up to a month at 4°C. 
2x Freezing solution; 4 ml of DMSO added to 16 ml of cell culture medium and filter 
sterilised. The solution was stored for up to a month at 4°C. 
Quench; An equal volume of serum was added to ES cell culture medium 
7.4.1 Growth conditions during ES cell culture 
Methods for routine culture of ES cells are based on those described in Smith, e. al. 1991. 
Briefly, ES cells were maintained in a humidified incubator (l-leraeus) at 7.5 % CO2 and 
37°C. All ES cell manipulations were carried out in a laminar flow sterile hood (ICN, 
flow). All solutions were warmed in a 37 °C water bath prior to use. Tissue culture grade 
flasks and dishes (Coming) were gelatin coated (0.1 % in PBS, Sigma) and then aspirated 
before use. ES cell manipulations methods varied depending on whether the cells were 
being grown in flasks and dishes or in 96 well plates, usually following clonal selection 
of ES cells. This section describes both methods. 
7.4.2 Passage, expansion and freezing of ES cells 
ES cell culture medium was changed every other day and cells were most commonly 
passaged at a confluence of 80-90% coverage of the culture vessel surface. Once this 
confluence was reached, cells were washed twice in PBS after which trypsin was added 
to the monolayer (approximately I ml/25cm 2) and the cells incubated at 37°C for 
approximately 2-3 minutes. After this time the flask was tapped gently and then 
inspected to ensure that the cells were completely dislodged from the culture vessel 
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surface. If the cells were not appropriately dislodged the flask was returned to the 
incubator. The typsinisation process did not proceed for longer than 5 minutes. 
Once dislodged the cells were made into a single-cell suspension with pipetting and then 
transferred to a universal. The flask was rinsed with an equivalent volume of ES cell 
culture medium and this was also transferred to the universal to inhibit the trypsinisation 
process. The cells were centrifuged at 1200 rpm for 3 minutes, and the cells resuspended 
in new ES cell culture medium and passaged into a new culture vessel at appropriate 
ratios (between 1:2 and 1:6), depending on experimental requirements. 
For freezing of ES cells, after centrifugation cells were resuspended in an appropriate 
amount of ES cell culture medium followed by the equivalent volume of 2x freezing 
solution (2x freezing solution; 20% DMSO ES cell culture medium), after which the 
solution was aliquoted into lml cryovials. For example for a well of a 6 well plate, after 
trypsinisation and centrifugation cells were resuspended in 500 j.tl of ES cell culture 
medium. 500 .xl of 2x freezing solution was then added and cells mixed gently. This 
cell-suspension was then transferred into a cryovial and place at -80°C. The next day, 
(and no later than 2 months) the vial was transferred to liquid nitrogen for long term 
storage. 
7.4.3 ES cell passage, expansion and freezing in 96 well plate format (1:5 passage) 
The cell monolayers in each well of the 96 well plate were washed twice in PBS using a 
multichannel pipette. 30 j.tl of trypsin was added to each well and the cells incubated as 
described above. Once the cells were dislodged from the surface of the plate they were 
made in a single cell suspension by pipetting. 70 tI of Quench media (1:1 serum:ES cell 
culture medium), was then added to each well to inhibit the trypsinisation process. 20 p1 
was then added to a pre-prepared 96 well plate (gelatinised and 180 p1 ES cell culture 
medium per well), for 1:5 passage. The remaining 80 p1 of ES cell suspension was often 
frozen at this point (addition of 80 p1 2x freezing solution and storage at -80°C) and 
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appropriate wells thawed upon determination of correct targeting by Southern blot 
hybridisation. 
7.4.4 Revival of frozen ES cells 
The cells were retrieved from the -80°C freezer or liquid nitrogen storage and kept on dry 
ice until the point of thawing. The vial was held in the 37°C waterbath until the liquid 
began to thaw and then the cells were transferred to a universal and centrifuged at 
1000rpm for 3 minutes. The cells were then resuspended in ES cell medium and 
transferred into an appropriate tissue culture vessel. 
7.4.5 Revival of frozen ES clones from a 96 well plate 
The 96 well plate was retrieved from the -80°C freezer and kept on dry ice until the point 
of thawing. 100 tl ES cell culture media was added to the wells that were to be thawed. 
When the cells began to thaw the suspension was transferred into the preprepared well 
(gelatinised and containing ES cell culture media) of a 24 well plate. 
7.4.6 Vector preparation of plasmid DNA for targeting experiments 
75 tg of targeting vector DNA was linearised with the appropriate restriction 
endonuclease, and the protein susequently removed from the digest by phenol/chloroform 
extraction. The DNA was precipitated in one-tenth volume of sodium acetate and two 
volumes of 100% ethanol for 20 minutes at -20°C, and then pelleted by centrifugation at 
13000 rpm for 10 minutes. 1 ml of 70% ethanol was pipetted into the eppendorf tube 
after which it was transferred to the laminar flow hood. The 70% ethanol was removed 
by aspiration and the pellet air-dried for 5 minutes. The linearised DNA was then 
resuspended in 100 jtl PBS. 
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7.4.7 Transfection of ES cells by electroporation protocol 
Cells were grown to confluency in two 150 cm  tissue culture flasks. The cells were 
washed twice in PBS and then trypsinised as described above. After centrifugation at 
1000 rpm for 5 minutes cells were pooled and resuspended in a total of 10 nils of PBS 
and then counted. The volume of cell suspension containing Ix 108  cells was transferred 
into a fresh universal and repelleted by centrifugation. This pellet was then resuspended 
in PBS to give a total volume of 500 j.il. 100 .il of PBS containing the resuspended 
linearised plasmid DNA (see section) was added to the cells and carefully mixed by re-
pipetting. The cells were then transferred to a 0.4 cm electroporation cuvette and capped. 
The cuvette was pulsed in a BioRad Gene Pulsar unit set a 3 iF, 0.8 kV. Cells were left 
for 10 minutes to recover and then transferred to a 20 ml universal containing lOmi ES 
cell culture media. This cell suspension was then transferred into two preprepared 150 
cm  flasks (gelatinised and containing 45mls medium). Cells were incubated for 24 
hours before clonal selection was added. 
7.4.8 HAT selection of targeted EI4TC2a ES cells 
The targeting of hprt correctional vectors into E14TG2a cells yielded HPRT positive 
clones owing to the reconstruction of a full hpri ORF upon correct integration of vector 
sequences (as they encoded the hprt promoter sequence, and exons 1, 2, which are absent 
in EI4TG2a cell owing to a deletion within the 5' region of the gene). HAT selection 
medium, selects the HPRT positive clones. The day after electroporation appropriate 
numbers of 10 cm diameter culture dishes were prepared by gelatinisation, and addition 
of 9 mIs of ES cell culture and 200 j.tl (50x) HAT selection. Cells were washed in PBS 
and trypsinised as described above. After pelleting by centrifugation at 1200 rpm for 5 
minutes the cells were pooled and resuspended in I Omls ES culture media, after which 
live cells were counted. The volume of cell suspension was adjusted to obtain a 
suspension of5xl0 6  cells/ml, repelleting the cells if necessary. Serial dilutions were 
made with culture media, e.g 5x10 6 cells, 2.SxlO6 cells, I.2SxlO6 cells, and I ml aliquots 
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of each dilution were added to the prepared 10 cm culture dishes. Selection was applied 
for 10 days before ES cell colonies were picked. 
HATselection medium; Effective concentration in ES cells Hypoxanthine 0.1 mM, 
Aminopterin 0.4 jiM, Thyrnidine 16 jiM 
7.4.9 6-TG selection of targeted ES cells 
6-Thioguanine selection was use to select for HPRT negative clones after the targeting of 
the M42 vector to the 3' region of hprt (this targeting event resulted in the disruption of 
the hprt ORF). Cells were passaged when needed for 7 days after electroporation to 
allow sufficient time for any HPRT protein present before electroporation to be degraded. 
Cells were then plated out a clonal density in prepared 10 cm diameter culture dishes 
containing 6-TG (final concentration 10 mM) in ES cell media. Selection was applied for 
6 days before ES cell colonies were picked. 
7.4.10 Picking ES cell colonies 
After the clonal expansion of ES cells in appropriate selective media, visible, discrete 
colonies of cells were observed. To isolate the colonies and expand for DNA analysis 
and storage, the 10 cm diameter plate was washed once in PBS, after which Smls of PBS 
was added. Using a pipette, the colonies were isolated and transferred into single wells 
of  96 well plate. 
7.4.11 Transient transfection of ES cells by LipofectamineT!I  protocol 
For all transient transfections lx 106  cells were washed in PBS, trypsinised and pelleted, 
after which they were resuspended in 2 mIs ES cell culture medium and transferred into a 
gelatinised well of a 6 well plate and placed in the 37°C incubator. 3 jg of DNA (to be 
transfected) was resuspended in 250 jil of ES cell culture media lacking serum and in a 
separate eppendorf tube 3 j.d Lipofectamine' TM 2000 was mixed in another 250 j.il ES cell 
culture media lacking serum. After 5 minutes incubation at room temperature the 
lipofectamineTM  2000 and DNA containing media was mixed by gentle pipetting and 
incubated for a further 20 minutes at room temperature, after which it was added to the 
cell culture and mixed by gentle rocking of the plate. 
7.4.12 Luciferase analysis 
Used in the analysis of the CMVins and CMVrep cell lines. Transient transfections were 
carried out in the wells of a 6 well plate. 1x10 6 cells were cotransfected with pBl-L 
(reporter plasmid containing TRE-linked firefly-luciferase) and ptk-renilla (encoding 
renilla luciferase linked to an HSV thymidine kinase promoter - this acted as an internal 
control for the transfection) using LipofectamineFM 2000 as described above. Two 
transfections were carried out for each cell line. The next day dox (1 tg/ml) was added 
to one of the wells. 48 hours after the addition of dox cell monolayers were lysed and 
analysed for firefly luciferase and renilla luciferase using the Dual-Luciferase® Reporter 
Assay System and a plate-reading luminometer (Mediators PhL). Deviations from the 
manufactures protocol are as follows: cells were lysed in 250 jd of passive lysis buffer 
instead of the recommended 500 d, and 50 p1 of LARII and Stop & Gb® reagent were 
used instead of 100 p1 
7.4.13 Preperation of cells for immunoblotting 
lx 106  cells were plated out into well of a 6 well plate in the presence or absence of I 
ig/ml dox as according to experimental procedure. After 60 hours the cells were placed 
in media lacking serum or LIF cytokine (serum starved), and incubated overnight. The 
next morning cells were either left untreated, or stimulated with LIF cytokine, at a 1:1000 
dilution (see above) or FGF4 (recombinant human - R&D systems) to a final 
concentration of 25 ng/p1 for 15 minutes, after which they were washed once in cold PBS 
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